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Abstract 
The most debilitating symptoms for patients with neuropsychiatric disorders, such as 
schizophrenia, are often cognitive deficits; yet they remain largely untreated by current 
medications. In preclinical animal models, the techniques used to measure cognitive 
deficits need to be improved to enhance our ability to screen novel drug targets and gain a 
better understanding of the neurobiological correlates of cognitive dysfunction. Therefore, 
the aim of this thesis was to develop and test a new high throughput cognitive task in 
rodents. I have designed a novel Signal Detection Task (SDT) for this purpose. 
The first aim in developing the SDT was to compare alternative tasks (such as the 5-
choice serial reaction time task) and address limitations including the extensive training 
time required and the lack of control over body position during stimulus presentation. 
Experiments were then selected to assess the face, construct and predictive validity of the 
SDT for measuring attentional deficits relevant to schizophrenia. Specifically, I determined 
if the effects of genetic, environmental, neurobiological and pharmacological manipulations 
could be detected in rats using this task. The SDT was conducted in rat operant chambers 
with a series of task variants to probe different components of performance, such as 
increasing detection difficulty and distraction. Briefly, the studies conducted compared 
strains (genetics), housing conditions (environment), the impact of a prefrontal cortical 
lesion (neurobiology) and the effects of amphetamine (pharmacology) on task 
performance. My findings indicate a relatively short training period was required for rats to 
perform the SDT with a high level of accuracy compared to other tasks; task acquisition 
was shown to be dependent on interactions between genetics and environment; prefrontal 
cortical lesions did not alter baseline performance but impaired attention during distraction 
and low dose amphetamine significantly improved accuracy. I demonstrated for the first 
time that the procognitive effects of amphetamine were dependent on baseline attentional 
performance. In addition, I found that individual variation in baseline performance was 
related to dopamine metabolism in the striatum. 
The research outlined in this thesis presents a novel tool for researchers exploring the 
cognitive phenotype of animal models relevant to neuropsychiatric disorders and for 
exploring the neurobiology of attention, including mechanisms of action for procognitive 
medication.
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 2 
1.1 Introduction 
Cognitive deficits are considered core features of schizophrenia yet they remain largely 
untreated (Keefe et al., 2007; Keefe and Fenton, 2007). This is despite evidence showing 
they are one of the strongest predictors of patient outcomes and a surge of research in 
this field over the last decade (Green et al., 2000). One solution for overcoming the 
‘translational bottleneck’ hindering the development of new medications may be the 
refinement of preclinical animal tasks used for measuring cognitive outcomes (Hyman and 
Fenton, 2003; Hyman, 2014; Young and Geyer, 2015). If animal models were more 
successful in detecting procognitive drug targets and for improving our basic 
understanding of cognitive deficits, this should lead to greater success in subsequent 
clinical trials. The research presented in this thesis focuses on the development and 
validation of a task for measuring attention in animal models with relevance to 
schizophrenia. 
1.2 Schizophrenia 
Schizophrenia is a disabling group of brain disorders affecting approximately 1% of the 
population worldwide (McGrath and Susser, 2009; Tandon et al., 2009; Javitt, 2010). It is 
characterised by positive, negative and cognitive symptoms. Positive symptoms include 
experiences such as hallucinations and delusions. Negative symptoms involve the lack of 
normal feelings or behaviours such as reduced speech, flattened affect and reduced 
motivation (Tandon et al., 2009). Cognitive symptoms include impairments across a range 
of domains and are central to the topic of this thesis. 
The onset of schizophrenia typically occurs during adolescence and early adulthood, 
however this is often preceded by a prodromal phase. During the prodromal phase, 
psychotic symptoms do not reach diagnostic criteria and yet cognitive deficits may already 
be evident (Tandon et al., 2009). Schizophrenia is a leading cause of disability and suicide 
rates are 12 times higher in people with this diagnosis (Rezvani et al., 2002). Substance 
abuse, including the use of nicotine, alcohol, cannabis and cocaine, are common in 
schizophrenia patients (Green et al., 2004a). These factors combined with the increased 
rates of somatic diseases such as heart disease and diabetes, lead to increased morbidity 
and mortality in patients with schizophrenia (Caldwell and Gottesman, 1992; Rezvani et 
al., 2002; Saha et al., 2007; Koychev et al., 2011). No diagnostic biomarker has been 
detected thus far and symptomology can vary greatly between patients (Tandon et al., 
Chapter 1. Introduction 
 3 
2009). In the 1950’s the first antipsychotic, chlorpromazine, was discovered and this led to 
the development of many other D2 antagonist-based medications (Agid et al., 2008). 
Antipsychotic medications often lead to unacceptable side effects (e.g. tremor, tardive 
dyskinesia) and show greatest efficacy in reducing positive symptoms with very little 
improvement in negative or cognitive symptoms (Marder and Fenton, 2004; Agid et al., 
2008; Carpenter and Koenig, 2008). In the 1970’s, the introduction of clozapine appeared 
to have superior efficacy for those with treatment resistance, which was followed by the 
introduction of a second generation of ‘atypical’ antipsychotics (Kapur and Remington, 
2001). These antipsychotic medications have a different side effect profile (e.g. obesity) 
and they were initially thought to be more effective in the treatment of cognitive symptoms, 
however results of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) 
study suggested this is not necessarily the case (Keefe et al., 2007). Despite the lack of 
progress that has been made in recent years, improving the treatment of cognitive 
impairments remains a priority for the field (Abbott, 2010; Hyman, 2014; Young and Geyer, 
2015). 
1.3 Cognitive deficits 
Cognitive deficits often appear early in the development of schizophrenia and performance 
remains relatively stable when tested across different phases of disease progression 
(Rund, 1998; Nithianantharajah and Hannan, 2006). Patients have impairments across a 
number of cognitive domains, such as memory, attention, executive function, speed of 
processing and verbal memory (Marder and Fenton, 2004; Nuechterlein et al., 2004; Goff 
et al., 2011). This array of deficits may reflect specific areas of difficulty or more global 
cognitive dysfunction (Lesh et al., 2011). Poor cognitive performance has also been 
reported in un-affected relatives, which suggests that shared familial (e.g. genes, shared 
environment) factors contribute to impaired cognition in affected families (Harris et al., 
1996; Cannon et al., 2000; Snitz et al., 2006). Despite cognitive dysfunction playing a 
prominent role in schizophrenia, they are not included in the DSM-V criteria (Widiger, 
1994; Keefe and Fenton, 2007). Functional patient outcomes have repeatedly been shown 
to correlate more strongly with cognitive performance than psychotic symptoms, yet 
antipsychotic medications are only effective in treating positive symptoms (Green et al., 
2000; van Praag et al., 2000; Kapur and Remington, 2001; Marder and Fenton, 2004; 
Keefe et al., 2007; Floresco and Jentsch, 2011; Simpson and Kelly, 2011). As positive 
symptoms represent only a portion of the disease state, it is not surprising that 
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therapeutics have had limited success in improving the long-term prognosis for 
schizophrenic patients (Marder and Fenton, 2004). 
With the lack of success in developing new medications, the MATRICS (Measurement and 
Treatment Research to Improve Cognition in Schizophrenia) initiative was developed to 
improve the transition from basic research to clinical outcomes and guide research 
investigating the treatment of cognitive deficits in schizophrenia (Green and Nuechterlein, 
2004). They determined that cognitive deficits in schizophrenia were best measured 
across 7 domains: speed of processing, attention/vigilance, working memory, verbal 
learning, visual learning, reasoning and problem solving, and social cognition 
(Nuechterlein et al., 2004). Based on these domains, a battery of the most promising 
clinical tasks was selected (Nuechterlein et al., 2008). Following this, the CNTRICS 
(Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia) 
initiative was formed to further these recommendations and address the need for 
translation between basic animal and human research (Carter et al., 2008). With the 
introduction of these recommendations, there has been an increasing focus on improving 
translation between rodent and human studies (Keeler and Robbins, 2011; Bussey et al., 
2012b; Homberg, 2013; McKenna et al., 2013; Young et al., 2013a; Young and Geyer, 
2015). The translation of clinically relevant tests may prove to be a highly valuable tool in 
the assessment of animal models and in the development of therapeutics (Barak and 
Weiner, 2011; Pratt et al., 2012). Human studies are often limited to observational data, 
while rodent-based studies allow researchers to ask more invasive questions using well-
controlled experimental designs. However, schizophrenia is challenging to model since 
there are no diagnostic biomarkers and many of the symptoms (e.g. hallucinations, 
delusions) cannot be modelled in rodents. However, given many cognitive abilities can be 
assessed in rodents and the broader affliction of these deficits among high-risk individuals, 
cognitive testing may be one of the best ways to validate animal models of schizophrenia 
(Pratt et al., 2012). 
1.4 Rodent models of Schizophrenia 
Rodent models of schizophrenia have used pharmacological, neurodevelopmental or 
genetic manipulations, as well as interactions of genetic and environmental manipulations. 
Schizophrenia is a heritable disorder and there was hope that gene-targeted approaches 
would generate clear candidates. However, the last 10 years of research has painted a 
much more complicated picture. Genetic rodent models will be critical in understanding the 
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role of specific genetic modifications associated with schizophrenia, but it is clear no single 
gene is responsible for the development of this disorder (Kellendonk et al., 2009; Wray 
and Visscher, 2010; Pratt et al., 2012). 
Many animal models of schizophrenia have been developed based on epidemiological 
evidence to assess risk factors thought to be associated with the disorder, and also to 
improve our understanding of the altered neurobiology (van den Buuse et al., 2005; 
Arguello and Gogos, 2006) (see database by Koenig et al. at 
http://schizophreniaforum.org/res/models/default.asp for further details). Key models in 
rats include developmental perturbations such as maternal infection (e.g. maternal 
immune activation (MIA) with PolyI:C (polyriboinosinic-polyribocytidilic acid)), 
developmental manipulations (e.g. developmental vitamin D deficiency) and anatomical 
alterations (e.g. neonatal ventral hippocampal lesioning) (Jones et al., 2011). 
Pharmacological schedules using repeated administration of psychomimetics such as 
amphetamine, phencyclidine (PCP) and MK-801 have also been widely used (Lillrank et 
al., 1995; Marcotte et al., 2001; Boksa and Luheshi, 2003; Lipska, 2003; Rung et al., 2005; 
Amitai et al., 2007; Meyer and Feldon, 2010). These animal models attempt to reflect 
features of interest to clinical schizophrenia, including sensitivity to drug administration, 
and behavioural changes in tasks designed to measure traits such as attention, memory 
and sensorimotor gating (Pratt et al., 2012). 
Unfortunately animal models have not been as useful as anticipated for developing and 
testing new antipsychotic medication. The use of drugs that appeared promising in 
preclinical studies have resulted in many failed clinical trials (Sarter et al., 1992b, a; Barak 
and Weiner, 2011). This major shortcoming added to the momentum for the formation of 
MATRICS and CNTRICS (Buchanan et al., 2005; Carter et al., 2008; Piontkewitz et al., 
2012). Testing in rodent models has proven central in the development and screening of 
therapeutics for a range of diseases. Without adequate tools for the assessment of 
cognitive deficits relevant to schizophrenia, the development of procognitive medications 
will be limited. 
Attention and vigilance is one of the cognitive domains identified by MATRICS with 
potential for measurement in humans and rodents (Nuechterlein et al., 2004). One of the 
human tasks selected for further development include variants of the Continuous 
Performance Task (CPT) (Carter et al., 2012). The CPT is a sustained attention task 
requiring participants to monitor a stream of stimuli and respond to targets. The robust 
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changes that have been detected using CPTs have lead to the suggestion that CPT 
deficits could be considered an endophenotype of schizophrenia, fitting the Gottesman 
and Gould (2003) criteria (Gottesman and Gould, 2003; Gur et al., 2007). The CPT 
protocol has been widely used with results robustly demonstrating deficits in people with 
schizophrenia and first-degree relatives (Snitz et al., 2006; Delawalla et al., 2008; 
MacDonald, 2008; Richard et al., 2013). Deficits have been shown to be stable from 
before first-episode of psychosis, during medication and remission, and performance 
errors do not correlate with psychotic symptoms in non-schizophrenia patients 
experiencing psychosis (Snitz et al., 2006; Richard et al., 2013). Together these findings 
suggest that deficits on CPT are at the foundations of this disorder. Deficits also correlate 
with the economic cost of the disorder in terms of loss of productivity and carer expenses, 
demonstrating the link between cognitive deficits and functional outcomes for patients (Ko 
et al., 2003). 
1.5 Rodent tasks 
1.5.1 Current tasks 
The closest equivalent tasks to human CPT testing in rodents are the 5-choice serial 
reaction time task (5CSRTT), the 5-choice continuous performance task (5C-CPT), the 
sustained attention task (SAT) and more recently the touchscreen CPT task (McGaughy 
and Sarter, 1995a; Bari et al., 2008; Young et al., 2009b; Kim et al., 2015). The 5CSRTT, 
5C-CPT and SAT were recommended by CNTRICS for further development (Lustig et al., 
2013). To date, results from the touchscreen CPT have only been reported in a single 
study in mice (Kim et al., 2015) and although further studies in rats were indicated in a 
review (Hvoslef-Eide et al., 2015), they have not yet been published. This task may be a 
promising new avenue for research in the future, however the lack of data limit 
comparisons being made with the other more widely used tasks at this point in time. The 
5CSRTT and 5C-CPT require rodents to attend to a spatial array of 5 holes and make a 
nose poke response when one hole illuminates. Each trial starts with either a fixed or 
variable inter-trial interval and if the rodent makes an impulsive nose poke response during 
this time, there is a time out period imposed. They also experience a time out for selecting 
the incorrect hole, but they receive an appetitive reward for selecting the correct hole. 
Omissions occur when the rodent does not respond within a limited hold period following 
stimulus presentation. The 5C-CPT differs by including a subset of trials where all 5 holes 
illuminate to indicate the rodent should withhold from making a response and therefore 
Chapter 1. Introduction 
 7 
includes a measure of response inhibition. The SAT differs in that the rodent is required to 
attend to a single stimulus and respond on one of two levers to indicate the presence or 
absence of a light presentation. This protocol is commonly presented with a distractor 
manipulation (dSAT), where a flashing houselight is presented during a block of trials. 
Each task has unique advantages and disadvantages. For example, the 5CSRTT has 
been more widely used and validated compared to the 5C-CPT and SAT. However, the 
5C-CPT and SAT can easily be analysed using signal detection theory indices that are 
commonly used in human CPT studies. Although the SAT results in far fewer omission 
responses than the 5CSRTT and 5C-CPT, the application of this task to mice has been 
challenging (Martin et al., 2006; St Peters et al., 2011a). However, mice have been used in 
both the 5CSRTT and 5C-CPT (Young et al., 2009b; Harms et al., 2012; Sanchez-Roige et 
al., 2012). With a focus on translational testing, it is important to acknowledge that each of 
these protocols have similarities and differences when compared to human CPT testing. 
1.5.2 Comparison with human CPT 
There are a number of variants of the human CPT, for example the AX-CPT and identical 
pairs versions, which have been found to be sensitive to discriminating deficits in 
schizophrenia patients (Cornblatt and Keilp, 1994). Considering the substantial differences 
between rodent and human testing, I will consider a generic CPT-type task structure rather 
than aiming to replicate a specific CPT variant. Therefore, key features to be replicated are 
the rapid presentation of a single stimulus where a decision about signal and non-signal 
events determines the subject’s response. In addition, the subject should maintain 
attention towards the source of the stimuli and respond appropriately with minimal 
deviation away from the task. To achieve these behavioural goals in a rat, some features 
must in fact be deliberately different from the human CPT. As an example, in human 
CPT’s the use of externally controlled fast stimulus pace is potentially a very important 
element required to induce errors. However, in rats, a faster pace can be achieved by 
allowing self-initiation of trials with minimal delays imposed. Rats may have trouble 
maintaining task rhythm with a fixed, fast trial pace. However, by removing delays and 
allowing self-initiation of trials the rat can rapidly complete trials without losing track of the 
order of events. Differences in protocol design may in fact lead to more similar behaviour 
when species-specific requirements have been considered. 
1.5.3 Body position and movement 
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A major difference between human CPT and rodent operant testing is the body position of 
the subject. Human subjects can be instructed to sit, facing a computer screen and 
maintain attention to detect a target stimulus. In contrast, a rodent may move freely around 
the chamber and perform alternative behaviours, such as grooming and even sleeping, 
during testing. The researcher cannot know whether the rodent was looking at the stimulus 
when it was presented or control the rat’s proximity to the stimulus. This may lead to 
incorrect responses due to poor visual angle rather than a lapse in attention. Indirectly, 
perhaps moving around the chamber is a form of inattention. However, it is not a brief 
lapse in vigilance and appears due to a loss of task-oriented goals. These alternative 
behaviours may even be considered ‘rest breaks’. This problem is exacerbated in the 
5CSRTT, 5C-CPT and SAT tasks by delivery of the reward on the chamber wall opposite 
to the stimulus presentation, encouraging lapping behaviour in rodents across the 
chamber between trials (McGaughy and Sarter, 1995a; Bari et al., 2008; Young et al., 
2009b). In addition, these three rodent tasks typically use relatively long inter-trial intervals 
and combined with imposed delays for reward collection and time out periods, the trial-to-
trial interval is much longer than human CPT testing. Therefore in this study, I aimed to 
reduce excessive ambulation around the chamber and minimising delays between trials to 
decrease incongruous behaviours. 
1.5.4 Omissions 
Omissions can occur in rodents because they missed the stimulus presentation, but also 
because they were performing a competing behaviour such as grooming. Omission rates 
typically increase with drug administration and are virtually impossible to distinguish from a 
withheld response on the 5C-CPT. Although there are relatively few omissions on the 
dSAT, omissions can occur on up to 20% of trials on the 5CSRTT. Omission errors on 
human CPT’s can be very informative as an indicator of a lapse in vigilance, however 
because an omission in rodent testing can occur for a plethora of other reasons, the 
interpretation and cross-species comparison of this measure is complicated. In addition, 
the requirement for responding on every trial will be used in the rodent paradigm. Many, 
but not all, human CPT’s instruct the subject to respond to targets and inhibit responding 
to non-targets. Given a lack of response in rodents cannot always be attributed to a 
deliberate choice to withhold responding, a forced choice design may be more beneficial in 
rodents. Even though response inhibition is an important aspect of cognitive assessment, 
it was not the focus of this task. Therefore, one goal was to reduce the rate of omissions. 
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1.5.5 Stimulus properties 
Next the type of stimulus must be considered. In human CPT’s, visual stimuli is most 
common, however there are auditory versions as well (Earle-Boyer et al., 1991; Riccio et 
al., 2002). Rodents do not have the visual capacity to perform human tasks using similar 
visual stimuli (Prusky et al., 2002). Rodents do not appear to identify colours, shapes and 
images in the same way as humans, although cognitive processing of images may be 
more advanced in rodents than generally assumed if sufficient training is provided (Jacobs 
et al., 2001; Zoccolan et al., 2009). Other sensory stimuli, such as olfactory cues, may be 
more informative or more easily acquired in rodents (Slotnick, 2001). However, a visual 
stimulus is advantageous in terms of control, both spatially and temporally, as compared 
to the presentation of olfactory stimuli. When testing many rodents simultaneously in the 
same room, a visual stimulus is unlikely to cause interference between animals compared 
with an auditory signal. Even with the use of sound attenuating chambers, the motoric 
sounds of a pellet dispenser can still be clearly heard throughout the room. Therefore, 
visual stimuli were used in the studies in this thesis. Species-specific differences in visual 
abilities must be considered when selecting appropriate stimuli. Due to the vast 
differences between rodents and human visual systems and the cognitive encoding of 
visual information, the presentation of stimuli will need to be carefully considered. At this 
point it should be noted that determining the correct choice based on the presentation of a 
single stimulus is likely to require different processes to the comparison and selection of 
two stimuli that are simultaneously presented. The use of an internalised rule, pairing a 
stimulus with the appropriate response in the human CPT is not replicated in the 5CSRTT 
where the location guides the response. In contrast, the 5C-CPT includes a rule about 
responding or inhibiting a response depending on the stimulus presented. And the SAT 
does require the rat to learn the association between different stimulus properties and the 
correct response, like the human CPT. Responding to the location of a stimulus is quite 
different to recognising features of a stimulus to respond correctly. Furthermore, identifying 
a stimulus without the opportunity to directly compare stimuli features may also require 
different cognitive processes. As construct validity is critical to translational testing and the 
aim was to maintain similar cognitive processes, stimuli were presented individually and 
rats were trained to make an association between the stimuli and response location. 
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1.5.6 Training 
Other differences between human and rodent testing include the training technique and 
time to perform the task. Firstly, rodents require weeks or months of training to complete 
studies using tasks such as the 5CSRTT, whereas human subjects receive instructions 
prior to testing and complete the task within a single session. The instructions provided to 
human subjects are carefully selected and humans generally have ample life experience 
to perform CPT-type tasks without difficulty. However studying cognition in humans brings 
a different set of challenges in terms of compliance, misunderstanding or different 
values/goals. On the other hand, rodents usually have no experience in learning tasks and 
are likely to have minimal handling or exposure to difference environments prior to testing. 
So despite obvious differences in the ability to follow instructions, the prior relevant 
experience of human and rodent subjects are also substantially different. Needless to say, 
the extensive time required to train rodents is rate limiting and impedes high throughput 
preclinical drug studies. A further aim of this study was to reduce training time in rats, while 
maintaining task validity. 
1.5.7 Motivation 
A second major difference between human and rodent testing is the form of reward. To 
motivate rodents to perform operant tasks, appetitive rewards are provided after every 
correct trial and animals are normally further motivated using a food-restricted dietary 
schedule. On the other hand, human subjects may be motivated by money, course credit 
or psychological assessment. They may or may not receive feedback on a trial-by-trial 
basis and expectations may play a role in how much effort they expend. These differences 
cannot be easily overcome. Rodents require feedback after each trial to learn, particularly 
during task acquisition. Ultimately, if the subject is trying to respond correctly then the 
purpose of the motivator is accomplished. Therefore, a reward that leads to a high level of 
accuracy and trial completion will be used. Based on all the differences outlined above, a 
series of goals were defined for the development of a novel rodent attention task. To 
achieve these goals, species-specific behaviours were considered and protocol 
parameters and equipment were carefully chosen. 
1.5.8 Attention 
The main point in developing comparable tasks is to maintain the cognitive construct being 
measured, even after changing the stimulus input, the type of response and the training 
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protocol to suit species-specific abilities. The construct of attention can be further divided 
into many sub-types, including vigilance or sustained attention, divided attention and 
selective attention (Chudasama and Robbins, 2004). As the human CPT may be best 
described as a measure of vigilance or sustained attention, this was also a focus in the 
development of a rodent paradigm. A sustained attention task required the subject to 
maintain attention to a rather monotonous task in order to detect and respond to signals. 
Although the task may be best categorised as a measure of attention, there are a number 
of other outcomes that are generated by the CPT. 
As with the human CPT, the rodent 5CSRTT and 5C-CPT measure attention, impulsivity, 
perseveration, response times and vigilance; with the 5C-CPT also measuring response 
inhibition. Human analogues of the rodent 5CSRTT have also been developed, including 
the CANTAB 5-choice task (Barnett et al., 2010), the spatial attentional resource allocation 
task (SARAT) (Hahn et al., 2012) and 4-CSRTT for humans (Worbe et al., 2014). The 
5CSRTT, 5C-CPT and the dSAT were identified by CNTRICS as having face, predictive 
and construct validity when compared to the human CPT (Young et al., 2009a; Lustig et 
al., 2013). More recently the translational value of the 5C-CPT was demonstrated by 
comparing drug-induced deficits in mice to the performance of schizophrenia patients on 
comparable version of the 5C-CPT (Young et al., 2013b). However, there are still a 
number of differences between the rodent and human versions of CPT including the 
spatial nature of stimuli and the speed of stimuli presentation. A critical goal for rodent 
tasks is being able to predict and detect drug targets for therapeutic use. Unfortunately, 
despite widespread use of task such as the 5CSRTT and major advances in 
understanding the neurobiology required for task performance, there has been limited 
success in discovering clinically effective novel drug targets (Robbins, 2002; Abbott, 2010; 
Hyman, 2014; Young and Geyer, 2015). Drugs that are known to have procognitive effects 
in humans, such as low doses of amphetamine (Wolraich et al., 2005), have not 
consistently demonstrated enhancement of performance in healthy, adult rodents on 
5CSRTT (Bizarro and Stolerman, 2003). Therefore, further development of these 
(5CSRTT, 5C-CPT, dSAT) and novel tasks for rodent have been suggested, along with a 
series of recommendations to guide researchers (Pratt et al., 2012; Lustig et al., 2013). 
1.6 Validation of rodent tasks 
The translational validity of rodent tasks has been determined by a number of factors, 
including the involvement of homologous brain regions, response to psychoactive drugs, 
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similar response to manipulations of the task and response to factors known to alter 
performance (Young et al., 2009a; Lustig et al., 2013). The value of a task is often 
determined by assessing face, construct and predictive validity and here these ideas will 
be applied to the comparison of human and rodent tasks. Face validity indicates the 
similarity between tasks in appearance or design. Construct validity provides an indication 
of whether the tasks are measuring the same underlying function. Finally, predictive 
validity requires the results of the rodent task to be indicative of the response in humans, 
particularly in terms of drug effects (Homberg, 2013). In the case of 5CSRTT, construct 
validity has been demonstrated as the prefrontal cortex (PFC) and thalamus are involved 
in task performance (Muir et al., 1996; Baunez and Robbins, 1999; Passetti et al., 2003); 
reflecting the importance of these brain regions in human CPT performance (Salgado-
Pineda et al., 2003; Young et al., 2009a). The 5CSRTT has also been shown to detect the 
attentional impairments that occur with ageing and sleep deprivation, which are known to 
alter attention in humans (Grottick et al., 2003; Cordova et al., 2006). Although low doses 
of amphetamine have been shown to reverse cognitive deficits in aged rats (Grottick and 
Higgins, 2002; Bizarro and Stolerman, 2003), reports of the positive effects of nicotine 
demonstrate the predictive validity in the 5CSRTT (Young et al., 2004). Predictive validity 
is further demonstrated by manipulations of the rodent task based on factors that alter 
performance on CPT in humans; for example reducing the stimulus duration (Grottick and 
Higgins, 2002). The translational value of the novel task developed in this thesis was 
determined using a number of experiments addressing the issues of face, construct and 
predictive validity. 
1.7 Aims and outline 
The overall aim of this project was to design and construct a novel rodent task analogous 
to human CPT for the purpose of identifying cognitive deficits in rodents relevant to the 
cognitive features of schizophrenia and for the assessment of procognitive treatments. 
Impairments on the CPT have consistently been associated with schizophrenia, leading to 
endorsements from leading consortia to pursue task development for wider use (Carter et 
al., 2012). This thesis presents the development of a modified signal detection task (SDT), 
which incorporates key aspects of the human CPT, which to date have not been mirrored 
in the rodent tasks (Chapter 2). After developing the SDT, a series of experiments were 
used to validate the task. Firstly, I compared performance outcomes on the SDT with a 
traditional rodent task for measuring attention, the 5CSRTT (Chapter 3). I then explored 
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different variables that were predicted to influence cognitive performance in rodents. For 
instance, it was predicted that genetic and environmental factors would influence a range 
of behavioural characteristics including cognition. This led to the next study where I 
determined the effect of different genetic strains and environmental housing conditions on 
a range of behavioural traits and SDT performance (Chapter 4). Following this study I 
aimed to establish neurobiological evidence for the SDT measuring processes relevant to 
attention and schizophrenia. Prior studies suggest that impairments of the PFC occur in 
schizophrenia and this region is known to be involved in executive control of behaviour in 
rats and humans (Dalley et al., 2004). Therefore, I assessed the effect of a PFC lesion on 
SDT performance to determine the role of the PFC on attentional performance (Chapter 
5). One of the main purposes for task development is to improve the ability of preclinical 
tests to predict drug response in humans. Hence in Chapter 6, I investigated the effects of 
amphetamine, which is an indirect dopamine agonist known to alter (and in some cases 
improve) attentional performance in humans and rats. These results demonstrated the 
SDT could detect procognitive drug response. Consequently, this was followed by a 
replication study investigating the procognitive effects of amphetamine with an additional 
examination of neurochemical changes associated with SDT performance (Chapter 7). 
Together these studies provide evidence of face, construct and predictive validity of the 
SDT. While this task was designed within the context of deficits associated with 
schizophrenia, attentional impairments are also associated with a range of neurocognitive 
disorders. Therefore, this task may be used to assess deficits in models relevant to 
dementia, traumatic brain injury, depression or attention deficit hyperactivity disorder 
(ADHD). Overall, the results of this thesis provide a novel tool for researchers investigating 
disorders with cognitive impairments and also work towards the larger goal of improving 
treatment for patients with schizophrenia. 
 







Chapter 2 Task Development: A novel Signal 
Detection Task 
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2.1 Foreword 
This chapter describes the development of the modified SDT with chamber design, 
protocol features and task modifications described. In addition, experiments were 
conducted to confirm (a) that visual stimuli were being used and (b) whether variations to 
the visual stimulus could be detected. Throughout the thesis some minor changes to the 
protocol have been made, for example signal durations vary, however the general flow of 
the paradigm remains the same. A thorough examination of unique task elements and 
contrasts with other rodent tasks has been discussed in the article in Chapter 3. 
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2.1.1 Abstract 
The translational testing of cognitive deficits in animal models of schizophrenia has gained 
momentum with the growing appreciation of the role cognitive symptoms play on functional 
patient outcomes. Although there is a range of cognitive tasks that have been developed 
for use in rodents, few reflect the type of tasks clinically shown to differentiate patient and 
control groups. A novel SDT was developed to reflect aspects of the human continuous 
performance task. Task manipulations were then used to measure different aspects of 
cognitive performance. Rats were able to determine signal and non-signal trials with 
minimal training. Task variants using distracting stimuli and reversal of task contingencies 
were then utilised. Distraction within the same modality resulted in reduced accuracy, 
however cross-modal distraction using auditory stimuli reduced the speed of trial 
completion while accuracy remained high. Reversing the task led to extinction of the 
previous response and acquisition of the new stimulus-response pairing. A short training 
time was achieved using the SDT with rats able to perform the task after 20 training 
sessions. This task differed from other operant protocols in a number of ways; including 
faster trial rate, a near absence of omissions, trials were self-initiated with immediate 
stimulus presentation and the rat was in a central position on signal presentation. These 
features resulted in rats performing tasks when motivated and located appropriately within 
the chamber; reminiscent of the way standard human computer-based tasks are 
completed. 
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2.1.2 Introduction 
Three rodent tasks have been identified as having face, construct and predictive validity 
for measuring the cognitive domain of attention/vigilance (Lustig et al., 2013). These are 
the 5CSRTT, 5C-CPT and dSAT. Each of these tasks has been said to reflect elements of 
the human CPT. However in comparing these tasks to the human CPT, a number of 
differences particularly in terms of face validity were identified. These differences have 
been discussed (Chapter 1) and therefore will not be repeated here. Based on these 
observations, species-specific differences in task performance and optimal task 
characteristics, a series of goals were established for the development of a novel task. 
These included: 
 rapid presentation of a single stimulus with a response required for both trial types 
 task acquisition should be relatively quick with minimal session duration 
 the rat’s body position should be in front of the stimulus during presentation 
 reducing unnecessary ambulation in the chamber and minimising task delays to 
decrease incongruous behaviours and decrease deviation away from the task 
 reducing the rate of omissions 
 carefully considering the visual stimuli to be used 
 using a reward that leads to a high level of accuracy and trial completion 
After the SDT was developed, performance was varied using a range of different 
manipulations. The purpose of these studies was to develop a method for the SDT, 
investigate factors involved in task performance and start to explore the use of variants 
that expand on the standard task. 
2.1.3 Methods 
2.1.3.1 Animals and housing 
Male Sprague Dawley rats (N=16; ARC, WA) aged 8 weeks were pair-housed in cages 
with wire lids containing aspen chip bedding, nesting and a wood chew (Able Scientific, 
WA, USA). Male rats were selected as sex differences were not being examined in this 
study and males are more commonly used in similar experiments. There were housed at 
21±2°C and 60% humidity on a 12-h light cycle (lights on at 0600 h). Each rat was 
regularly tail-marked for identification and weighed daily. At 10 weeks of age rats were 
food restricted to 90% for their free-feeding body weight and had ad libitum access to 
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water. All procedures were performed with approval from The University of Queensland 
Animal Ethics Committee, under the guidelines of the National Health and Medical 
Research Council of Australia. 
2.1.3.2 Apparatus 
Training was conducted using Med Associates operant chambers for rats (Med Associates 
Inc., St. Albans, VT, USA). Each chamber was located within a sound attenuating box with 
a ventilation fan and overhead camera (CCD Mini CCIR, Samsung, Suwon, South Korea) 
for monitoring behaviour during training. The operant chambers were arranged specifically 
for the SDT as depicted in Figure 2.1A. All components were placed on a single wall with a 
houselight, custom-made signal display panel and a nose poke port located down the 
middle of the wall. On either side of the nose poke port there was a food magazine. Both 
the nose poke port and food magazines were equipped with a light and infra-red beam for 
head entry detection. The signal display panel was constructed using a filler panel with a 
grid of 3 x 3 light emitting diodes (5mm, green diffuse, 80MCD, Jaycar Electronics, NSW, 
Australia) that were plugged into output connections on the Med Associates SmartCtrl 
connection panel. For the distractor study a background noise generator was included on 
the back wall. Grain pellets (45mg, F0021 dustless precision pellet, Bioserv, Frenchtown, 
NJ, USA) were delivered to the food magazines to reward rats. All protocols were written 
using MedState Notation and Med-PC for Windows software (Med Associates Inc., St. 
Albans, VT, USA) was used for chamber operation and data collection. 
2.1.3.3 Operant training 
Firstly, rats were trained to collect pellets from a food magazine where each head entry 
resulted in another pellet being dispensed. After consuming 50 pellets on two consecutive 
days rats moved to the next level requiring a central nose poke to initiate trials. After nose 
poke detection, both magazines illuminated and head entry into a magazine lead to the 
delivery of a food pellet. A maximum of 100 pellets could be achieved with up to 50 pellets 
being delivered to each side. Collecting 80 pellets was considered sufficient to move to the 
next protocol. Two visual stimulus conditions (signal versus son-signal) were then 
presented after the central nose poke and if the correct receptacle was selected a reward 
was delivered (Figure 2.1B). The visual stimulus and response location contingency was 
counterbalanced across subjects in each study of this thesis. A list of outcome measures 
derived from the SDT is provided in Table 2.1. 
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Figure 2.1 Signal Detection Task. 
(A) Graphic of chamber design1 (B) Each trial runs through a procedure starting with the central nose poke, after which the stimuli was displayed and magazines 
become available for responding. If the correct magazine was chosen a pellet was delivered, however if the incorrect side was selected the trial ends with a time out. 
The next trial can be started when the central nose poke aperture illuminated. 
                                            
1 *Graphic image from Chapter 3 was published in Frontiers in Behavioral Neuroscience, 9:370, shared under Creative Commons Attribution Licence and originally created by Nick 
Valmas. 
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Table 2.1 Outcome measures on SDT 
Measure Calculation 
Trials initiated Number of trials initiated by centre nose poke 
Session duration Minutes taken to complete maximum trials (120) 
% Omissions Percentage of trials initiated but no magazine response 
within 4s 
% Accuracy signal trials Correct signal responses / (Correct signal + Incorrect signal 
responses)*100 
% Accuracy non-signal trials Correct non-signal responses / (Correct non-signal + 
Incorrect non-signal responses)*100 
Latency to initiate trials Time taken to initiate trial after central nose poke illuminates 
Response latency Time taken from stimulus cessation and magazine 
illumination to head entry detection 
Premature HE during ITI Number of head entries into the central nose poke prior to 
illumination during ITI 
Premature HE during stimulus Number of head entries into the magazine during stimulus 
presentation window 
 
2.1.3.4 Signal Detection Theory 
Other measures can be derived from the SDT using signal detection theory indices. The 
basis for signal detection theory analysis is that decision-making by the individual is 
determined by the statistical difference between the signal and noise. The advantages of 
using signal detection theory include the isolation of signal discriminability and response 
bias as opposed to using accuracy, within which these factors can vary independently. As 
the protocol has two choices and a response is recorded on every trial, four values can be 
calculated (Young et al., 2009b; Carandini and Churchland, 2013). A hit (correct signal 
trial), miss (incorrect signal trial), correct rejection (correct non-signal trial) or a false alarm 
(incorrect non-signal trial) can be made. These scores can be further analysed to 
determine an animal’s sensitivity to detecting the trial type with Sensitivity Index (SI) and a 
Responsivity Index (RI), which indicates if a rat was responding on one side more than the 
other. Calculations are as follows: 
Equation 2.1 Probability of a Hit 
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Equation 2.2 Probability of a False Alarm 
𝒑𝒑(𝑭𝑭𝑭𝑭) =   
𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭  𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂
(𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭  𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂+ 𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪𝑪  𝒓𝒓𝒓𝒓𝒓𝒓𝒓𝒓𝒓𝒓𝒓𝒓𝒓𝒓𝒓𝒓𝒓𝒓)
 
Equation 2.3 Sensitivity Index 
𝑺𝑺𝑺𝑺 =   
𝒑𝒑 𝑯𝑯𝑯𝑯𝑯𝑯 − 𝒑𝒑(𝑭𝑭𝑭𝑭)
𝟐𝟐 𝒑𝒑 𝑯𝑯𝑯𝑯𝑯𝑯 + 𝒑𝒑 𝑭𝑭𝑭𝑭 − [𝒑𝒑 𝑯𝑯𝑯𝑯𝑯𝑯 + 𝒑𝒑(𝑭𝑭𝑭𝑭)]𝟐𝟐
 
Equation 2.4 Responsivity Index 
𝑹𝑹𝑹𝑹 =   
𝒑𝒑 𝑯𝑯𝑯𝑯𝑯𝑯 − 𝒑𝒑 𝑭𝑭𝑭𝑭 − 𝟏𝟏
𝟏𝟏− [𝒑𝒑(𝑭𝑭𝑭𝑭)− 𝒑𝒑 𝑯𝑯𝑯𝑯𝑯𝑯 ]𝟐𝟐
 
The application here is slightly different to use in the human CPT in that the rat was 
required to respond, rather than inhibit responding, on non-signal trials. Therefore the 
interpretation also differs. RI has been defined as the likelihood to respond (effectively hits 
and false alarms vs. correct rejections and misses) and on an inhibitory task this would 
indicate the subject’s ability to withhold responding. However, in this study RI would be 
more indicative of a side bias. Although RI has been used on similar tasks, the different 
forms of responding (press/inhibit compared to left/right) must be considered when 
interpreting this measure. 
Due to the near absence of omissions on the SDT, p(Hit) and p(FA) are equivalent to 
signal accuracy and the inverse of non-signal accuracy, respectively. Therefore, these 
measures replicate the results derived using % correct. SI and RI are derived from these 
values and represent a combined score, where SI indicates overall detectability and RI 
indicates the ratio of responding to the signal or non-signal side. These values are distinct 
from each other, but are both highly correlated with % correct on signal trials, % correct on 
non-signal trials, p(Hit) and p(FA). Thus, they provide useful information in some 
situations, such as when accuracy on both signal and non-signal trials is affected or when 
the decision-making criterion is altered. However, if only one parameter is manipulated 
these values become less informative, for example when using a manipulation of signal 
trials with reduced stimulus durations in a pseudorandom order interspersed with non-
signal trials. The % correct on non-signal or p(FA) stays the same and % correct on signal 
or p(Hit) decreases as stimulus length was reduced. Using SI and RI in this instance does 
not provide additional information about performance as only one value was changing with 
the manipulation of interest. 
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In considering the use of signal detection theory in this thesis, the application was deemed 
superfluous for the majority of chapters due to the manipulation of interest. In Chapter 3 
signal detection theory could not be applied to the 5CSRTT and the key outcome was 
comparison of results between tasks. In Chapter 4, task acquisition rate was the primary 
outcome measured. In Chapter 5 data were analysed using both signal detection theory 
and % correct on signal and non-signal trials to demonstrate the application and similarity 
between the measures. In Chapter 6 and 7 the primary measures were reducing signal 
durations where signal detection theory measures only shift with the change in % correct 
on signal trials. Therefore, the majority of studies report % correct on signal and non-signal 
trials. 
2.1.3.5 Manipulations 
A range of manipulations was applied once the basic detection protocol was learnt. An 
occlusion manipulation was used in a restricted cohort (n=4) to confirm that the rats were 
only using the visual information and not potential tactical, auditory or olfactory cues from 
the illumination of the LEDs. The panel was covered with a lightproof shield but still 
operated using the same procedure as described previously. Responses were again 
rewarded based on the standard training schedule, despite the rat not being able to view 
the stimuli. 
Based on the literature a number of stimulus changes were tested. Firstly, could rats 
discriminate between 3 vertical lights and 3 horizontal lights? Secondly, could patterns 
using different numbers of lights be discriminated? Thirdly, could rats discriminate between 
a red and green light? However, even after weeks of training, accuracy did not improve on 
any of these manipulations and therefore these data have not been presented. Although 
rats may be able to make these visual discriminations with extensive training, 
improvements were not observed within the time available for this study. 
Four manipulations were used to further characterise performance under different 
experimental conditions. Firstly, the threshold for signal detection was determined by 
providing a range of illuminated LEDs from 0-9 and recording the proportion of responses 
to the signal and non-signal magazines (n=16). Trials were pseudo-randomly ordered from 
a list containing 8 non-signal (0 LEDs) trials, 8 signal (9 LEDs) trials or one of 8 
intermediate stimuli (1-8 LEDs) trials. On the intermediate stimuli trials responses to both 
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left and right magazines were not rewarded to reduce reinforcement of either response 
type. Responses on signal and non-signal trials were rewarded as per standard training. 
Then the effects of a visual and auditory distractor were used to determine if performance 
was differentially impaired by a distractor within the same or different modality in a subset 
of trained rats (n=4). The session was broken into 4 blocks of 30 trials, the first and last 
blocks containing standard trials while the second block included a visual distractor and 
the third block included an auditory distractor. The distractors pulsed on and off at 10Hz, 
using either the house light or a background noise generator, throughout the 30 trial block. 
Next, a reversal of the schedule was performed to determine how many sessions were 
required for rats to flexibly switch their responses to the opposite contingency (n=16). For 
this manipulation rats that were trained to response left for signal and right for non-signal 
were switched to right for signal and left for non-signal and vice versa for the alternative 
contingency. 
Finally, to determine if accuracy was dependent on motivation, a separate cohort of 20 
male rats was trained on the SDT using 120 trials per session (60 signal and 60 non-
signal). They were then individually pre-fed 200 reward pellets (9g food) 30min prior to 
testing. The amount of pellets they consumed prior to starting testing and the number of 
pellets attained, but not consumed, was also recorded. 
2.1.3.6 Statistical analysis 
Statistical analysis was performed using SPSS software package (ver.20, SPSS Inc. IL, 
USA). Where appropriate, repeated measures ANOVA, independent t-tests or paired t-
tests were used. Bonferroni correction for multiple comparisons was used. Significance 
was set at p<0.05. 
2.1.4 Results 
2.1.4.1 Visual occlusion 
To ensure the rats could not use other senses (for example auditory or olfactory cues) to 
determine if the visual stimuli were on or off, the panel was occluded but still operated for 
a test session (Figure 2.2A). Accuracy was significantly reduced (from 89% to 56% 
correct) when the panel was covered, indicating that rats were using visual cues to 
perform the task accurately (t(3)=13.68, p=0.001). 
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2.1.4.2 Detection threshold 
To determine the threshold for a response shift between signal and non-signal trials, a 
discrimination session was conducted where additional LEDs were presented but not 
rewarded (Figure 2.2B). While rats could clearly discriminate between 0 and 9 LEDs (t(14)=-
9.41, p<0.001), the illumination of a single LED resulted in performance at chance levels 
(t(14)=0.14, p=0.894). Any more than 1 LED illumination resulted in a strong preference for 
signal responding (groups differed across 1-9 LEDs with a range of t(14)=2.82 to 9.78, 
p=0.014 to <0.001). Therefore, it was decided that using all 9 lights on or off provided the 
best results and this was used for future studies. 
 
Figure 2.2 Performance measures on the signal detection task 
(A) Performance indicated by correct detection of stimulus with the light panel either visible or occluded 
(n=4). (B) Discrimination curve showing the percentage of responses to the left magazine for rats in the 
group associating signal (closed) trials with a left response and the group associating non-signal (open) trials 
with a left response across increasing numbers of LEDs being presented (n=8/group). As all trials were 
completed and responses are mutually exclusive, the % responses to the right magazine for each group 
mirror these results and are not presented. Mean and SEM shown, *p<0.05. 
2.1.4.3 Distraction 
The results of the distractor manipulation were assessed using both % correct and signal 
detection theory indices. On both measures the distractor conditions differentially 
influenced performance. There was no main effect of Block on % correct for signal or non-
signal trials. When the same data was analysed using signal detection theory indices it 
was found that p(Hit) and p(FA) also did not varying significantly by Block. SI was found to 
vary (F(3,9)=4.39, p=0.037) with the visual distractor block being significantly lower than the 
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between Blocks (Figure 2.3). The auditory distractor did decrease trial rate compared to 
the normal trial blocks (Block 1 vs. 3 t(3)=4.38, p=0.022; Block 3 vs. 4 t(3)=-9.86, p=0.002; 
Figure 2.4). 
 
Figure 2.3 Performance measures for distraction manipulation 
(A) Signal accuracy and (B) Non-signal accuracy did not vary across blocks. (C) p(Hit) and (D) p(FA) also did 
not differ with distraction. (E) However, SI was reduced during the visual distractor compared to the auditory 
and end block but (F) RI did not differ across blocks. N=4, *p<0.05. 
p(Hit) during distraction
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Figure 2.4 Effect of distracting stimuli on trial rate 
When compared for trial rates, the auditory distractor reduced trial pace more than the visual distractor 
(n=4). Mean and SEM shown, *p<0.05. 
2.1.4.4 Reversal learning 
Rats were able to determine signal from non-signal trials with >80% accuracy. The 
protocol was then reversed so the correct response was now to enter the opposite 
magazine. Rats initially respond as per prior training, before gradually acquiring the new 
pairing (Figure 2.5). 
 
Figure 2.5 Reversal learning 
Scatter plot showing individual values (as well as mean and SEM) for each session of reversal learning (n=6-
16). 
Trial Rate during distraction
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2.1.4.5 Pre-feeding 
All rats consumed pellets prior to testing, with consumption ranging from 3.6-9.0g with 9.0g 
being equal to the entire 200 pellets supplied (mean was 7.8g). Paired t-test comparing 
measures from the day before and after pre-feeding found that the number of trials 
completed was significantly reduced (t(19)=-3.55, p=0.002) and the number of omissions 
was significantly increased (t(19)=2.24, p=0.037) after pre-feeding (Figure 2.6A,B). 
However, % correct was not significantly different (t(19)=-1.67, ns; Figure 2.6 C). In 
addition, 10 out of the 20 rats did not consume all the reward pellets they received during 
task performance (ranging from 8-121 pellets left in magazines). 
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Figure 2.6 Pre-feeding manipulation 
Prefeeding rats reward pellets before testing 
resulted in (A) fewer trials being completed and 
(B) a marginal, yet significant increase in 
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2.1.5 Discussion 
The aim of this study was to develop a novel SDT for measuring attention in rats. These 
preliminary experiments were conducted to explore aspects of the task design and derive 
pilot data for task manipulations, such as distraction and reversal learning. Firstly, I 
confirmed through the occlusion study that rats were using visual information to make 
decisions and not relying on other senses to determine when the display panel was 
illuminated. This may seem obvious, however this needed to be confirmed given the 
superiority of other senses, such as olfaction, in rodents. Having confirmed rats were using 
visual cues from the LEDs, the importance of the number and position of the LEDs were 
examined. Initial studies looking at different light patterns were not successful and this was 
not surprising given rats seem to use a detection strategy in this paradigm. When 
presented with varying stimuli, rats responded on the signal side with a strong bias after 
two or more LEDs were illuminated. Although rats may be able to learn to discriminate 
different patterns of visual stimuli, this would be likely to take significantly more training 
than was considered reasonable for this study. It has been shown that rats can 
discriminate very complex images, including photographs and morphed images (Bussey et 
al., 2008), although rats may use low level features rather than the whole image to 
discriminate. However, an important consideration for this study was that stimuli were 
presented in succession rather than simultaneously. Therefore, rather than being able to 
directly compare stimuli side-by-side and make a choice, the rat needed to maintain an 
internal rule about the stimulus-response pairing. It was also found that the threshold for 
switching from signal to non-signal responding occurs at a very low level of illumination 
with one LED leading to chance responding but two or more LEDs resulting in a strong 
preference for signal responding. This limits the use of variable LED patterns in terms of 
varying luminance levels, but clearly demonstrates the light from two LEDs was sufficient 
for detection. This may make more complex discriminations more difficult. Therefore, it 
was decided to use the light panel for detection (0 versus 9 lights) rather than display 
different arrangements of lights for the remainder of the thesis. 
With the use of distractors, it was found that the auditory distractor did not reduce 
accuracy of responding, but did significantly slow trial completion rate. This is likely to 
occur because the rats were paying attention to the source of the noise rather than 
focussing on the task. In contrast, it was found that the visual distractor reduced 
performance to chance levels (50%) of accuracy on both signal and non-signal trials, 
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however this was only statistically detected using SI. Where signal detection theory was 
applied, SI was found to vary significantly between blocks whereas % correct for signal 
and non-signal, as well as p(Hit) and p(FA), were not different across blocks. As SI 
incorporates both these values, this may indicate a lack of power for detecting significance 
in these other measures. It would be expected that if accuracy on one trial type was 
driving the SI finding, then it would be significant on its own. However, if it is an additive 
effect, then either measure on its own may not reach significance. This is quite likely given 
the low number of animals used (n=4) in some experiments. These indices have been 
applied later in Chapter 5 where the distraction manipulation was used in study with 
greater sample numbers. It should be noted that these preliminary studies were conducted 
with small sample sizes and therefore may lack power to detect significant differences. 
However, the objectives for these studies were qualitative, rather than strictly quantitative. 
These results may indicate that the visual distractor is in fact preventing the rats from 
seeing the signal when it is presented. Rather than operating as a distractor that diverts 
attention away from the task, it may be visually interfering with their ability to complete the 
task. 
Reversal learning was then examined and it was found that rats gradually acquired the 
new contingency over 2 weeks of testing. There was quite a lot of variation in the 
acquisition rate between individuals and this may be a useful manipulation for assessing 
behavioural flexibility in future studies. Finally, pre-feeding rats prior to testing examined 
the effect of reducing motivation on task performance. This experiment demonstrated that 
even when motivation was reduced, accuracy of responding was maintained. However, 
the number of trials completed was reduced and omissions increased as expected. This 
demonstrates that accuracy on the SDT provides a cognitive measure that is independent 
of motivational changes. Overall, these pilot studies were used to determine feasibility and 
protocol parameters that produced the desired outcome. From this work a modified signal 
detection task has been designed and task variations have been trialled. Having 
established training and testing procedures, the utility of the SDT can now be examined. 
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3.1 Foreword 
The next step was to determine how the outcomes on the SDT compared to an alternative 
task. One of the most widely used and well-validated rodents tasks used to measure 
attention is the 5CSRTT. The tasks differ in a number of features, including predictability of 
stimulus onset and location, the number of response locations and stimulus properties 
(e.g. luminance). These differences are part of what makes the tasks unique and neither 
task was altered from the standard versions that have been previously published. 
Therefore the purpose of this study was to compare acquisition and performance on the 
5CSRTT and SDT. Of particular interest was the time taken to train rats, the rate of 
omissions and level of accuracy on each task. A number of differences in task 
performance are highlighted including fast training time, reduced omission rate and the 
control of body position on the SDT. This article was published in Frontiers in Behavioral 
Neuroscience.  
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3.2 Measuring attention in rodents: comparison of a modified signal 
detection task and the 5-choice serial reaction time task 
Karly M. Turner, James Peak and Thomas H. J. Burne 
3.2.1 Abstract 
Neuropsychiatric research has utilised cognitive testing in rodents to improve our 
understanding of cognitive deficits and for preclinical drug development. However, more 
sophisticated cognitive tasks have not been as widely exploited due to low throughput and 
the extensive training time required. We developed a modified SDT based on the growing 
body of literature aimed at improving cognitive testing in rodents. This study compares 
performance on the modified SDT with a traditional test for measuring attention, the 
5CSRTT. Adult male SD rats were trained on either the 5CSRTT or the SDT. Briefly, the 
5CSRTT required rodents to pay attention to a spatial array of 5 apertures and respond 
with a nose poke when an aperture was illuminated. The SDT required the rat to attend to 
a light panel and respond either left or right to indicate the presence of a signal. In 
addition, modifications were made to the reward delivery, timing, control of body 
positioning and the self-initiation of trials. It was found that less training time was required 
for the SDT, with both sessions to criteria and daily session duration significantly reduced. 
Rats performed with a high level of accuracy (>87%) on both tasks, however omissions 
were far more frequent on the 5CSRTT. The signal duration was reduced on both tasks as 
a manipulation of task difficulty relevant to attention and a similar pattern of decreasing 
accuracy was observed on both tasks. These results demonstrate some of the advantages 
of the SDT over the traditional 5CSRTT as being higher throughput with reduced training 
time, fewer omission responses and their body position was controlled at stimulus onset. 
In addition, rats performing the SDT had comparable high levels of accuracy. These 
results highlight the differences and similarities between the 5CSRTT and a modified SDT 
as tools for assessing attention in preclinical animal models. 
Accepted: 24th December 2015 
Reference: Turner KM, Peak J, Burne THJ (2016) Measuring attention in rodents: 
comparison of a modified signal detection task and the 5-choice serial reaction time task. 
Front Behav Neurosci 9:370. 
Hyperlink: http://journal.frontiersin.org/article/10.3389/fnbeh.2015.00370/full 
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3.2.2 Introduction 
Cognitive symptoms are the strongest predictor of functional outcomes in patients with 
schizophrenia, yet current antipsychotic medications are no more effective in treating 
cognitive symptoms than those developed in the 1950’s (Green et al., 2000; Keefe et al., 
2007). To guide future clinical research in the development of more effective medications, 
the MATRICS panel was formed (Green and Nuechterlein, 2004). For each domain of 
cognition, tasks administered in human subjects were selected as part of a cognitive 
battery for assessing the efficacy of novel medications (Nuechterlein et al., 2008). Within 
the domain of attention/vigilance they selected versions of the CPT (Nuechterlein et al., 
2008). Following these recommendations the CNTRICS panel devised a similar list of 
tasks for evaluating these cognitive domains in animals (Carter and Barch, 2007). These 
tasks were selected based on evidence of face, predictive and construct validity relative to 
the human CPT and each has been reverse-translated back into human tasks (Demeter et 
al., 2008; Young et al., 2009a; Young et al., 2013b; Worbe et al., 2014). A key issue that 
was raised throughout this process was the need for greater translational validity between 
rodent and human tasks (Hagan and Jones, 2005; Young et al., 2009a). The purpose of 
this study was to further develop a CPT-like task for the assessment of attention in 
rodents. 
Firstly, elements of the human CPT and dissimilarities with current rodent protocols were 
carefully considered. The human CPT exists in many versions with deficits in 
schizophrenia patients widely reported (Earle-Boyer et al., 1991; Cornblatt and Keilp, 
1994). These deficits have even been suggested to represent an endophenotype of 
schizophrenia as there is evidence of mild deficits in first-degree relatives, stability in 
patients from first-episode through to remission, and a lack of correlation between severity 
of psychotic symptoms and CPT deficits (Chen and Faraone, 2000; Snitz et al., 2006; Gur 
et al., 2007; Delawalla et al., 2008; Richard et al., 2013). A common feature of continuous 
performance tasks is the rapid presentation of stimuli where the subject is required to 
monitor, identify and respond to target stimuli. Key outcome measures are the accuracy of 
responding and the reaction times of participants, with both measures altered in 
schizophrenia patients. By translating important features of the human CPT into a rodent 
task, researchers can more invasively investigate how attentional deficits are related to 
neurobiological changes and test novel drug targets for treating cognitive symptoms in 
schizophrenia. 
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The corresponding rodent tasks selected for the domain of attention were the 5CSRTT, 
5C-CPT and SAT (Lustig et al., 2013). The 5CSRTT has been widely used in rats and 
mice with extensive investigation of the underlying neurobiology and use of 
pharmacological agents to probe performance (Robbins, 2002). It has been shown to be 
highly sensitive to pharmacological agents and to manipulations used in animal models of 
schizophrenia (Chudasama and Robbins, 2004; Featherstone et al., 2007b; Fletcher et al., 
2007; Paine and Carlezon, 2009). The 5CSRTT requires rodents to attend to an array of 
five apertures and make a nose poke response into an illuminated aperture. As an 
extension of this paradigm, the 5C-CPT incorporates a subset of trials requiring inhibition 
of responding when all five apertures illuminate to receive a reward. Therefore the 5C-CPT 
allows the assessment of response inhibition, which is an important component of 
executive functioning. A clear difference between human CPT and the rodent 5CSRTT is 
the use of a spatial array of stimuli and response locations. In contrast, a single, constant 
position is typically used for presenting stimuli and responding on the CPT for human 
subjects. While the rodent may correctly identify the response location via a spatial 
stimulus-response association in the 5CSRTT, the human CPT requires the maintenance 
of a rule to determine the correct response based on stimulus properties. Hence, the use 
of a rule is a valuable feature of the rodent SAT protocol when considering translational 
task components. The SAT requires the detection of a single, central stimulus followed by 
a response on the correct lever to receive a reward (McGaughy and Sarter, 1995a). On a 
subset of trials, a flashing light can also be presented to assess performance changes 
during dSAT. The SAT has incorporated the use of a rule about the properties of a single 
stimulus, however it has not been as widely used or validated as the 5CSRTT. In both 
these tasks a major issue that has not been addressed is the lack of control over the 
rodent’s body position during stimulus presentation. 
In human studies the subject is often placed in a fixed position relative to the stimuli and 
maintains eye gaze in the direction of the stimulus stream. However, in rodent tasks, the 
animal can move anywhere within the operant chamber and may not have the stimuli 
within their visual field when it is presented. This leads to a number of differences in the 
interpretation of performance measures between human and rodent testing. Firstly, 
accuracy will depend on the body position of the rodent during stimuli presentation. 
However, body position cannot be determined without additional video recording and 
tracking analysis. Secondly, the lack of control over body position interferes with the 
interpretation of omission errors. In human studies an omission most likely occurs when 
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the subject misses a stimuli due to a lapse in vigilance, whereas in rodents studies an 
omission may occur for any number of reasons including grooming, sleeping or 
investigating the chamber. To demonstrate the importance of body position, we analysed 
video recordings from our previous 5CSRTT study in rats (Turner et al., 2013) and show 
that more omissions occurred when the rat was more distant and had their head turned 
during stimulus onset (see Figure 3.1). 
 
Figure 3.1 5CSRTT Body Position 
On 5CSRTT the angle of the rat’s head and distance from the stimulus are important for correct identification 
of the illuminated aperture. Correct responses typically occurred when the rat was very close to or looking 
straight at the 5-hole wall. However, rats were frequently on the other side of the chamber and looking away 
from the 5 holes prior to an omission (dotted line indicates half the width of the chamber). The plot shows 
individual responses from seven rats with correct, incorrect and omission responses. 
 
Another point raised by CNTRICS for the optimisation of rodent testing included reducing 
the training time to encourage more widespread use (Lustig et al., 2013). Reducing the 
time required to train rodents on cognitive tasks would also promote preclinical screening 
of novel compounds, which has been limited due to the extensive investment required. 
Another issue that has been raised is the acknowledgment that no task provides a pure 
assessment of a single cognitive modality and therefore a number of behaviour measures 
should be considered when interpreting changes in performance. Therefore, it was 
suggested that tasks should endeavour to include dimensions where performance can be 
concurrently observed over a range of difficulties, such that deficits due to more general 
impairments can be isolated from cognitive deficits (Lustig et al., 2013). This would serve 
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as an internal control for changes in motivation, motoric effects of drugs and satiety as 
opposed to changes in attentional performance. 
After considering the differences between rodent and human CPT testing and the 
recommendations made for optimising task qualities, a modified SDT was developed. We 
focussed on reducing training time, reducing omissions and controlling body position while 
maintaining construct validity for measuring attention. This fast-paced SDT was designed 
with consideration for the species-specific differences in task performance. This includes 
consideration of the stimuli and response devices used, but more importantly to improve 
task engagement and vigilance. The SDT was compared to the well-validated 5CSRTT to 
determine the advantages and disadvantages of each paradigm. It was hypothesised that 
acquisition of the SDT would be faster as the task has a simpler design with fewer 
outcomes that are punished, thereby limiting inappropriate responding and promoting 
rapid task acquisition. It was predicted that there would be fewer omissions on the SDT for 
a number of reasons. Firstly, trials are self-initiated without delay to signal or non-signal 
presentation and therefore the rat should be motivated to complete each trial. Secondly, 
the stimuli are immediately presented directly in front of the rat and responses require only 
minor movement from the initial start position. Thirdly, there is minimal delay between 
trials. Collectively these features promote engagement in the task rather than performance 
of alternative behaviours. Finally, it was predicted that accuracy would be comparable on 
both tasks during baseline testing and when challenged with more difficult stimuli. 
3.2.3 Materials and Methods 
3.2.3.1 Animals 
Adult 12 week old male Sprague Dawley (ARC, WA) rats were housed in a room 
maintained at 21 ± 2°C and 60% humidity and on a 12-h light/dark cycle (lights on 0600 h). 
Male rats were selected as sex differences were not being examined in this study and 
males are more commonly used in similar experiments. They were pair-housed in 
polypropylene cages (41x28x24cm) with high-top wire lids, aspen chip bedding (Able 
Scientific, WA, USA), nesting and wood chew (Able Scientific, WA, USA), which was 
cleaned weekly after operant testing. Rats were micro-chipped (Microchips Australia Pty 
Ltd, Australia) and regularly tail marked to ensure accurate identification of individuals. 
Prior to training, rats were food restricted to 90% of their free-feeding body weight with free 
access to water. Throughout testing rats were weighed daily and food rations were 
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adjusted to maintain constant body weight. All procedures were performed with approval 
from The University of Queensland Animal Ethics Committee, under the guidelines of the 
National Health and Medical Research Council of Australia. 
3.2.3.2 Apparatus 
Operant chambers were contained in sound attenuated boxes with ventilation fans (Med 
Associates Inc., St. Albans, VT, USA) and overhead cameras for monitoring behaviour 
(CCD Mini CCIR, Samsung, Suwon, South Korea). All chambers were 50x50x50cm and 
were assembled for either 5CSRTT or SDT training (Turner et al., 2013). For 5CSRTT 
there was a curved wall with five horizontal apertures each containing a light and head 
entry detector. On the opposing wall there was a house light and food magazine that was 
also equipped with a light and head entry detector. The arrangement for SDT training was 
on a single chamber wall with a house light, signal display panel and nose poke port in the 
middle and a food magazine on either side of the nose poke port. The central nose poke 
port and magazines each contained a light and head entry detector. The signal display 
panel consisted of a 3x3 grid of light emitting diodes (5mm, green diffuse, 80MCD, Jaycar 
Electronics, NSW, Australia). All rats were rewarded with 45mg grain pellets (F0021, 
dustless precision pellet, Bioserv, Frenchtown, NJ, USA) delivered to the food magazines. 
The protocol was designed using MedState Notation while operation and data acquisition 
was conducted using Med-PC for Windows software (Med Associates Inc., St. Albans, VT, 
USA). 
3.2.3.3 5CSRTT Protocol 
Training for the 5CSRTT (N=18) was conducted based on methods described previously 
(Bari et al., 2008; Turner et al., 2013) with a summary presented in Table 3.1. In the 
5CSRTT protocol rats were required to attend to an array of 5 apertures and respond with 
a nose poke to the aperture that was briefly illuminated. Rats must withhold from 
responding during the inter-trial interval (ITI) where a premature response resulted in a 
time out (5s). One of the 5 apertures was then briefly illuminated and the rat must respond 
within the limited hold (LH) period (5s). Following selection of the correct aperture the rat 
received a food reward, however if an incorrect aperture was chosen there was a brief 
time out (5s). Unlike the methods described elsewhere, prior to training stage 1, this 
protocol required rats to be habituated to the chambers and collect reward pellets from the 
apertures and magazine. To automate this process, rats were first trained to collect 
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rewards from the magazine by placing 10 pellets in the magazine and every head entry 
resulted in the delivery of another pellet (Habituate). After achieving 100 pellets on 2 days, 
rats moved to level 0 where a response into any nose poke aperture results in a reward. 
These steps were used to automate the habituation procedure and ensure all rats had 
acquired the basic steps required for level 1. Rats were then trained progressively through 
levels 2-6 to collect rewards and respond to briefer stimuli until attaining level 7 with >80% 
accuracy and <20% omissions on a 1s stimulus duration. For details of each level see 
Table 3.1. 
3.2.3.4 SDT protocol 
An overview of the SDT protocol has been presented in Figure 3.2. For the SDT, rats were 
first trained to collect a food reward from the magazines. Each subsequent head entry 
resulted in another reward delivery until 50 rewards were collected from each magazine or 
20min had elapsed (level 1). Next rats were trained to make a nose poke into the 
illuminated central port to activate reward delivery on head entry in the magazines (level 
2). Finally, rats were trained to make a central nose poke, then the stimulus panel 
illuminated (signal trial) or remained off (non-signal trial) before both magazines 
illuminated and the rat could respond left or right (level 3, then level 4). A summary of the 
training step requirements has been listed in Table 3.2. 
If the correct side was selected a reward was delivered; however if the incorrect side was 
selected a brief time out (5s) delayed the beginning of the next trial. Stimulus (signal or 
non-signal) and magazine (left or right) pairings were balanced across the cohort, but 
constant for an individual. By incorporating the central nose poke to start trials, the rat’s 
body position was confined to directly beneath the panel when the stimulus was 
presented. The location of the magazines on either side of the nose poke also reduces the 
amount of movement required to respond. During development of the task it was observed 
that if responses could be made immediately when stimuli were presented, more impulsive 
and inaccurate choices were made during training (data from pilot study not presented). As 
a result some animals did not learn the rule, preferring to respond quickly with 50% chance 
of success. Therefore the inclusion of a 1s stimulus presentation window when responses 
were not rewarded was critical to task acquisition. This also ensures that all animals are 
exposed to the same signal duration prior to responding, otherwise a faster response 
would reduce the amount of time the stimulus was presented. The session ended after 120 
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trials or 30min and rats were required to achieve >80% accuracy with an equal number of 
signal and non-signal trials presented pseudorandomly.
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Figure 3.2 The Signal Detection Task 
(A) Schematic of chamber arrangement including a house light, grid of lights for signal presentation and central nose poke with a magazine on each side. (B) Trials 
started with a brief inter-trial interval (ITI) before the central nose poke aperture illuminates and the rat makes a nose poke response to begin the trial. Immediately 
upon nose poke detection, the signal was presented (or absent for non-signal trials) for 1s. Following the signal presentation both the left and right magazines 
illuminated indicating the rat should make a choice. If the correct side was chosen a food reward was delivered, alternatively if the incorrect side was chosen there 
was a brief time out (5s). If no response was made after a 4s limited hold (LH) the trial ends with an omission scored. Nose pokes and head entries (HE) made at 
inappropriate times were recorded but not punished.  
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Table 3.1 Training requirements for the 5CSRTT 
Level Trials Session min Stim Dur s Time Out s LH s Reward Dur s ITI s Criteria 
Habituate 100 30 - - - 1 - 100 responses, 2 days 
0 100 30 - 5 30 10 0 >30 correct 
1 100 30 30 5 30 10 2 >30 correct 
2 100 30 20 5 20 5 2 >50 correct 
3 100 30 10 5 10 2 5 >50 correct 
4 100 30 5 5 5 2 5 >50 correct,>80% accuracy 
5 100 30 2.5 5 5 2 5 >50 correct,>80% accuracy,<20% omission 
6 100 30 1.25 5 5 2 5 >50 correct,>80% accuracy,<20% omission 
7 100 30 1 5 5 2 5 >50 correct,>80% accuracy,<20% omission 
 
Table 3.2 Training requirements for the SDT 
Level Trials Session min Stim Dur s Time Out s LH s ITI s Criteria 
1 Collect pellets 100 20 - - - - >=80 trials, 2 days 
2 Nose poke 100 30 - - - 0,2,4,6,8,10 >=80 trials, 2 days 
3 Signal Detection 
 
120 30 Unlimited - - 1,2,3 >=80% correct, 2 days 
4 Signal Detection 120 30 1 5 4 1,2,3 >=80% correct, 2 days 
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There are a number of modifications that have been made in the SDT compared to other 
signal detection tasks, such as the SAT. Changes to the chamber design include the 
location of the reward, the use of nose pokes instead of lever press responding, the use of 
a central nose poke aperture and the LED light panel. In terms of protocol design, one of 
the most influential changes was the positioning of the rat in the centre, underneath the 
light panel at stimulus onset. This ensured the rat was located in front of the stimulus when 
the signal was displayed. In addition, the ITI period occurs prior to the self-initiation nose 
poke, rather than after to encourage responding. Timed events and latencies are typically 
shorter than on other protocols to promote rapid trial pace (e.g. ITI). A mandatory pause 
(1s) was incorporated during stimulus presentation, however as all other delays are 
minimal a rat can rapidly complete 100 trials without stopping if they chose too. The 
continuous nature of task performance differs from other rodent tasks where delays often 
lead to alternative behaviours. 
3.2.3.5 Signal duration manipulation 
Following training, both tasks were adapted to include a variation in stimulus duration to 
increase attentional load. For both tasks there were 120 trials per session with 20 standard 
trials at the start and end of the session consisting of only 1s stimulus for 5CSRTT and 0 
or 1s stimulus for SDT as per training. These trials could be used to assess the changes 
that occur across the length of the session. For the 5CSRTT the central block of 80 trials 
consisted of 0.5, 0.25, 0.12 or 0.06s signal duration trials. On the SDT, the central block of 
80 trials consisted of 60 signal trials of 0.5, 0.25, 0.12 or 0.06s and 20 non-signal (0s) 
trials. These parameters were selected to derive similar measurements from each task 
although all analyses were conducted separately for 5CSRTT and SDT. Inter-trial interval 
(ITI) was fixed for both tasks to increase stimulus onset predictability in both tasks. 
3.2.3.6 Behavioural measures 
The primary outcome measure during training was the number of sessions required to 
reach criteria, which was >80% accuracy on 1s signal duration for both tasks. Once they 
reached this stage a range of measures were used to compare performance including % 
accuracy, % omissions, session duration, trial rate and response latency. Other measures 
could also be derived from each task but were not directly comparable due to differences 
in protocol requirements such as premature responses, latency to initiate trials and reward 
latency. For the signal duration manipulation, % accuracy at each signal duration was 
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calculated along with measures previously identified. The session was also split into three 
blocks including the start (first 20 standard trials), middle (80 reduced signal duration trials) 
and end (final 20 standard trials) blocks to investigate changes in performance that occur 
due to session length as compared to changes that occur due to altered stimulus duration. 
3.2.3.7 Statistical Analysis 
All data were analysed using SPSS software package (ver.20, SPSS Inc. IL, USA) and 
significance was set at p<0.05. Task acquisition and baseline performance measures were 
compared using independent t-tests. Comparison of performance measures across blocks 
in the signal duration manipulation were analysed by repeated measures ANOVA and 
followed with paired t-tests where appropriate. One rat was removed from signal duration 
analysis, as performance was unusually poor on the day of testing (<20% accuracy and 
70% omissions on start block). Data are presented as mean ± S.E.M, *p<0.05. 
3.2.4 Results 
3.2.4.1 Task comparison 
Performance was compared between rats trained on 5CSRTT and SDT with the number of 
sessions required for each training step presented in Table 3.3. On both tasks there were 
individual rats who took longer than average to reach criteria at certain steps, however to 
achieve an objective measure of training time on both tasks every animal was included 
and trained until they reached criteria. 
The average number of sessions required to reach criteria with a 1s stimulus duration was 
significantly greater for 5CSRTT than for the SDT (t(34)=4.75, p<0.001, Figure 3.3A). Trial 
rate was significantly greater for the SDT than the 5CSRTT (t(34)=-17.18, p<0.001, Figure 
3.3E) and consequently average session duration was significantly shorter on the SDT 
compared to the 5CSRTT (t(20.72)=9.17, p<0.001, Figure 3.3D). Both groups of rats 
performed to a high level of accuracy (>87%, t(34)=-0.11, ns, Figure 3.3B), however the 
5CSRTT included significantly more omissions than the SDT (t(17.05)=11.36, p<0.001, 
Figure 3.3C). Premature responses on the 5CSRTT were punished and therefore occurred 
infrequently (13.67±1.36) compared with premature responses on the SDT (155.28±9.75) 
where additional head entries were inconsequential. Non-signal trials only occur on the 
SDT, where accuracy was 71.9% ± 2.8, which was lower than for 1s signal trials (90.8% ± 
2.3) possibly due to greater uncertainty when perceiving the absence of a signal. 
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Mean ± SEM 
Min Max Training 
Steps 
Sessions 
Mean ± SEM 
Min Max 
Habituate 3.06 ± 0.21 2 5 1 3.44 ± 0.47 2 10 
0 4.33 ± 0.46 2 8 2 3.39 ± 0.14 3 5 
1 1.33 ± 0.16 1 3 3 8.61 ± 0.99 3 18 
2 1.06 ± 0.06 1 2 4 2.89 ± 0.61 1 12 
3 1.22 ± 0.13 1 3     
4 3.61 ± 0.45 1 9     
5 5.39 ± 0.76 1 13     
6 5.94 ± 0.70 2 14     
7 4.94 ± 0.86 1 13     
Total 27.83 ± 1.65 19 46  18.33 ± 1.33 12 27 
Each training step for 5CSRTT (N=18) and SDT (N=18). 
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Figure 3.3 Comparison of performance measures on 5CSRTT and SDT 
(A) The number of sessions required to train rats to the final level of 5CSRTT was significantly greater than 
the number of sessions required to train rats on the SDT. (B) Accuracy was not different between the two 
protocols. (C) The number of omissions was greatly reduced on the SDT compared to the 5CSRTT. (D) The 
average session duration was significantly longer for rats to complete 5CSRTT (100 trials) than the time 
taken to complete the SDT (120 trials). (E) This was also reflected in the trial rate, where a significantly 
greater number of trials were completed per minute on the SDT compared to the 5CSRTT. (F) The reduced 
signal duration manipulation led to a decrease in accuracy on both the 5CSRTT and SDT. Compared to 
baseline testing with only 1s signal duration trials (Figure 3A), accuracy at 1s remained high on SDT (from 
87.6% to 90.8%) but was reduced on 5CSRTT (from mean of 87.4% to 73.2%) possibly due to fatigue 
effects (Figure 4A). n=18/task, *p<0.05 
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3.2.4.2 Reduced stimulus duration 
Accuracy was reduced with decreasing signal duration from very high accuracy to near 
chance responding on both protocols (see Figure 3.3F for SDT). The first and last blocks 
of 20 trials consisted of standard trials on both tasks. On the 5CSRTT it was found that 
accuracy was significantly different across blocks (F(2,32)=53.22, p<0.001, Figure 3.4A) with 
a significant reduction from the start to end blocks (t(16)=4.23, p<0.001), from start to 
middle (t(16)=12.16, p=0.001) and from middle to end (t(16)=-5.35, p<0.001); indicating 
reduced accuracy with the signal duration manipulation but also an overall decrease in 
performance over the session length indicative of fatigue. Omission rate varied across 
blocks (F(2,32)=5.85, p=0.07, Figure 3.4C), with an increase from the start to middle block 
(t(16)=-4.15, p=0.001), while an intermediate rate of omissions was found in the end block 
that did not differ from the start or middle blocks. Response latency (F(2,34)=0.78, ns, Figure 
3.4E) and reward latency (F(2,32)=3.09, ns, Figure 3.4G) did not differ between blocks on 
the 5CSRTT. On the other hand, although there was a significant effect of block on 
accuracy on the SDT (F(2,34)=37.48, p<0.001, Figure 3.4B) this was due to the reduced 
stimulus duration in the middle block and was not reduced from the start to end blocks 
(t(17)=1.35, ns). There was only a single rat that recorded any omissions and therefore 
there was no effect of block on omission rate on the SDT (F(2,34)=1.00, ns, Figure 3.4D). 
Also in contrast to the 5CSRTT, response latency on the SDT was reduced (F(2,34)=11.00, 
p<0.001, Figure 3.4F) from start to the middle block (t(17)=5.12, p=0.001) and middle to the 
end block (t(17)=-2.87, p=0.011), indicating rats were responding faster across the session. 
In addition, centre latency was altered (F(2,34)=53.54, p<0.001, Figure 3.4H) between start 
and middle blocks (t(17)=8.32, p<0.001) and start and end blocks (t(17)=7.59, p<0.001) but 
not middle and end blocks (t(17)=1.34, ns). It was noted that centre latency was more 
variable in the start block on SDT and an individual plot of centre latency across trials has 
been provided as an example of the higher values commonly observed during the initial 
trials of a session (Figure 3.5A,B). 
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Figure 3.4 The reduced signal duration session 
The session was broken into blocks for the first 20 standard trials (start), the reduced signal durations 
(middle) and the final 20 standard trials (end) on the 5CSRTT and SDT. Measures from both tasks are % 
accuracy (A, B, with dotted line indicating chance accuracy), % omissions (C, D), response latency (E, F) 
and reward latency for 5CSRTT (G) and centre latency for SDT (H). *p<0.05. 
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Figure 3.5 Variability in centre latency time on the SDT across session blocks 
(A) A scatterplot of the mean centre latency values for each individual within each block. (B) A plot of an 
individual rat’s trial-by-trial values for centre latency across a session. Of interest is the occurrence of higher 




This study compared the performance of separate groups of rats on the modified SDT and 
the 5CSRTT under standard conditions and across reduced stimulus durations. Both tasks 
replicate features of the human CPT yet differ substantially in their protocol design. The 
5CSRTT is a reaction time task with spatially separated response locations, whereas the 
SDT is a signal detection task where the presence or absence of a central signal indicates 
the correct response. In addition, a number of limitations were addressed in the 
development of the SDT, including reducing the time taken to train animals and limiting 
omissions, which may occur for different reasons in rodent tasks compared to human 
studies. 
It was found that task acquisition to a comparable level of performance took 50% more 
sessions for the 5CSRTT compared to the SDT. Furthermore, the duration of each daily 
session on the SDT was nearly half the time taken for session completion on the 5CSRTT. 
Together, these findings suggest higher throughput studies would be possible with the 
SDT as more animals could be trained in less time. The investment of time required for 
operant testing is often seen as a drawback for researchers, but it is also a critical issue for 
preclinical testing (Young et al., 2009a). Therefore, tasks that can be implemented with 
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interest. Both these tasks are targeted towards measuring the construct of attention and 
vigilance; hence accuracy of responding was a critical outcome on the rodent tasks. 
Importantly, accuracy was high (>85%) and did not differ between the two tasks. On the 
other hand, errors of omission are more difficult to interpret in rodent studies and therefore 
changes were made to the SDT protocol to reduce omission rate. 
To encourage responding on every trial, rats were required to initiate trials and were then 
immediately presented with the stimuli. This ensured the rat was positioned directly in front 
of the stimuli when it was presented. By contrast, on the 5CSRTT rats may be anywhere 
within the chamber when the stimulus is presented and inaccurate responses may occur 
due to poor positioning, as indicated in Figure 1. In addition, all events in the SDT 
occurred on the same wall of the operant chamber to reduce the amount of ambulation 
required, promoting rapid and continuous task performance. Overall, these protocol 
differences resulted in negligible levels of omissions on the SDT (<0.1%) compared to the 
5CSRTT (>10%). While omission rates are an important measure on human CPT’s, they 
are a more ambiguous outcome in rodent studies because they can occur for a number of 
reasons such as changes to sensory, motoric or motivational factors (Robbins, 2002). For 
example, rodents have been observed performing behaviours such as grooming, sleeping 
and exploring while in the operant chamber. These may be considered an indicator of 
distractibility, but do not seem comparable with a lapse in attention as recorded by an 
omission in human studies. Omissions also typically increase with drug exposure, 
irrespective of the pharmacological target (Robbins, 2002; Paine et al., 2007). Because 
the rat may not be engaged in the task, it is often difficult to simply interpret the lack of 
response in terms of attentional processing. Other measures such as magazine head 
entries, trials completed as well as response and reward latencies need to be considered 
before suggesting that increased omissions reflect reduced vigilance (Amitai and Markou, 
2010). For these reasons, it is also difficult to measure response inhibition by including 
withhold responses in rodent paradigms without careful task design and interpretation. 
In comparing the effects of the reduced stimulus duration block, it was found that accuracy 
dropped as predicted for both tasks. Performance decrements can occur for a number of 
reasons so other variables were carefully considered to determine the likely reason for 
reduced accuracy. We found that the number of omissions increased when accuracy 
decreased during the variable signal durations on the 5CSRTT, which was also found by 
Fletcher et al. (2007) and has been reported in mice (Sanchez-Roige et al., 2012). Both 
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the response latency and reward latency were unchanged in the 5CSRTT across the 
session indicating variable stimulus durations do not alter response speed, which is also in 
agreement with the literature (Fletcher et al., 2007). This indicates that the rats were not 
satiated or less motivated to respond across the 5CSRTT session. 
By contrast, the reduced accuracy on the SDT reduced signal duration trials was not 
accompanied by an increase in omissions. However both response latency and centre 
latency were reduced during the variable stimulus duration block. Response latency was 
transiently reduced when stimulus duration varied. As stimuli are shorter than the standard 
1s duration, response times may be faster due to rats moving to the chosen response side 
at signal offset. Centre nose poke latency was also reduced from the start block to the 
variable stimulus duration block and remained low for the final block of trials, indicating an 
effect of session rather than a transient shift due to changes in stimulus properties. 
Because occasional large latency values were seen in the start block for individual rats 
(see Figure 4B), we suggest this reduction in centre latency time maybe due to habituation 
to the chamber during the first block of trials. Distractions, such as odours from the 
previous animal, and competing behaviours may reduce within a few trials as the rat 
becomes more focussed on performing the task. Despite the SDT trial rate being self-
paced by the rat, the rate of stimuli presentation was roughly double that of the 5CSRTT 
(average inter-stimulus interval of 6.4s on SDT versus 12.7s on 5CSRTT) and was more 
similar to the fast rate used in the human CPT (commonly ranging between 0.5s - 2s) 
(Riccio et al., 2002). This indicates rats are initiating and responding on trials consistently 
and rapidly. At face level, this type of rapid and continuous responding reflects the 
monotonous pattern of responding required on the human CPT. 
Compared to versions of the human CPT, there are still a number of missing features. 
There was no response inhibition or no-go component incorporated into this task, such as 
that in the rodent 5C-CPT and many human CPT’s. However, some versions do require 
responses to both target and non-target stimuli, such as the CPT in the commercially 
available Cogtest battery. The focus of this study was on measuring attention and given 
the issues associated with correctly identifying an inhibited response in rodents, this 
component was not included. In human CPT studies a large range of visual stimuli (e.g. 
the alphabet) can be used simultaneously and easily identified by subjects, whereas this is 
not feasible in rodents. In addition, there are many versions of CPT to tax different 
processes, such as working memory and cognitive control. Given the heterogeneity in 
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human CPT design, incorporating core features like the continuous and rapid response to 
stimuli were the priorities in modifying the SDT. Additional modifications could be made in 
the future to measure other cognitive processes assessed by versions of the CPT. 
Few studies have compared alternative paradigms to the 5CSRTT, however a recent 
study by Leite-Almeida et al. (2013) showed that impulsive responding on their novel 
Variable Delay-to-Signal task correlated with impulsivity during early stages of 5CSRTT 
training (although not when attentional load increased). It is important to note the 5CSRTT 
is very useful for measuring impulsive behaviour but this has not been a priority in 
developing the SDT. Although inappropriate head entries can be made on the SDT, they 
were not punished and therefore interpretation about this behaviour is quite different to 
premature responding on the 5CSRTT. In addition, preservative responding was easily 
measured with the 5CSRTT however this was not possible with the SDT as response and 
reward occur together. Therefore, if impulsive or compulsive behaviours are of interest, the 
5CSRTT should be used. With the recent adaptation of many rodent tasks to use 
touchscreens, more tasks may be compared to the 5CSRTT using a battery approach 
(Hvoslef-Eide et al., 2015). Unfortunately, as the touchscreen chambers utilise an entire 
wall for stimulus display, rewards are delivered on the opposite side of the chamber to 
stimulus presentation. This limits the inclusion of modifications made in this study to 
control body position and promote fixation. 
Another rodent task designed to measure attention is the sustained attention task (SAT or 
dSAT when a distractor is included) (McGaughy and Sarter, 1995a). This task is also a 
type of signal detection task, however there are a number of differences. In construction, 
these include the position of the reward magazine relative to the response panel and the 
use of levers in the SAT rather than nose poke receptacles in the SDT (McGaughy and 
Sarter, 1995a). By providing the reward on the same side of the chamber, ambulation was 
reduced allowing the rat to remain in front of the stimulus throughout training. This allows 
sessions to run at an increased task pace and promotes vigilance through stillness, as in 
human CPT testing. More recent SAT papers indicate the reward delivery system has 
been moved to the same wall as stimulus presentation (Demeter et al., 2008; Paolone et 
al., 2013); however the reward is provided in a central position rather than in the location 
of the correct response and there is not a separate port for trial initiation like in the SDT. 
Additionally, on the SDT the stimulus was presented when the rat makes a central nose 
poke directly underneath the light panel, controlling body position within the chamber. By 
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comparison, stimulus onset on the SAT occurs after a variable ITI during which time the rat 
can move anywhere within the chamber. The issue of body orientation has been 
acknowledged as ITI was reduced (from 12±3s to 9±3s) and stimulus duration was 
reduced (from 1s to 0.025-0.5s) in an attempt to “constrain their behaviour and 
presumably maintain persistent orientation towards the intelligence panel” (Demeter et al. 
(2008), p. 790). The self-initiation of trials also promotes trial completion and as an 
example omission rate on SAT has been reported around 2.5%, whereas on SDT it was 
0.05% (Demeter et al., 2008). With the administration of pharmacological agents that 
typically increase omissions, self-paced trials on the SDT will allow the separation of 
inability to complete a trial from motivation or ability to start trials. The inclusion of levers 
has also limited the use of the SAT in mice, where a nose poke receptacle may be 
favourable (St Peters et al., 2011a). We have successful trained and tested 
pharmacological agents in two mouse strains using the SDT protocol with only minor 
changes, such as reward type, as the equipment used and protocol parameters were 
originally selected to accommodate both species (pilot study, unpublished). Other 
differences include the time schedule used. On the SDT, rapid trial rate was promoted 
through limited ITI’s of 2±1s versus 9±3s on the SAT. Substantial training is required for 
stable levels of performance on the SAT, with the suggestion that 4-8 months was 
required when training 5-6 days per week. This is around 80-200 sessions and 
significantly longer than the SDT training reported here, albeit stability criteria on each task 
have not been matched (Arnold et al., 2003). Therefore, there are a number of differences 
between these three tasks measuring attention that create unique forms of rodent 
performance and outcomes. 
3.2.6 Conclusions 
In summary, compared to the 5CSRTT, there were fewer training sessions and reduced 
session duration on the SDT, allowing higher throughput testing of animals. In preclinical 
settings this would reduce the time taken to test compounds, while in a research 
environment with limited operant chambers this would allow larger cohorts to be tested. 
Omissions can be difficult to interpret, particularly when they typically increase after drug 
administration, and hence modifications were made to reduce omissions on the SDT. We 
have also demonstrated that manipulating the signal duration leads to a comparable 
reduction in accuracy across both tasks. Importantly, we have controlled body position in 
relation to stimulus presentation and encouraged rapid trial progression on the SDT to 
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emulate features of the human CPT. This study highlights key differences and similarities 
between the traditional 5CSRTT and a SDT modified to meet modern demands. 
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4.1 Foreword 
The SDT has now been developed and compared to an alternative task. The next goal 
was to determine if the task was sensitive to detecting factors relevant to cognitive 
performance. Genetic and environmental housing conditions are known to have a 
significant influence on behavioural outcomes in research animals. Furthermore, strain 
and housing conditions often differ between studies making generalisations difficult. 
Therefore, it was the purpose of this study to determine how performance was altered in 
different rat strains that were housed either under standard or mildly enriched housing. 
This work was also useful in determining the importance of strain and housing conditions 
for subsequent studies. This chapter contains a perspective article published in Frontiers 
in Behavioral Neuroscience discussing the importance of considering the background 
strain and housing conditions when assessing cognition in animal models of 
schizophrenia. The second manuscript is a research article published in PLOS One 
investigating behavioural and cognitive differences between two rat strains and housing 
environments. In this paper, the effects of strain and housing conditions were first 
characterised across a behavioural test battery prior to operant training. These 
experiments were designed to provide insight into the behavioural phenotype of each 
group and confirm the housing manipulation had altered behaviour. The results indicated 
both genetic and environment factors influence aspects of behavioural and cognitive 
performance. Furthermore, there was strain by housing interactions, where the effect of 
housing was only observed in one strain. In addition, some strains appear more useful for 
certain tests, for example due to cohort variability on pre-pulse inhibition or faster 
acquisition of the SDT. Given these strains differ in a range of behavioural traits, the 
differences observed on the SDT may be due to a number of factors, including cognitive 
abilities, visual abilities or motivational factors. Therefore, strain and housing conditions 
must be carefully considered in the interpretation of cognitive performance. 
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4.2 Interaction of genotype and environment: Effect of strain and 
housing conditions on cognitive behaviour in rodent models of 
schizophrenia 
Karly M. Turner and Thomas H. J. Burne 
4.2.1 Abstract 
Schizophrenia is associated with many genetic and environmental risk factors and there is 
growing evidence that the interactions between genetic and environmental ‘hits’ are critical 
for disease onset. Animal models of schizophrenia have traditionally used specific strain 
and housing conditions to test potential risk factors. As the field moves towards testing 
gene (G) x environment (E) interactions the impact of these choices should be considered. 
Given the surge of research focused on cognitive deficits, we have examined studies of 
cognition in rodents from the perspective of GxE interactions, in which strain or housing 
manipulations have been varied. Behaviour is clearly altered by these factors, yet few 
animal models of schizophrenia have investigated cognitive deficits using different strain 
and housing conditions. It is important to recognise the large variation in behaviour 
observed when using different strain and housing combinations because GxE interactions 
may mask or exacerbate cognitive outcomes. Further consideration will improve our 
understanding of GxE interactions and the underlying neurobiology of cognitive 
impairments in neuropsychiatric disorders. 
Published: 31st July 2013 
Reference: Turner KM, Burne THJ (2013) Interaction of genotype and environment: Effect 
of strain and housing condition on cognitive behaviour in rodent models of schizophrenia. 
Front Behav Neurosci 7:97. 
Hyperlink: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728474/ 
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4.2.2 Introduction 
Schizophrenia is a complex group of disorders in which genetic vulnerability may lead to 
greater sensitivity to adverse environmental conditions (Bayer et al., 1999; van Os et al., 
2008; van Os et al., 2010; Tost and Meyer-Lindenberg, 2012). Psychiatric epidemiology 
has provided clues about biologically plausible combinations of genetic and environmental 
risk factors for the neuroscience field to examine (Caspi and Moffitt, 2006; Meyer and 
Feldon, 2010). For example, being raised in an urban environment has repeatedly been 
linked to an increase in psychotic symptoms, however this risk is amplified in individuals 
with a genetic predisposition to psychosis (van Os et al., 2004; Krabbendam and van Os, 
2005; Spauwen et al., 2006; Weiser et al., 2007). Unravelling the neurobiological changes 
that lead to vulnerable or resilient phenotypes may provide important information about 
how gene (G) x environment (E) interactions occur and provide clues for the research 
community. Rodents have been used to model biologically plausible risk factors and we 
are beginning to appreciate the complexity of GxE interactions on outcomes relevant to 
schizophrenia. With the recent focus on measuring cognitive deficits in rodent models 
(Jentsch, 2003; Kellendonk et al., 2009; Young et al., 2009a; Keeler and Robbins, 2011; 
Bussey et al., 2012a) and the known influence of strain and housing conditions on 
cognitive measures (Chapillon et al., 2002; Harker and Whishaw, 2002; Wolff et al., 2002; 
Pena et al., 2009; Simpson and Kelly, 2011), it is important to consider whether 
schizophrenia-related outcomes are dependent on the strain or housing conditions used. 
Currently there is a lack of animal models of schizophrenia investigating these GxE 
interactions on cognitive outcomes. For example, a PubMed search using the terms 
‘strain’, ‘housing’, ‘schizophrenia’, ‘cognition’ and ‘animal model’ returned no results; 
substituting ‘strain’ for ‘gene’, and ‘housing’ for ‘environment’ or ‘enrichment’ only returned 
7 research articles although none in which housing conditions were compared. Guidelines 
for cognitive testing in rodents have been established to improve the progression of novel 
drug treatments, and the use of animal models to examine GxE interactions on 
established cognitive tests are needed to bridge the translational gap. The next challenge 
is, therefore, to develop animal models to test the hypothesis that GxE interactions affect 
cognitive behaviour in animal models of schizophrenia. This article focuses on the 
consequences of strain and housing conditions on cognitive outcomes in rodent models of 
schizophrenia and how these factors may be useful in modelling GxE interactions. 
 
Chapter 4. Genetic and Environmental Conditions 
 62 
4.2.3 Modelling the cognitive deficits in schizophrenia 
Cognitive deficits are a core symptom group associated with schizophrenia and are the 
strongest predictor of functional patient outcomes (Green et al., 2000). While cognitive 
remediation techniques are beneficial, current drug treatments to improve cognitive deficits 
are largely ineffective and the failure to translate drug findings from animal models to 
clinical settings has impeded progress (Pratt et al., 2012). To guide future research an 
initiative of the NIMH was formed, MATRICS, to make suggestions for the development of 
cognitive testing in animal models of schizophrenia (Green et al., 2004b; Young et al., 
2009a). Based on the core cognitive deficits found in patients with schizophrenia seven 
cognitive domains were identified including working memory and attention/vigilance 
(Green et al., 2004b). From these domains various clinical tests were selected by the 
follow-up group CNTRICS to be used in validating drug efficacy and to improve 
consistency between research groups (Carter and Barch, 2007). In order to bridge the 
translational gap, tests used in animal models have also been considered and selected for 
future use and development (Gilmour et al., 2013; Lustig et al., 2013). Domains such as 
verbal learning and memory cannot be translated to rodents, however processes such as 
attention, memory and executive control can be measured in a number of ways (Powell 
and Geyer, 2007). The tests selected for rodents that best reflect the cognitive constructs 
measured in patients include the 5CSRTT (Robbins, 2002) and dSAT for measuring 
attention (Lustig et al., 2013), the attentional set-shifting task (ASST) (Birrell and Brown, 
2000) and reversal learning (Izquierdo and Jentsch, 2012) as measures of executive 
control and the radial arm maze (RAM) and delayed match to position (DMTP) task 
(Dudchenko, 2004), which provide the best assessment of working memory. 
The CNTRICS panel reviewed the use of these tests in both rats and mice, however the 
selection of species and strain should be determined based on suitability for the 
experimental manipulation and the cognitive test being implemented (Young et al., 2009a). 
The use of non-human primates may also be warranted where processes need to be 
defined differently for humans and rodents, for example in tests of working memory 
(Castner et al., 2004). For example, GxE interactions were examined on cognition 
outcomes in an animal model of schizophrenia using catechol-o-methyl transferase 
(COMT) knockout mice and the 5CSRTT (Papaleo et al., 2012b). At baseline there was no 
effect of sex or genotype on cognitive performance, however by manipulating the inter-trial 
interval, measures of impulsivity were found to differ by sex and genotype. After a mild 
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stressor, males had impaired performance in terms of accuracy and impulsivity measures 
and this was particularly so for males with reduced (+/-) and absent (-/-) COMT. Other 
measures were found to differ based on sex and genotype only after reducing motivation. 
This study illustrates that phenotypes based on sex or genotype may not be readily 
apparent, however, differences were revealed after manipulating environmental 
conditions. These findings are in agreement with the suggestion that genes alone do not 
lead to schizophrenia, but they may predispose an individual to greater vulnerability 
following exposure to certain environmental insults or ‘hits’. 
4.2.4 Environmental conditions and cognition 
Epidemiological evidence for the role of environmental factors suggests that housing 
environment may be an important factor for modelling schizophrenia in rodents (McDonald 
and Murray, 2000). Housing conditions can have a significant influence on rodent 
behaviour and have been used to induce stress or anxiety and to alter cognitive 
development (van Praag et al., 2000; Nithianantharajah and Hannan, 2006; Burrows et al., 
2011; Simpson and Kelly, 2011).  Environmental enrichment has been incorporated to 
enhance sensory and motor experience through the inclusion of novel objects, expanded 
caging and larger social groups (van Praag et al., 2000). Environmental enrichment has 
been linked to a number of brain-related outcomes, such as increased brain weight, 
increased branching and synapse formation in the cortex, increased expression of brain-
derived neurotrophic factor (BDNF), glial-cell-derived neurotrophic factor (GDNF) and 
nerve growth factor (NGF) and increased acetylcholine levels (see review van Praag et al. 
(2000)). Many of these factors are likely to affect cognitive functioning, for example NGF 
and BDNF are both known to play a role in learning, while acetylcholine levels have been 
shown to correlate with attentional performance in rodents (St Peters et al., 2011b). 
Housing conditions have been difficult to standardise across research groups, particularly 
when enrichment is used. Rather than viewing this noise as a nuisance, it could be seen 
as an opportunity to investigate how environmental conditions interact with proposed risk 
factors (Toth et al., 2011). 
Rodents reared in more stimulating conditions often acquire tasks after fewer trials (Park 
et al., 1992), have reduced age-related deficits (Soffie et al., 1999; Harati et al., 2011) and 
recover from injury faster (Hicks et al., 2002) (see Pena et al. (2009)). This may indicate 
phenotypes are being rescued in enriched environments or that deficits only develop in a 
deprived environment. In some cases, such as animal models of depression, standard 
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housing may be largely contributing to the phenotype, possibly by reducing an animal’s 
compensatory ability to deal with additional challenges (Brenes et al., 2009). The brain 
may require stimulation beyond that provided in standard housing to develop sufficient 
connectivity and functionality to detect higher order cognitive deficits. Whether enrichment 
should be considered as a therapeutic intervention or the standard conditions required for 
developing a ‘normal’ brain continues to be debated (Wurbel, 2001). 
4.2.5 Genetic background and cognitive performance 
Mutant mouse models have been used to investigate other key candidate genes linked to 
schizophrenia (Chen et al., 2006). Despite the availability of tasks for cognitive testing in 
rodents, a recent review by Arguello and Gogos (2006) did not report any mutant mouse 
models in which the “top 30” genes linked to schizophrenia had been tested on an 
attentional paradigm. Considering the need to investigate cognitive symptoms in animal 
models, there is an obvious gap that needs to be addressed. The genetic risk for 
schizophrenia is likely to be the result of hundreds or even thousands of genes of small 
effect (Wray and Visscher, 2010). Systematically testing each individual mutation is 
unlikely to replicate the disorder, nor is this approach feasible. However, specific genetic 
mutants may be useful for identifying the origin of cognitive endophenotypes of 
schizophrenia (see review Kellendonk et al. (2009)). While using single gene mutants 
provides information about a particular gene of interest (Papaleo et al., 2012b), the 
polygenic nature of schizophrenia may be better modelled by comparing different strains. 
Strain-dependent changes in behaviour have been observed on many cognitive tasks and 
in response to drugs; but these changes are also dependent on the manipulation applied 
(Andrews et al., 1995; Schmitt and Hiemke, 1998; Mirza and Bright, 2001; Harker and 
Whishaw, 2002; Wahlsten et al., 2003; Zamudio et al., 2005; Higgins et al., 2007). For 
example, a widely used task in animal models of schizophrenia, pre-pulse inhibition of the 
acoustic startle response (PPI), is a well validated test of sensorimotor gating but results 
are known to vary depending on the background strain (Rigdon, 1990; Glowa and Hansen, 
1994; Varty and Higgins, 1994; Varty et al., 1999; Swerdlow et al., 2001; van den Buuse, 
2003). Given the variability on this pre-attentive task, it is not surprising that strain 
differences have also been reported using more sophisticated cognitive tasks, such as the 
5CSRTT (Didriksen and Christensen, 1993; Mirza and Bright, 2001; Higgins et al., 2007; 
Auclair et al., 2009). These studies also demonstrate the variability between studies using 
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the same strain, which may be due to variation in the protocol used or the source of the 
strain (Andrews, 1996; Karl et al., 2011). 
Rat models of schizophrenia have been developed predominantly using two albino strains, 
however the reasons for these selections are not always obvious. Furthermore, studies of 
schizophrenia-related manipulations comparing rat strains are lacking. The neonatal 
ventral hippocampal lesion model was compared in the outbred SD and two inbred strains, 
Lewis and Fischer 344, which differed in stress responsivity (Lipska and Weinberger, 
1995). For example, SD and Lewis rats show habituation of the HPA-axis response to a 
repeated restraint stress paradigm, whereas F344 rats do not habituate within or between 
stress-inducing sessions (Dhabhar et al., 1997). As predicted the hyper-responsive F344 
strain showed greater behavioural vulnerability to the neonatal lesion, while the hypo-
responsive Lewis rats showed greater resistance when both were compared to the SD 
strain. Thus, stress responsivity is a critical consideration both for models utilising stressful 
manipulations and for the interpretation of behavioural results from different strains 
(Faraday, 2002). Spontaneous and amphetamine-induced hyperlocomotion varied across 
development with strain, indicating genetic predisposition has a critical role in determining 
the phenotype derived from this neurodevelopmental model, although cognitive outcomes 
were not assessed in this study (Lipska and Weinberger, 1995). 
4.2.6 GxE interactions and cognitive endophenotypes 
The focus of GxE interaction studies in animal models of schizophrenia has taken 
advantage of the genetic tools available in mice, comparing mutant and control animals 
after adverse environmental exposures such as immune activation, stress or drug 
administration (Kannan et al., 2013). The influence of enriched housing conditions on 
rodent models of schizophrenia has been addressed by only a few studies (Karl et al., 
2007; McOmish et al., 2008; Ishihama et al., 2010). However, the neurological and 
behavioural effects of environmental enrichment have been assessed in a range of other 
animal models including Huntington’s disease, Alzheimer’s disease, Parkinson’s disease, 
Epilepsy and drug addiction ((Bezard et al., 2003), see reviews Nithianantharajah and 
Hannan (2006); Laviola et al. (2008)). For example, the influence of environmental 
enrichment has been well demonstrated using the transgenic mouse model of 
Huntington’s disease (van Dellen et al., 2000). This neurodegenerative condition has a 
genetic cause, yet mice housed in enriched cages show delayed onset and progression of 
both the motor and cognitive deficits compared to standard housed controls (Hockly et al., 
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2002; Nithianantharajah and Hannan, 2006; Pang et al., 2006). Using animal models of 
schizophrenia, it will not only be important to address the detrimental effects of the 
environment, but also conditions that have a protective influence (Takuma et al., 2011; 
Pang and Hannan, 2013). 
With the aim of developing biologically-relevant animal models of schizophrenia, studies 
using a GxE approach are rapidly emerging (Millstein et al., 2006; Millstein and Holmes, 
2007; Oliver and Davies, 2009; Desbonnet et al., 2012; Hida et al., 2013; Petrovszki et al., 
2013). Prenatal stress followed by acute stress during adulthood was used in three rat 
strains to examine how genetic background interacted with adverse environmental 
conditions to alter hippocampal gene expression (Neeley et al., 2011a). Five relevant 
genes (Nr3c1, Chrna7, Grin2b, Bdnf, Tnfα) were found to be altered by either strain or 
stress treatments, however changes were inconsistent across strains indicating a 
modulatory role of genotype. A second experiment comparing these strains using a stress 
protocol found that changes in Bdnf expression and associated pathways were also strain 
dependent (Neeley et al., 2011b). These studies demonstrate the importance of strain 
selection and genetic diversity in understanding GxE interactions. 
In another recent study, rats were exposed to two commonly used risk factors, post 
weaning social isolation and chronic ketamine treatment, and selectively bred based on 
behavioural deficits relevant to schizophrenia to produce a vulnerable sub-strain 
(Petrovszki et al., 2013). After 15 generations, four groups were compared on three 
behavioural tests and the results were accumulated into an overall score. Rats with a 
standard genetic background raised under standard conditions were used as a control 
group. The environment-only group consisted of genetically-naïve rats that were then 
isolated and treated with ketamine. Rats from the selectively bred vulnerable sub-strain 
that were raised under standard conditions were used as the genetic-only group. And 
finally rats from the vulnerable sub-strain that also underwent social isolation and chronic 
ketamine treatment were used to investigate the GxE interaction. The GxE group scored 
the highest on schizophrenia-relevant deficits and the control group scored the lowest, 
indicating that both genetic and environmental insults were important. The behavioural 
tests used assess nociception, sensorimotor gating and recognition memory, which do not 
address the key cognitive domains identified by CNTRICS and therefore further work 
would be required to understand the influence of these manipulations on cognitive deficits 
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relevant to schizophrenia. Nevertheless, this study does present a new way of 
investigating previously tested risk factors. 
4.2.7 Future Recommendations 
A recent review of mouse models of GxE interactions relevant to schizophrenia has 
discussed a comprehensive list of weaknesses to be addressed by future studies (Kannan 
et al., 2013). The authors suggested standardising strain and housing conditions to reduce 
variability between studies. However, genetic and environmental choices clearly alter 
outcomes relevant to schizophrenia and phenotypes may only be detected under specific 
strain or housing conditions. Furthermore, the way genetic and environmental conditions 
interact to protect or exacerbate phenotypes is of key importance in understanding the 
pathways that lead to schizophrenia. 
Investigating genetic changes, such as mutant mouse models, may be easily replicated 
across laboratories, however environmental manipulations are more difficult to 
standardise. For example, wildtype mice show different behavioural phenotypes when 
tested under similar conditions but at different laboratories (Crabbe et al., 1999). More 
recently, heterozygous neuregulin mutant mice showed different behavioural phenotypes 
when tested in different laboratories, despite being on the same genetic background (Karl 
et al., 2011). Although these differences may be unavoidable, it is recommended the 
housing conditions of rodents be clearly stated in research methods. Unfortunately many 
articles do not list the forms of enrichment used (such as type of bedding, shelters, wood 
chews and tubes) however these should be indicated even if considered to represent 
‘standard’ housing conditions. Recommending a standardised enrichment protocol would 
reduce variability between experiments, but would also limit the scope of enrichment 
studies (Wurbel, 2002). Protocol design should take into consideration the species-specific 
relevance of environmental changes, the timing and duration of exposure, the ethical 
implications and the reproducibility of the chosen design. Therefore, optimal enrichment 
conditions should be selected based on experimental aims. 
Future studies could take a number of directions, including the use of GxG and ExE 
studies to identify the influence of genetic and environmental factors; as well as 
understanding the mechanisms that lead to increased vulnerability (Giovanoli et al., 2013). 
To more fully assess the effects of GxE interactions on cognitive endophenotypes, the 
field also needs to improve the range of the behavioural tasks available. The potential 
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therapeutic benefit of improved animal models may be limited by the sensitivity of the 
behavioural measures employed. Incorporating GxE clues from epidemiology into our 
animal models, and improving assessment techniques will advance our understanding of 
schizophrenia. 
4.2.8 Conclusion 
There is clear evidence to show that genetic and environmental conditions alter cognitive 
outcomes in rodents. However, the lack of studies comparing cognitive deficits in rodent 
models of schizophrenia using different strain and housing conditions is surprising. 
Schizophrenia develops from the complex interaction of GxE and we need to incorporate 
this complexity into animal models to understand the etiology of schizophrenia. While 
disorders, such as schizophrenia, cannot be fully encapsulated in a rodent model, the use 
of endophenotypes in carefully controlled experiments may allow us to understand some 
of the mechanisms behind GxE interactions. Current animal models are falling short of 
replicating the complex suite of risk factors implicated in schizophrenia and using a 
different strain or housing condition may provide an accessible stepping stone towards 
understanding altered brain development. Given the infancy of GxE interaction research in 
animal models of schizophrenia, manipulating these factors in existing as well as novel 
animal models will not only be informative in terms of GxE interactions, but will also allow 
researchers to determine a suitable foundation for further exploration. GxE interaction 
models will be particularly informative for understanding the role of vulnerable and resilient 
phenotypes in determining the influence of secondary ‘hits’ on cognitive outcomes in 
schizophrenia. 
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4.3  Comprehensive behavioural analysis of Long Evans and Sprague-
Dawley rats reveals differential effects of housing conditions on 
tests relevant to neuropsychiatric disorders 
Karly M. Turner and Thomas H. J. Burne 
4.3.1  Abstract 
Genetic (G) and environmental (E) manipulations are known to alter behavioural outcomes 
in rodents, however many animal models of neuropsychiatric disorders only use a 
restricted selection of strain and housing conditions. The aim of this study was to examine 
GxE interactions comparing two outbred rat strains, which were housed in either standard 
or enriched cages. The strains selected were the albino SD rat, commonly used for animal 
models, and the other was the pigmented Long Evans (LE) rat, which is frequently used in 
cognitive studies. Rats were assessed using a comprehensive behavioural test battery 
and included well-established tests frequently employed to examine animal models of 
neuropsychiatric diseases, measuring aspects of anxiety, exploration, sensorimotor gating 
and cognition. Selective strain and housing effects were observed on a number of tests. 
These included increased locomotion and reduced pre-pulse inhibition in LE rats 
compared to SD rats; and rats housed in enriched cages had reduced anxiety-like 
behaviour compared to standard housed rats. LE rats required fewer sessions than SD 
rats to learnt operant tasks, including a signal detection task and reversal learning. 
Furthermore, LE rats housed in enriched cages acquired simple operant tasks faster than 
standard housed LE rats. Cognitive phenotypes in animal models of neuropsychiatric 
disorders would benefit from using strain and housing conditions where there is greater 
potential for both enhancement and deficits in performance. 
Published: 26th March 2014 
Reference: Turner KM, Burne THJ (2014) Comprehensive behavioural analysis of Long 
Evans and Sprague-Dawley rats reveals differential effects of housing conditions on tests 
relevant to neuropsychiatric disorders. PLoS ONE 9:e93411. 
Hyperlink: http://www.ncbi.nlm.nih.gov/pubmed/24671152   
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4.3.2 Introduction 
Complex neuropsychiatric disorders, such as schizophrenia and autism, are affected by 
multiple genetic and environmental risk factors, possibly through the interaction between a 
vulnerable genotype (G) and an adverse environmental (E) ‘hit’ (Bayer et al., 1999; van Os 
et al., 2010; Tost and Meyer-Lindenberg, 2012). For example, cannabis use and having 
the catechol-o-methyl transferase (COMT) valine allele are separately implicated as 
schizophrenia risk factors (van Os et al., 2002; Chen et al., 2004) and the functional 
polymorphism in the COMT gene has been found to alter the effects of cannabis (Egan et 
al., 2001; Collins, 2004; Henquet et al., 2006). However, schizophrenia is associated with 
hundreds of genes of small effect rather than a few genes of large effect (Wray and 
Visscher, 2010). Genetic models of relevance to schizophrenia have investigated the 
functions of individual candidate genes (Chen et al., 2006; Kellendonk et al., 2006; Karl et 
al., 2007; O'Tuathaigh et al., 2007; McOmish et al., 2008; Papaleo et al., 2012a). While 
these models provide important information about the gene of interest, they cannot 
encapsulate the polygenic nature of this disorder. On the other hand, rodent strains were 
bred to produce consistent strain-dependent phenotypes that differ on a range of 
behavioural and physiological measures (Didriksen and Christensen, 1993; Andrews, 
1996; Swerdlow et al., 2000; Faraday, 2002; Aubert et al., 2006). Comparing strains may 
provide an avenue to investigate how polygenetic vulnerability interacts with environmental 
conditions to produce deficits relevant to neuropsychiatric disorders (Crawley et al., 1997). 
For example, a comparison of SD, Lewis and Fischer 344 rat strains demonstrated that 
F344 rats, which are more responsive to stress (Faraday, 2002) had the greatest 
vulnerability to a neonatal ventral hippocampal lesion (Lipska and Weinberger, 1995) 
which is used as a neurodevelopmental animal model of schizophrenia. 
Both genetic and environmental risk factors have been investigated using animal models 
of neuropsychiatric disorders, however most of these manipulations have only been tested 
under standard housing conditions. Standard housing conditions vary between facilities 
and over time, however generally this is referring to a rather barren cage containing 
nesting material and minimal in dimensions. Environmental enrichment in rodents 
incorporates greater sensory, cognitive and motor stimulation (Nithianantharajah and 
Hannan, 2006) and may be considered therapeutic, or conversely standard housing may 
be seen as impoverished (van Praag et al., 2000; Hutchinson et al., 2005). Whether 
effects of enrichment are positive or negative may also depend on the animal model or 
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disorder being investigated. Either way, enriching the housing conditions of laboratory 
rodents has been found to alter behaviour, stress hormone levels, neurogenesis, dendrite 
structure, and gene expression (see review Simpson and Kelly (2011). We need to 
consider how standard housing conditions are impacting on brain development, especially 
with increasing research focussed on GxE interactions (Burrows and Hannan, 2013). 
Despite evidence that environmental enrichment has reversed or retarded deficits in 
animal models of neurological disorders, few studies have assessed these effects in 
rodent models of schizophrenia (Laviola et al., 2008). 
The validity of both genetic and environmental animal models has been assessed using 
tests that are relevant to the disorder being modelled. With many neuropsychiatric 
disorders diagnosed based on cognitive and behavioural symptoms, assessment of animal 
models also relies on measuring relevant behavioural characteristics (Moy et al., 2007). 
Using tests employed in behavioural screens, strain and housing conditions have been 
shown to affect multiple behavioural domains including locomotion, anxiety, pre-pulse 
inhibition and acquisition of operant tasks. However, few papers have directly evaluated 
strain and housing manipulations across a broad screen of behavioural tests in the same 
study, making comparisons between tasks difficult and often conflicting (Simpson and 
Kelly, 2011). Therefore, the aim of this experiment was to behaviourally phenotype 
pigmented LE, which are commonly used in cognitive experiments, and compare them to 
albino SD rats, which are frequently used to model neuropsychiatric disorders after they 
are reared in either standard or enriched housing conditions. Tests used in the behavioural 
test battery were selected to measure a broad range of behaviours that are frequently 
assessed in animal models of neuropsychiatric disorders. These tests highlight the 
behavioural alterations between strains and housing conditions and suggest animal 
models should consider using different strains for different purposes. 
4.3.3 Materials and methods 
4.3.3.1 Animals and housing 
Nine-week old male SD (Asmu:SD) and LE (Asmu:LE) rats were both obtained at weaning 
(3 weeks of age) from Monash Animal Services (Melbourne, Australia) to ensure transport 
and housing prior to weaning were equivalent. Male rats were selected as sex differences 
were not being examined in this study and males are more commonly used in similar 
experiments. They were then housed in a room maintained at 21 ± 2°C and 60% humidity 
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and on a 12-h light/dark cycle (lights on 0600 h). Standard rat chow (Specialty Feeds, WA, 
Australia) and water were supplied ad libitum. On arrival rats were pair-housed in either 
standard or enriched cages (n=8/strain/housing) with groups balanced for initial body 
weight and pairs matched to avoid excessive dominance. Standard housing consisted of a 
polypropylene cage (41 x 28 x 24 cm) with a high top wire lid, aspen chip bedding (Able 
Scientific, WA, Australia), nesting, and wood chew (Able Scientific, WA, Australia). The 
alternative enriched housing condition used a larger sized polypropylene cage (54 x 36 x 
30 cm) with a high top wire lid, bedding, nesting, wood chew, an enclosed shelter (15 x 15 
x 12 cm) and running wheel (20.3 cm diameter, Super Pet Run-Around Wheel, IL, USA). 
Rats were weighed weekly and all testing was conducted during the light phase. Bicycle 
computers were used to record running wheel rotations (Bontrager Trip 2, Trek Bicycle 
Corporation, WI, USA). Rats were observed to play and jump on the wheels as well as 
running as a pair simultaneously as juveniles, which interfered with the accuracy of 
running distance. However, the values recorded confirmed the wheels were used 
particularly during the dark phase (data not presented). After completion of this study, rats 
were used for a follow-on experiment using the operant protocol. All procedures used were 
performed with the approval from The University of Queensland Animal Ethics Committee, 
under the guidelines of the National Health and Medical Research Council of Australia. 
4.3.3.2 Behavioural test battery 
The effects of strain and housing conditions were characterised using a behavioural test 
battery that began at 9 weeks and concluded at 12 weeks of age. This was followed by a 
3-week rest period and one week of food restriction before operant training started. Rats 
were weighed weekly and food restriction was delayed until adulthood when free-feeding 
weight stabilised to avoid changes in growth. The tests selected assessed a range of 
domains including anxiety-related behaviour, spatial memory, exploration, locomotion and 
sensorimotor gating. These tests have been widely used and standard protocols were 
adopted (Crawley, 1999; Karl et al., 2003; Burne et al., 2004). Tests were conducted 
during the light phase on separate days in the following order to reduce the influence of 
test order: elevated plus maze, hole board, light-dark emergence, open field, 8-arm radial 
maze, Y-maze, PPI of the acoustic startle response and finally operant task acquisition. 
Although the elevated plus maze may be more stressful than tests conducted afterwards, 
it is also very sensitive to order effects and hence was conducted first. An extra rest day 
was included after the elevated plus maze. All behaviours were recorded using automated 
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software or scored blind to treatment. Computerised tracking software, EthoVision ver.3.1 
(Noldus, Netherlands) was used to analyse video recordings from a camera mounted 
above each testing arena. Ethologically relevant behaviours were scored using Observer 
ver.5.0 (Noldus, Netherlands). Rats were habituated to the testing room 30 minutes prior 
to testing and the apparatus was cleaned with 70% ethanol between each trial. 
Elevated plus maze (EPM): The elevated plus maze was used to measure anxiety-related 
behaviours, but also provided measures of exploration and locomotion (Pellow et al., 
1985). The plus-shaped platform was made of opaque grey plastic, elevated on a stand 
(70 cm) with two arms enclosed by walls (10 x 47 x 40 cm; 1 lux) and the other two arms 
open (10 x 47 cm; 8 lux). Rats were placed in the centre of the maze facing an open arm 
and allowed to explore the maze for 10 minutes. Measures included percentage of time 
spent on the open arms and distance travelled. 
Equation 4.1 EPM percentage time on open arms: 
 
  %  𝑶𝑶𝑶𝑶𝑶𝑶𝑶𝑶   =
𝒕𝒕𝒕𝒕𝒕𝒕𝒕𝒕  𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔  𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐  𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂
𝒕𝒕𝒕𝒕𝒕𝒕𝒕𝒕  𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔  𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐  𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂+ 𝒄𝒄𝒄𝒄𝒄𝒄𝒄𝒄𝒄𝒄𝒄𝒄  𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂
×  𝟏𝟏𝟏𝟏𝟏𝟏    
These results were further investigated by scoring ethologically relevant behaviours such 
as rearing, grooming and risk assessment behaviours were also scored. Rearing was 
defined as standing with fore limbs lifted; grooming was scored when the animal was 
licking and cleaning their body; head dip was scored when the rats head was pointed 
downward over the edge of the platform; scanning was scored when the rats head was 
pointed outward and upward while the rat was stationary; and stretch attend posture was 
defined as stretching the head forward without stepping forward. If behaviours were split 
for zone, protected describes behaviours in the closed arms and centre zone, while open 
describes behaviours that occurred on the open arms. 
Hole board: The hole board test was used to measure exploration and locomotion (File 
and Wardill, 1975). An opaque grey arena (60 x 60 x 40 cm; 8 lux in centre) with an 
elevated floor containing four holes (4 cm wide, 12.5 cm from each corner) was used. The 
rat was placed into a corner and explored the arena for 10 minutes. Measures included the 
distance travelled, time spent in the centre of the arena and the duration, frequency and 
latency to perform head dipping, grooming and rearing behaviour. 
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Light dark emergence: Light dark emergence was used as an alternative measure of 
anxiety-related behaviours and exploration (Arrant et al., 2013). The dark compartment 
provides shelter and an increase in the time taken to leave the shelter to explore the open 
compartment is indicative of greater anxiety. A plastic arena (44 x 44 x 30 cm, 7 lux in 
open) was divided such that half the arena was open and the other half was completely 
enclosed with the exception of a central doorway (8 x 11 cm). To start the 10-minute trial 
the rat was positioned at the doorway and required to enter the dark section. The key 
measures were time to emerge from the dark chamber and the number of transitions 
between the light and dark sections. 
Open field: The open field test was used to measure locomotion, however the use of 
different zones within the arena also provides information on anxiety-related behaviours 
(Prut and Belzung, 2003). Rats were placed in the centre of an open arena (60 x 60 x 40 
cm; 5.5 lux) and tracked over 10 minutes. Measures included distance travelled, time 
spent in the centre and crossings into the centre. 
8-Arm radial maze: The 8-arm radial maze has been used for a number of protocols to 
assess different aspects of cognition. A simplified protocol was used in this study to 
investigate exploratory behaviour in a novel arena (Olton and Samuelson, 1976; Nguyen 
et al., 2006). The opaque grey plastic maze consisted of 8 arms (60 x 10 x 20 cm, 3 lux) 
joined by a central octagon (25.5 cm wide; 8 lux). The rat was placed in the centre and the 
order and timing of arm visits was recorded over 10 minutes. The rat should visit each arm 
once until all arms have been explored. Revisiting an arm prior to exploring all 8 was 
considered an error. The number of errors and time taken to visit all the arms were 
recorded, as well as distance travelled. 
Y-maze: Three arms of the 8-arm radial maze were used for this test and the other arms 
were blocked off at the centre. Two trials were conducted to investigate short-term 
recognition memory. During the first trial the rat was placed at the end of the ‘home’ arm 
and given access to one other arm, referred to as the ‘familiar’ arm for 10 minutes. After an 
inter-trial interval of one hour the rat was placed back in the home arm and has access to 
the familiar arm in addition to a previously occluded arm, the ‘novel’ arm for 5 minutes. The 
amount of time spent in each arm and the number of transitions was recorded. The rat 
should spend more time exploring the novel arm if it has remembered visiting the home 
and familiar arms in the previous trial. Within each pair the familiar and novel arm was 
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alternated between the left and right arms. The ends of these arms were decorated with 
either vertical or horizontal barred patterns to facilitate recognition. 
Pre-Pulse Inhibition (PPI) of Acoustic Startle Response (ASR): PPI was used as a 
measure of sensorimotor gating, whereby a startle reflex is reduced if a weaker pre-pulse 
precedes the startling pulse. Responses were recorded in startle chambers by placing rats 
into clear Plexiglas cylinders on platforms connected to piezoelectric transducers, which 
were housed in sound attenuating chambers containing speakers and controlled using 
specialist software (SR-Lab, San Diego Instruments). The session consisted of pseudo-
randomised presentation of the different trial types. The ASR was measured using a single 
40 ms pulse at various intensities (70, 80, 90, 100, 110, 120 dB) and within-session 
habituation was measured as the change in startle response to a 110dB pulse presented 
at the start, middle and end of the session. Pre-pulses at a three different intensities (74, 
78, 86 dB) were played at a variety of intervals (8, 16, 32, 64, 128, 256 ms) prior to the 
startle pulse (120 dB) to assess pre-pulse inhibition. Each trial type was presented five 
times and the median was used for further analysis. Percentage PPI was calculated as 
follows: 
Equation 4.2 % Pre-pulse Inhibition 
 
%𝑷𝑷𝑷𝑷𝑷𝑷 =
𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔  𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂  𝑨𝑨𝑨𝑨𝑨𝑨  𝒕𝒕𝒕𝒕𝒕𝒕𝒕𝒕𝒕𝒕– 𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔  𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂  𝒇𝒇𝒇𝒇𝒇𝒇  𝒑𝒑𝒑𝒑𝒑𝒑 − 𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑  𝒕𝒕𝒕𝒕𝒕𝒕𝒕𝒕𝒕𝒕
𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔𝒔  𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂𝒂  𝑨𝑨𝑨𝑨𝑨𝑨  𝒕𝒕𝒕𝒕𝒕𝒕𝒕𝒕𝒕𝒕
×𝟏𝟏𝟏𝟏𝟏𝟏 
4.3.3.3 Operant training 
Training was conducted in operant chambers housed in ventilated, sound attenuating 
boxes (50 x 50 x 50cm, Med Associates Inc., St. Albans, VT, USA). Rats were initially 
trained to collect a reward (45 mg, F0021, dustless precision pellet, Bioserv, Frenchtown, 
NJ, USA) from one of two receptacles equipped with head entry detectors that were 
located on the left and right side of the wall. Every head entry was rewarded with one 
pellet until 50 pellets were delivered from each receptacle or until the session ended after 
20 mins. Once rats had attained >80 pellets on 2 days they were trained to nose poke a 
central aperture when it was illuminated to receive a reward, which was delivered to either 
the left or right receptacle. Finally, after learning to initiate trials by nose poking, the signal 
detection task was implemented. After initiating trials with a nose poke, a panel of 9 green 
LEDs were either illuminated (signal trial) or remained off (non-signal trial). After 1s both 
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the left and right magazines illuminated to indicate the rat should make a choice. 
Depending on the visual cue presented, a head entry into one side would lead to a pellet 
and the other had no consequence. The pairing of a trial type (signal or non-signal) and 
the correct magazine side (left or right) remained the same for each individual but was 
balanced across the group. Between trials there was a variable inter-trial interval (1, 2, 3s) 
and the session concluded after either 100 trials or 30min. The chamber was operated 
using MED-PC for Windows software and interfacing (Med Associates Inc., St. Albans, VT, 
USA). 
4.3.3.4 Statistical analysis 
Results were analysed using SPSS software (ver. 20, SPSS Inc., Chicago, Illinois). A 
power analysis determined that a group size of 8 was required to detect a difference with 
an effect size of 0.85 with 95% power and at the criterion of p<0.05. Key behavioural 
measures were assessed for skewness and kurtosis for confirm the assumption of normal 
distribution. The main effect of Strain (SD or LE) and Housing (standard or enriched) on 
key parameters for each test was subjected to an ANOVA or repeated measures ANOVA 
was applied where required. Significant interactions were then assessed using 
independent t-tests. Due to the large difference in variation, the effect of housing was 
assessed in each strain separately for PPI. Data is presented as mean ± standard error of 
the mean (SEM) and statistical significance was determined if p<0.05. 
4.3.4 Results 
The body weight of LE and SD rats housed in either enriched or standard housing was 
recorded from 3-16 weeks of age. Overall, there was a main effect of strain (F(1,28)=54.75, 
p<0.001), but not housing (F(1,28)=0.24, p=0.625; Figure 4.1). LE rats from standard and 
enriched housing tended to deviate more towards the end of the experiment, however this 
was not significant even at 16 weeks (t(10.85)=2.18, p=0.052). 
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Figure 4.1 Growth Curve 
The body weight of Long Evans (LE, circles) and Sprague Dawley (SD, squares) rats from 3-16 weeks of 
age housed in either enriched (EE, open) or standard housing (SH, closed). Overall, there was a main effect 
of strain (F(1,28)=54.75, p<0.001), but not housing (F(1,28)=0.24, p=0.625). LE rats tended to separate more 
towards the end of the experiment, however this was not significant even at 16 weeks (t(10.85)=2.18, p=0.052). 
 
4.3.4.1 Behavioural test battery 
Due to the number of behavioural parameters reported, the main measures from the 
behavioural test battery are presented in Table 4.1, with ethological measures presented 
in Table 4.2. 
Elevated plus maze: There was a significant effect of both Strain (F1,31=9.45, p=.005) and 
Housing (F(1,31)=17.24, p<0.001) but no interaction (F(1,31)=0.31; p=.582) on the percentage 
of time spent on the open arm of the EPM. LE rats spent significantly longer on the open 
arm than SD rats, and standard housed rats spent significantly longer on the open arms 
than those from enriched cages. There was no significant difference between Strains, 
however SD rats from enriched cages spent less time than those from standard housing in 
the centre of the maze (t(14)=-2.19, p=.046). The total distance travelled on the EPM 
differed based on Strain, such that LE rats had greater locomotion than SD rats 
(F(1,31)=8.93, p=.006). Within the ethological behaviours, it was found that enriched rats 
performed protected stretch-attend risk assessment behaviour earlier (F(1,31)=4.74, p=.039) 
and more frequently (F(1,31)=6.58, p=.016) than standard housed rats. There was no 
significant effect of Strain detected for these measures, however when analysed 
separately frequency of protected stretch-attend behaviour was only greater in enriched 
Growth Curve
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LE compared to those in standard housing (t(14)=2.66, p=.019). An analysis of grooming 
behaviour revealed main effects of Strain and Housing on latency (F(1,31)=4.31, p=.048; 
F(1,31)=4.37, p=.046) and duration (F(1,31)=12.45, p=.001; F(1,31)=15.4, p=.001) with a 
significant Strain x Housing interaction (F(1,31)=5.47, p=.027) but no significant effect on 
frequency of grooming. These results indicated LE rats groom earlier and for longer than 
SD rats, and that rats from enriched housing groomed earlier and for longer than those 
from standard housing. A post-hoc t-test revealed LE rats housed in enrichment groomed 
for significantly longer than those from standard housing (t(14)=3.50, p=.004). 
Hole board: A main effect of Strain was found for distance travelled on the hole board with 
LE rats travelling significantly further than SD rats (F(1,31)=14.97, p=.001) and spending 
more time in the centre zone (F(1,31)=7.21, p=.012). The latency to head dip differed by 
Housing condition (F(1,31)=9.48, p=.005) and there was a significant interaction of Strain x 
Housing (F(1,31)=6.10, p=.020). SD rats reared in standard housing took significantly longer 
to head dip on the hole board compared to those housed in enriched cages (t(14)=-3.14, 
p=.007). Frequency of head dipping (F(1,31)=7.15, p=.012) and rearing (F(1,31)=5.45, p=.027) 
was significantly greater in LE rats compared to SD rats, but there was no main effect of 
Housing. 
Light dark emergence: The key measure of the light dark test was the latency to enter the 
open section and there was a significant effect of Housing in SD rats (t(14)=-2.85, p=.013), 
without a main effect of Strain (F(1,31)=1.61, p=.215). By contrast there was a main effect of 
Strain (F(1,31)=6.54, p=.016) but not Housing (F(1,31)=0.64, p=.432) on the percentage of 
time spent in the open. An effect of Strain (F(1,31)=23.79, p<0.001) was again detected for 
distance travelled, indicating LE rats had increased locomotion compared to SD rats. 
Open field: While distance travelled was found to differ between strains on a number of 
other tests, no significant effect of Strain (F(1,31)=3.53, p=.071) was found on the open field 
test. However, there was a main effect of Housing (F(1,31)=9.09, p=.005), in which enriched 
rats moved less than standard housed LE rats. While the total distance travelled after 10 
minutes differed between strains, these groups did not differ after the 1st minute time bin, 
indicating altered habituation. There was a significant effect of Strain (F(1,31)=5.17, p=.031) 
on number of crossings into the centre, but no significant difference between groups on 
the percentage of time spent in the centre. 
Chapter 4. Genetic and Environmental Conditions 
 79 
8-Arm radial maze: Each rat visited all 8 arms of the maze. There was a main effect of 
Strain, but not Housing, on the time to enter all 8 arms (F(1,30)=23.22, p<0.001), the total 
number of arms entered to visit all 8 arms (F(1,30)=14.75, p<0.001) and the distance 
travelled (F(1,30)=7.63, p=.010). LE rats completed the 8-arm radial arm maze faster and 
with fewer errors than SD rats. 
Y-maze: The percentage of time spent in the novel arm was greater than the familiar arm 
in each group, indicating rats were able to recognise the previously visited arm after a one-
hour inter-trial interval. There was no significant effect of Strain or Housing on the 
percentage of time spent in the novel vs. familiar arm, the number of novel arm entries or 
the distance travelled. 
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Table 4.1 Behavioural Test Battery 
 Sprague Dawley Long Evans Strain (F(1,31)) Housing (F(1,31)) Interaction (F(1,31)) 
Test and measure Standard (n=8) Enriched (n=8) Standard (n=8) Enriched (n=8)    
Elevated Plus Maze        
  Distance (cm) 4057.2 ± 227.4 3863.5 ± 452.7 5555.0 ± 239.3 4494.1 ± 439.5 8.93** 3.10 1.48 
  Duration in Centre (s) 153.5 ± 15.8 112.2 ± 10.4 122.3 ± 13.9 125.2 ± 12.8 0.46 2.07 2.73 
  % Duration Open Arm 31.4 ± 5.6 10.3 ± 3.6 42.6 ± 4.4 26.6 ± 4.0 9.45** 17.24** 0.31 
Hole board        
  Distance (cm) 3929.7 ± 186.2 3538.7 ± 261.9 4740.5 ± 150.8 4449.1 ± 268.1 14.97** 2.35 0.05 
  Time in centre (%) 2.1 ± 0.8 3.1 ± 0.9 5.7 ± 1.0 4.9 ± 1.3 7.21* 0.09 0.88 
  Latency Head Dip 60.5 ± 14.7 12.7 ± 4.1 29.2 ± 5.8 24.0 ± 5.7 1.35 9.48** 6.10* 
Light Dark Test        
  Distance (cm) 1437.5 ± 94.7 1303.4 ± 185.2 2477.1 ± 251.7 2230.6 ± 236.5 23.79** 0.89 0.08 
  % Duration in Open 54.4 ± 2.7 45.5 ± 6.2 62.7 ± 5.2 63.4 ± 5.7 6.54* 0.64 0.88 
  Latency to Open (s) 20.3 ± 4.1 7.6 ± 1.7 12.7 ± 1.8 8.8 ± 1.5 1.61 10.93** 3.02 
Open Field        
  Distance (cm) 3485.0 ± 250.7 2832.4 ± 277.6 4189.0 ± 381.3 3169.9 ± 148.2 3.53 9.09** 0.44 
  Time in centre (%) 3.7 ± 1.1 3.6 ± 1.0 6.7 ± 1.7 4.9 ± 0.4 3.62 0.72 0.63 
  Entries to centre 11.0 ± 2.7 8.8 ± 1.7 17.9 ± 3.4 12.9 ± 1.2 5.17* 2.25 0.32 
Y-Maze        
  Distance Day 2 (cm) 2919.3 ± 90.2 2968.9 ± 174.3 3183.5 ± 210.5 2706.4 ± 125.7 0.00 1.85 2.81 
  Novel vs Fam Dur 63.1 ± 5.1 71.6 ± 3.1 59.2 ± 6.7 63.5 ± 6.2 1.22 1.37 0.14 
  Novel arm entries 6.4 ± 1.0 6.3 ± 0.3 7.9 ± 1.0 5.4 ± 0.6 0.16 2.75 2.25 
Radial Arm Maze        
  Distance (cm) 5770.4 ± 706.5 6424.6 ± 424.0 7709.3 ± 411.9 7692.0 ± 729.1 7.63* 0.30 0.33 
  Time to complete 226.7 ± 17.4 188.6 ± 19.0 137.0 ± 10.5 139.9 ± 8.5 23.22** 1.50 2.03 
  Entries to complete 12.0 ± 0.7 12.0 ± 0.8 9.6 ± 0.5 9.6 ± 0.5 14.75** 0.00 0.00 
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Key behavioural parameters from each test in the behaviour screen for Sprague Dawley and Long Evans rats housed in standard or enriched conditions. Data are 
presented as mean ± SEM and statistical results for strain comparison. Main effect of Strain and Housing was assessed by ANOVA and independent-samples t-tests 
were then performed if a significant Strain x Housing interaction was detected; *p<0.05, **p<0.01. 
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Table 4.2 Ethological measures 
 Sprague Dawley Long Evans Strain (F(1,31)) Housing F((1,31)) Interaction (F(1,31)) 
Test and measure Standard (n=8) Enriched (n=8) Standard (n=8) Enriched (n=8)    
Elevated Plus Maze        
Latency to Protected 
Groom 
338.5 ± 68.3 233.7 ± 53.1 234.4 ± 61.0 116.2 ± 24.3 4.31* 4.37* 0.16 
Duration Groom (s) 8.0 ± 2.4 30.5 ± 12.4 24.8 ± 7.4 113.6 ± 24.3 12.45** 15.41** 5.47* 
Freq. Groom 3.3 ± 0.9 4.9 ± 1.1 5.1 ± 1.3 6.5 ± 1.0 2.69 1.98 0.01 
Duration Protected 
Scanning (s) 
61.8 ± 7.7 67.7 ± 9.9 27.5 ± 4.4 35.4 ± 3.2 23.78** 1.03 0.02 
Freq. Open Head Dip 11.3 ± 3.0 3.0 ± 1.0 22.5 ± 2.9 16.9 ± 2.4 26.34** 8.03** 0.29 
Freq. PSA 4.3 ± 0.8 5.1 ± 0.8 2.0 ± 0.9 5.6 ± 1.0 1.00 6.58* 2.46 
Latency PSA (s) 162.5 ± 35.2 69.4 ± 13.8 164.7 ± 41.9 128.0 ± 26.1 1.04 4.74* 0.90 
Hole board        
Latency to Groom (s) 229. ± 29.7 231.8 ± 57.0 204.9 ± 52.2 165.5 ± 56.6 0.82 0.14 0.18 
Duration Groom (s) 2.9 ± 0.6 7.0 ± 3.3 4.6 ± 0.8 7.8 ± 2.1 0.44 3.43 0.05 
Freq. Groom 3.9 ± 0.8 3.8 ± 1.0 5.0 ± 1.1 5.8 ± 0.8 2.76 0.11 0.22 
Freq. Head Dip 23.0 ± 2.1 24.8 ± 3.7 34.4 ± 3.9 30.5 ± 2.8 7.15* 0.11 0.77 
Freq. Rear 42.1 ± 4.0 41.9 ± 7.3 56.9 ± 3.5 54.6 ± 7.6 5.45* 0.05 0.03 
Behavioural observations from EPM and Hole board tests showing the mean and SEM for each group. Data are presented as mean ± SEM and statistical results for 
strain comparison. Main effect of Strain and Housing was assessed by ANOVA and independent-samples t-tests were then performed where a significant Strain x 
Housing interaction was detected. *p< 0.05, **p<0.01. PSA=Protected Stretch Attend posture. 
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Pre-Pulse Inhibition (PPI) of Acoustic Startle Response: All groups showed an increase in 
startle amplitude with increased pulse intensity, however using a repeated measures 
ANOVA no effect of Strain (F(1,27)=1.00, p=.326) or Housing (F(1,27)=0.08, p=.774) was 
detected (Figure 4.2A,B). Habituation was measured by comparing startle amplitude at the 
start and end of the session and while there was no difference between Strain or Housing 
at the start, at the end there was a main effect of Strain (F(1,30)=7.96, p=.009) but not 
Housing (F(1,30)=0.84, p=.368; Figure 4.2C,D). % PPI was pooled across pre-pulse 
intervals for each of the three intensities and analysed using a repeated measures 
ANOVA. A main effect of Strain (F(1,30)=4.68, p=.040), but not Housing (F(1,30)=1.10, 
p=.304) was found (Figure 4.2E,F). Within strains it was found that enriched SD rats when 
compared to standard housed SD rats had impaired PPI at 74dB (t(14)=-2.31, p=.038). 
When pre-pulse interval was pooled across intensity there was also a reduction in PPI at 
64ms in SD from enriched cages compared to those from standard housing (t(8.27)=-2.40, 
p=.042; Figure 4.2G,H). 
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Figure 4.2 Pre-pulse inhibition 
(A,B) Acoustic startle response in SD and LE rats demonstrating increasing startle amplitude with louder 
acoustic pulses. (C,D) Habituation of the startle response to 110db pulses presented at the start, middle and 
end of the session showing a clear within-session reduction in LE rats compared to SD rats, such that there 
was a main effect of strain at the end of the session (F(1,30)=7.96, p=.009). (E,F) %PPI is presented as each 
intensity (74, 78 and 86dB) averaged across different six pre-pulse intervals. %PPI at 74dB was significantly 
reduced in SD rats housed in enrichment compared to standard housed rats (t(13)=-2.31, p=.038). Variability 
of PPI within LE rats was noticeably greater than in SD rats and no significant effect of housing was found. 
(G,H) %PPI for each pre-pulse interval (averages across the three intensities) shows reduced PPI at 64ms in 
SD rats from enriched cages compared to standard housed SD rats (t(8.27)=-2.40, p=.042) while LE rats from 
both housing conditions did not differ. Standard housing (open ☐), enriched housing (closed n). Data 
presented as mean ± S.E.M.*p<0.05.  
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4.3.4.2 Operant training 
After 3 days learning the initial protocol, where rats were required to respond with head 
entries to receive rewards, there was a significant interaction between Strain and Housing 
on the number of trials completed (F(1,31)=5.59, p=.025); however there was no significant 
main effect of Strain or Housing. LE rats raised in enriched housing performed significantly 
more trials that those from standard housing conditions (t(13)=2.41, p=.032; Figure 4.3A). 
Next rats learnt to nose poke a central aperture to receive a reward. On the first day of 
training there was a main effect of Strain (F(1,31)=26.3, p<0.001) and Housing (F(1,31)=4.39, 
p=.045), and a Strain x Housing interaction (F(1,31)=4.18, p=.050). These results indicated 
that LE rats performed more successful trials than SD rats and that those from enriched 
housing performed better, which was most pronounced in LE rats (t(13)=2.41, p=.032; 
Figure 4.3B). There was a main effect of Strain on the number of sessions required to 
learn the signal detection task (F(1,31)=6.47, p=.017; Figure 4.3C) and the reversal 
(F(1,31)=21.21, p<0.001; Figure 4.3D), finding in both cases that LE rats required less 
training than SD rats. 
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Figure 4.3 Operant Training 
(A) Fixed ratio (FR1) training in LE rats, showing the number of trials completed was greater in enriched rats 
compared to those from standard housing conditions after 3 days of training (t(13)=2.41, p=.032). (B) On the 
first session of learning to nose poke to receive a food reward, LE rats completed more trials than SD rats 
(F(1,31)=26.3, p<0.001). Additionally, LE rats from enriched housing successfully performed more trials 
compared to those from standard housing (t(13)=2.41, p=.032). (C) The number of sessions required to reach 
criteria on a signal detection task was greater in SD rats compared to LE (F(1,31)=6.47; p=.017). (D) LE rats 
were able to acquire the reversed contingency on a signal detection task in fewer sessions than SD rats 




The genetic and environmental background of rodent models are known to influence 
behavioural phenotypes, however many animal models of schizophrenia use the same 
strain and standard housing conditions. In the current study we used two outbred rat 
strains, one used for modelling neuropsychiatric disorders (SD) and a strain more 
frequently used for cognitive testing (LE) and compared their behaviour when raised in 














































































Chapter 4. Genetic and Environmental Conditions 
 88 
behavioural measures across a number of behavioural domains relevant to animal models 
of neuropsychiatric disorders; including altered locomotion, increased anxiety, impaired 
PPI and altered learning (Duffy et al., 2008; Fone and Porkess, 2008; van den Buuse, 
2010; Jones et al., 2011). Importantly, these genetic and environmental manipulations 
may help us to understand complex phenotypes relevant to human neuropsychiatric 
disorders. 
4.3.5.1 Strain 
Overall LE rats were more active, had greater exploration, reduced anxiety, reduced PPI 
and improved cognitive performance compared to SD rats. Sensorimotor gating was 
measured using PPI and LE rats showed greater habituated to the startle pulse than SD 
rats, however the increased variation observed in LE rats made PPI comparisons difficult. 
LE rats generally showed facilitation, whereas SD rats showed inhibition of the startle 
reflex. Facilitation can occur if the pre-pulse interval is too short or too long resulting in 
summation of the startle response. However, the same protocol has been used previously 
by our group using SD rats from a different supplier with similar results to the SD rats 
tested in this study (Kesby et al., 2012). Strain and supplier differences in PPI have been 
identified by a number of studies (e.g. Varty and Higgins (1994); Swerdlow et al. (2000); 
Aubert et al. (2006)) however the facilitation observed in LE rats is likely to be a 
characteristic of the strain under these testing conditions. 
When compared using an operant task it was found that SD rats required more training 
sessions than LE rats to learn to self initiate trials, to learn a signal detection task and to 
acquire reversal of task contingencies. Strain differences in the acquisition of operant 
behaviours have been observed previously in studies comparing lever press acquisition in 
LE, SD and Wistar strains (Andrews et al., 1995). All strains acquired the task, however 
albino strains took longer than LE rats to learn this behaviour. It is interesting to note the 
widespread use of pigmented strains for cognitive tasks, while most animal models of 
schizophrenia are developed in albino strains. Comparing strains that differ in cognitive 
performance within existing animal model preparations may provide a useful tool for 
modelling and understanding cognitive deficits relevant to schizophrenia. 
4.3.5.2 Housing 
While some effects were strain-specific, it was found that minimal enrichment lead to a 
phenotype characterised by reduced anxiety-related behaviour, locomotion and PPI, and 
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enriched rats completed more trials successfully during operant training. On the EPM 
enriched rats of both strains spent less time on the open arms than those from standard 
housing, which is indicative of greater anxiety. This is contrary to many studies showing 
increased open arm usage in rats from environmentally enriched cages (Pena et al., 
2009), however reduced open arm time after enrichment has been seen in mice 
(Pietropaolo et al., 2006) and after access to wheel running in rats (Burghardt et al., 2004). 
Latency to emergence on the light dark test was also used to measure anxiety and SD rats 
raised in the enriched environment emerged earlier than those raised in standard housing, 
a result found by others using Wistar rats and indicating enriched rats were less anxious 
(Harris et al., 2009). Additionally, SD rats from enriched cages performed head dips on the 
hole board test earlier than those from standard housing. Previously, enrichment in SD 
rats has been associated with greater exploration and reduced corticosterone levels on the 
hole board test (Pena et al., 2009). Together these results indicate enriched housing 
results in a less anxious phenotype. While this initially appears to conflict with the results 
from the EPM, the inclusion of a shelter in the enriched cages may have led to differential 
use of the protective zones. 
Further analysis of ethologically relevant behaviours revealed that on the EPM, stretch-
attend behaviour from the protected zone was performed earlier and more frequently in 
enriched rats. The stretch-attend posture is adopted when a rodent explores a novel or 
potentially dangerous space (Rodgers and Dalvi, 1997), indicating enriched rats used a 
protective posture to investigate the open arm rather than walking out. Rats from enriched 
housing also began grooming earlier and for longer than standard housed rats. 
Furthermore, although the duration of grooming was longer, the number of bouts was not 
the same, indicating that enriched rats were performing longer uninterrupted bouts of 
grooming. Increased grooming can be triggered in both high and low stress situations, 
however broken or rapid bouts of grooming are associated with increased stress in rats 
and mice (Kalueff and Tuohimaa, 2005). These results suggest that rats from enriched 
housing are less anxious than standard housed rats. Reduced latency to head dip on the 
hole board and earlier emergence on the light dark test provide further evidence for 
reduced anxiety-related behaviours in rats from enriched cages. 
Enriched LE rats had reduced locomotion on the open field test, which is in agreement 
with a previous study in mice comparing standard and enriched conditions using either a 
freely spinning or locked wheel. This study isolated reduced locomotion in the open field 
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test to enriched caging with the addition of a functional running wheel (Pietropaolo et al., 
2006). The inclusion of enrichment toys, but without a running wheel, has also been 
associated with faster habituation and reduced locomotion in the open field test in SD rats 
when compared to socially housed controls (Varty et al., 2000). 
Enrichment within SD rats was associated with a PPI deficit at the lowest pre-pulse 
intensity and this pattern was also observed at higher intensities and when split for pre-
pulse interval. Some studies report no effect of enrichment (Varty et al., 2000), however 
other studies have reported reduced PPI at low pre-pulse intensities after environmental 
enrichment (Pena et al., 2009), and this deficit appears to be modulated by exercise in 
mice (Pietropaolo et al., 2006). PPI is one of the most widely used tests for validating 
animal models of schizophrenia due to the translatability of this behaviour across many 
species and the well established deficit found in patients (Swerdlow et al., 1999). It was 
not expected that the simple environmental changes used in this study would disrupt PPI, 
but the results highlight the sensitivity of this test to environmental manipulations. 
The acquisition of simple operant protocols was faster in LE rats raised in enriched cages 
compared to those from standard housing conditions. A study investigating performance 
on the Morris water maze found that enriched rats outperformed those from standard 
housing (Harris et al., 2009). However, this result could be explained by the difference in 
thigmotaxis, indicating enriched rats were less anxious rather than having improved 
cognition. This is an important consideration, as changes in stress or anxiety will interfere 
with performance measures on behavioural tasks. Rats in the current study had been 
handled extensively prior to operant training, however greater anxiety may have 
contributed to the impaired learning observed in standard housed LE rats. 
Environmental enrichment altered the behavioural phenotype of both strains, confirming 
that including a running wheel and shelter were sufficient to alter adult behaviour. This 
design does not result in the large changes in complexity or novelty used in other EE 
studies, but has increased the opportunity for voluntary exercise. While SD rats grew 
significantly larger than LE rats, voluntary running did not alter body weight. This study 
used an enrichment protocol that was readily reproducible and required minimal 
equipment or labour. This makes improved housing more appealing, less expensive and 
reduces the variable experiences that would occur in a more dynamic environment. 
Investigating the compounding effects of GxE manipulations has become increasingly 
important for understanding neuropsychiatric conditions (Caspi and Moffitt, 2006; van Os 
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et al., 2008). Changing the background strain or housing environment of established 
animal models of schizophrenia may reveal important changes in behavioural outcomes 
and a better understanding of how GxE interactions impact on altered phenotypes (Turner 
and Burne, 2013). 
While the order of testing has been shown to alter some behavioural outcomes (Blokland 
et al., 2012), the consistency of the results across tests suggests the differences observed 
can be reliably assessed using a behavioural test battery. As testing on one paradigm can 
influence performance on later tests, the order of testing was determined based on the 
requirement for novelty-based responding and to reduce the effects of stress. Running a 
battery in a different order may change the outcomes, however a key benefit of using test 
batteries is that responses to a number of different challenges can be compared and the 
most robust phenotypic features can be determined. Three tests of cognition were used in 
this study with no difference in performance on the Y-maze, the RAM found overall effects 
of strain, and the operant tasks found the same main effect of strain but also that LE rats 
with enrichment acquired tasks faster. These results suggest that LE rats can outperform 
SD rats on various measures of cognition, but also that cognitive performance in LE was 
sensitive to environmental manipulations. With an increasing interest in cognitive 
phenotypes, strains that not only display deficits but that are also capable of enhancement 
should be used. The lack of strain variation used in rat models of neuropsychiatric 
modelling may need to be revised to answer questions about cognitive functioning and for 
the development of procognitive treatments. 
By comparing two strains commonly used for either neuropsychiatric animal models or 
cognitive studies, this study has highlighted that while SD rats have a less variable PPI 
response, they were outperformed by LE rats on cognitive tasks. Furthermore, the effects 
of enrichment on cognition were only apparent in LE rats. Using a strain that acquires 
cognitive tasks faster, makes fewer errors and shows greater sensitivity to environmental 
manipulations on cognitive measures may be beneficial when cognitive phenotypes are 
being explored. 
Future studies should investigate whether changing strain or housing conditions alters the 
outcomes derived from manipulations relevant to some of the well-established animal 
models of neuropsychiatric disorders. Given the importance of understanding the GxE 
interaction in disorders, such as schizophrenia, it seems imperative that further 
consideration is given to the restricted range of strain and housing conditions being tested. 
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Altering strain and housing conditions may provide important clues to help us understand 
how GxE interactions ultimately lead to changes in behavioural phenotypes relevant to 
human disorders. 
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5.1.1 Abstract 
Due to the extensive literature highlighting the importance of the PFC for executive 
functioning in rodents and humans, this study aimed to characterise the deficits induced by 
a PFC lesion. Rats were well trained on the SDT before bilateral lesioning of the medial 
PFC (mPFC). Performance on the standard task was not expected to differ as rats had 
acquired the task prior to lesioning. Therefore, two manipulations were used to vary task 
requirements. The first manipulation used distracting stimuli to increase attentional load 
and the second changed the response contingency from using visual stimuli to applying a 
spatial rule. As expected it was found that the mPFC lesion did not alter performance at 
baseline, however during auditory distraction lesioned rats made more errors on non-
signal trials than sham treated animals. Accuracy on signal trials during auditory distraction 
was not reduced, however detecting a signal may be easier than detecting the absence of 
a signal. There were no mPFC lesion-related deficits detected on either the switch to the 
spatial rule or the switch back to the visual rule. There was a trend level reduction in 
accuracy towards the end of the session in the lesion group and this may indicate that 
these animals are affected by fatigue across the extended session to a greater extent than 
the sham treated group. Overall, these results indicated that performance at baseline was 
not dependent on mPFC input, however deficits were detected under conditions where 
task conditions were altered. This demonstrates the importance of manipulations that 
challenge rodents as they may become very proficient and respond habitually on the 
standard task. Additional task demands may be required to engage the neural networks 
used for complex cognitive functions.  
Chapter 5. PFC Lesion and SDT 
 95 
5.1.2 Introduction 
One of the key hurdles in translating the results from rodent studies to humans has been 
determining whether behavioural functions occur by comparable neural pathways in 
rodents and humans (Pratt et al., 2012). This comparison has been important for 
determining the validity of cognitive tasks, but also for linking structural and functional 
abnormalities relevant to neuropsychiatric disorders, such as schizophrenia. Cognitive 
deficits occur across a range of different functions so it is not surprising that changes in the 
PFC have been associated with schizophrenia both structurally and functionally (Perlstein 
et al., 2003; Bonilha et al., 2008; Lewis and Gonzalez-Burgos, 2008). It is generally agreed 
that the PFC is important for ‘higher order’ functioning (Floresco et al., 2009). Ultimately 
however the rodent brain is far less evolved than the human brain, particularly in cortical 
areas. 
Whether the rodent PFC is homologous to the highly evolved primate PFC has been 
extensively debated (Jones, 2002; Uylings et al., 2003; Holmes and Wellman, 2009). 
However, the relatively simple and restricted circuitry of the rodent brain provides a more 
tangible system for understanding cognitive processes shared by rodents and humans. 
This may be particularly important for understanding essential cognition functions, such as 
attention, memory and behavioural flexibility, which are altered in many disorders 
(Chudasama and Robbins, 2006; Kesner and Churchwell, 2011). The role of the PFC in 
cognitive performance has been explored using a number of tasks in rodents, providing 
valuable information about cortical functioning (Chudasama and Robbins, 2006; Young et 
al., 2009a). 
The rodent PFC operates as part of a much larger network including projections to/from 
the thalamus, striatum, hippocampus, amygdala and subcortical areas. The PFC itself 
consists of a number of sub-regions including the prelimbic (PrL), infralimbic (IL), anterior 
cingulate (ACC) and orbitofrontal cortices (OFC). Each sub-region has been associated 
with different cognitive functions, for example the ACC has been associated with rule 
learning, while the PrL region has been associated with attention and response selection, 
and the IL region may be more important in fear-related learning (Uylings et al., 2003). 
Studies often manipulate two or three subregions simultaneously when exploring PFC 
function and collectively the PrL and IL cortices can be described as the mPFC. 
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In rodents, one function proposed for the mPFC is higher-order rule learning, while the 
OFC may be more important for lower-order rules. This was based on evidence that 
switching between a spatial and visual cue on the water maze or moving from matched to 
non-match versions of delayed match to position task were impaired after mPFC lesions 
(but not OFC). Conversely, reversal learning was hampered after OFC damage, but not 
after mPFC lesioning. Therefore, it would be predicted that changes in task contingency 
that involve abstract rule learning would require the mPFC, while simpler changes to 
stimulus valence would rely on the OFC. This is also in agreement with the idea that the 
mPFC is important for paying attention to the important aspects of stimuli during learning 
(see review Dalley et al. (2004)). The neurobiology behind performance on an alternate 
attentional task, the 5CSRTT, has been extensively studied.  
It has been shown that mPFC lesions do not alter performance at baseline but impair 
performance on manipulations such as reducing the signal duration and after the inclusion 
of an auditory distractor (Robbins, 2002). Using the attentional set-shifting task, it was 
shown that mPFC lesioning prior to testing did not alter discrimination learning, reversal 
learning or ability to perform an intra-dimensional shift. However, lesioned animals 
required more sessions to acquire the extra-dimensional shift (Birrell and Brown, 2000). 
These studies indicate that the mPFC is recruited when greater attention is required for 
successful task performance. 
We have designed a modified SDT and assessed performance in two outbred rats strains 
(SD and LE) housed under standard and enriched housing conditions (see 4.3). Rats had 
previously been trained and tested under baseline conditions on this task. Given the 
extensive literature on the role of the PFC on cognitive functioning in rodents and humans, 
the aim of this experiment was to determine how performance on the SDT was altered 
after lesioning the mPFC. It was expected that performance would generally remain intact, 
but that deficits, such as reduced accuracy, would be detected on more difficult task 
manipulations. Given rats in this experiment were well trained, performance at baseline 
was not expected to require PFC functioning. However when behavioural responses 
needed to adapt or when suppression of irrelevant behaviours was required, then we 
expected the PFC to be involved. Therefore, two additional manipulations were used in 
this study, firstly the inclusion of distracting stimuli and then secondly the task rules were 
changed. In addition, data from this study was examined using both standard measures 
and signal detection theory indices. 
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5.1.3 Methods 
5.1.3.1 Animals and Housing 
Male Sprague-Dawley (Asmu:SD) and Long Evans (Asmu:LE) rats were obtained 
(Monash Animal Services, Australia) at 3 weeks of age and housed in a room maintained 
at 21 ± 2°C and 60% humidity and on a 12-h light/dark cycle (lights on 0600 h). Male rats 
were selected as sex differences were not being examined in this study and males are 
more commonly used in similar experiments. Standard rat chow (Specialty Feeds, WA, 
Australia) and water were supplied ad libitum. Rats were housed in either standard or 
enriched cages in same-strain pairs (n=8). Standard housing consisted of a standard sized 
polypropylene cage (41 x 28 x 24 cm) with a high top wire lid, aspen chip bedding (Able 
Scientific, WA, USA), nesting, and wood chew (Able Scientific, WA, USA). The alternative 
enriched housing condition used a larger sized polypropylene cage (54 x 36 x 30 cm) with 
a high top wire lid, bedding, nesting, wood chew, an enclosed shelter (15 x 15 x 12 cm) 
and running wheel (20.3 cm diameter). Rats were weighed weekly and had performed 
previous behavioural testing (see 4.3). All testing was conducted during the light phase. All 
procedures used were performed with the approval from The University of Queensland 
Animal Ethics Committee, under the guidelines of the National Health and Medical 
Research Council of Australia. 
5.1.3.2 Apparatus 
Training was conducted in operant chambers housed in ventilated, sound attenuating 
boxes (50 x 50 x 50cm, Med Associates Inc., St. Albans, VT, USA). Rats were initially 
trained to collect a reward (45 mg, F0021, dustless precision pellet, Bioserv, Frenchtown, 
NJ, USA) from one of two receptacles equipped with head entry detectors that were 
located on the left and right side of the wall. The chamber was operated using MED-PC for 
Windows software and interfacing (Med Associates Inc., St. Albans, VT, USA). 
5.1.3.3 Protocol 
Key features of the SDT and protocol design have been described previously in Chapter 2 
and Chapter 3 (Turner et al., 2015). Manipulations were included in this study to measure 
task acquisition, rule switching, reversal learning and distraction of attention. Outcome 
measures included % correct on signal and non-signal trials, trial rate, head entries into 
the magazines either before the central nose poke or during the stimulus presentation. 
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5.1.3.4 Signal detection theory 
Signal detection theory indices were calculated for comparison with the results generated 
from % correct signal and non-signal. Four values were derived and calculations are as 
described in Chapter 2. SI provided a measure of how distinct signal and non-signal trials 
were in terms of detectability. RI provided a measure of whether more responses were 
made on the signal or non-signal side and was indicative of biased responding. 
5.1.3.5 Surgery 
This experiment investigated deficits that would be detected across both strain and 
housing conditions. There were no significant main effects or interactions detected for 
strain or housing condition at baseline or after distractor. Therefore throughout this study 
data was pooled for strain and housing conditions and split for lesion and sham treatment 
groups. Within each strain and housing group (n=8) rats were split into lesion (n=5) or 
sham (n=3) and individuals were allocated to treatment groups based on pre-surgery 
cognitive performance. A greater number of rats were selected for the lesion group with 
the expectation individuals would be excluded for incorrect lesion placement. This led to a 
total of 20 lesioned and 12 sham treated rats. Rats were anaesthetised in an induction 
chamber using 4% isoflurane in medical oxygen before being placed in a stereotaxic frame 
(Koft Instruments, CA, USA). The eyes were protected with ointment (Polyvisc, Alcon 
Laboratories, TX, USA) and body temperature was maintained using a heating pad with 
rectal probe feedback (Harvard Bioscience, MA, USA). The incision site was shaved and a 
subcutaneous injection of bupivacaine and lidocaine was made to provide analgesia. A 
scalp incision was made and a small hole was drilled once the injection sites were 
identified. Injections were made using a 33G needle attached to a 5ul Hamilton syringe at 
the following co-ordinates relative to Bregma: AP+0.32mm, ML+/-0.07mm, DV-0.33mm 
from dura (Paxinos and Watson, 2005). Rats were injected bilaterally with 0.55µL of 
8mg/ml ibotenic acid (American Radiolabeled Chemicals Inc (ARC), MO, USA) for the 
lesion group or 1M phosphate buffered saline (PBS, Lonza, MD, USA) for the sham group 
into the medial prefrontal cortex (mPFC) over 4min. The needle remained in place for a 
further 3min before being slowly removed. Bone wax was used to fill the cranial hole and 
the incision was sutured before post surgery analgesic and antibiotics were administered. 
Rats were housed individually overnight following surgery, but were then returned to their 
home cage and testing recommenced after a minimum of 10 days of recovery.  
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5.1.3.6 Histology 
After testing was completed, rats were anaesthetised with an overdose of sodium 
pentobarbital and transcardially perfused with PBS followed by 4% paraformaldehyde 
(PFA). Brains were then removed and post-fixed in 4% PFA overnight at 4°C. Brains were 
blocked in agar and sectioned using a vibratome at 100µm thickness before being 
mounted and stained with cresyl violet. A scorer who was blind to treatment used the 
Paxinos and Watson atlas (Paxinos and Watson, 2005) to determine lesion placement and 
extent. 
5.1.3.7 Drugs 
Bupivacaine hydrochloride (0.5% in saline, Sigma-Aldrich, St. Louis, MO, USA) and 
lidocaine (1% in 0.1M HCl, St. Louis, MO, USA) solution was made 50:50 v/v and 0.8ml/kg 
was given subcutaneously prior to scalp incision. 5mg/kg of Baytril (Enrofloxacin 1µl/10g, 
Bayer Corporation, Germany) and 2.5mg/kg of Torbugesic (Butorphanol tartrate 2.5µl/10g) 
was given subcutaneously for analgesia immediately after surgery and Baytril was 
administered again two days post surgery. 
5.1.3.8 Post Surgery Cognitive Testing 
Ten days after recovering from surgery, rats were food restricted and returned to testing 
on the SDT. Rats were to perform a minimum of three days of baseline testing and 
achieve >70% correct before being tested on the distractor manipulation. During the 
distractor session, the first and last blocks of 30 trials were conducted as per normal, 
however during trials 31-60 a visual distractor was presented and during trials 61-90 an 
auditory distractor was presented (total of 120 trials in session). Both distractors operated 
at 1hz frequency throughout the block with the visual distractor being the house light and 
the auditory distractor was a background noise generator (80dB). Rats also performed a 
within-session rule-switching task to assess behavioural flexibility. Instead of following the 
rule imposed by the visual cues, rats were now only rewarded for responding to one 
receptacle side. Rats rapidly learnt the spatial rule and after 120 trials the rule switched 
back to using the visual cues for the remaining 120 trials (total of 240 trials per session). 
There were no cues to indicate the rule had changed in either case. 
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5.1.3.9 Statistical analysis 
Results were analysed using SPSS software (ver. 20, SPSS Inc., Chicago, Illinois). The 
main effect of Lesion on key parameters was subjected to independent t-tests, ANOVA or 
repeated measures ANOVA was applied where required. If a significant interaction was 
detected, post-hoc analysis using independent t-tests were performed. Data has been 
presented as mean ± SEM and statistical significance was determined if p<0.05. 
5.1.4 Results 
5.1.4.1 Histology 
Histological assessment resulted in the exclusion of two lesioned and three sham animals 
from analysis, resulting in a final sample size of n=18 lesion and n=9 sham rats. Criteria 
was set based on previous literature (Birrell and Brown, 2000), with inclusion in the lesion 
group requiring significant damage to the prelimbic cortex with additional damage in the 
infralimbic cortex and may include damage in the anterior cingulate cortex. Representative 
sham and lesion sections are presented in Figure 5.1A and B, with a schematic of the 
mPFC outlined based on the rat brain atlas in Figure 5.1C (Paxinos and Watson, 2005). 
 
Figure 5.1 Histological verification of lesion placement 
Monochromatic microscopic images of rat brain slices stained with cresyl violet to identify apoptosis and 
gliosis. (A) The left image is a hemisphere from a mPFC lesioned animal with the lesion outlined by arrows. 
(B) The right image is from a rat after sham surgery. All rats received bilateral injections. (C) Corresponding 
image from rat brain atlas edited to highlight the position of the mPFC, composed of the prelimbic and 
infralimbic cortices (Paxinos and Watson, 2005). 
 
5.1.4.2 Performance after mPFC lesion 
Overall, there was no effect of lesioning on baseline SDT performance as predicted 
(Figure 5.2). With the introduction of distractor, there was an overall effect of block, such 
A B C 
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that performance was significantly reduced during the visual distractor on a number of 
measures (% correct Signal F(3,72)=33.15, p<0.001; % correct Non-Signal F(3,72)=13.41, 
p<0.001; p(Hit) F(3,72)=33.15, p<0.001; p(FA) F(3,72)=18.14, p<0.001; SI F(3,72)=42.90, 
p<0.001) however not on RI (F(3,72)=0.96, p=0.42). 
The a priori prediction was that mPFC-lesioned rats would perform worse than sham-
treated rats during distraction. Independent group t-tests found that lesion and sham 
groups did not differ during visual distraction on any measure. However, during auditory 
distraction lesioned rats made more non-signal errors and had a greater p(FA) (t(25)=-2.19, 
p=0.038; Figure 5.3B,D). But did not differ on % correct signal trials, p(Hit), SI or RI 
(p=0.054 to 0.866; Figure 5.3). The groups did not differ in the number of head entries 
made prior to the central nose poke or during stimulus presentation (Figure 5.2). 
 
Figure 5.2 Rats with PFC lesions were able to perform the SDT 
(A) Measures of accuracy on signal and non-signal trials as well as (B) premature responding rates 
(measured as head entries before central nose poke and head entries during stimulus presentation) 
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Figure 5.3 Effects of distraction after mPFC-lesioning 
The session started with a normal block of trials before the introduction of visual distractor, followed by an 
auditory distractor and concluded with a normal block of trials. There was no effect of mPFC lesioning on (A) 
signal trial accuracy, (C) p(Hit), (E) sensitivity index (SI) or (F) responsivity index (RI). However, for (B) more 
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A repeated measures ANOVA considering three 10-trial bins during auditory distraction 
found a significant Bin x Lesion interaction, demonstrating a greater effect of lesioning 
during the first 10-trials after stimulus onset (F(2,50)=3.54, p=0.036; Figure 5.4). 
 
Figure 5.4 Non-signal accuracy in 10 trial bins during auditory distraction 
The difference in non-signal accuracy between sham and lesioned rats was greatest in the first 10 trials after 
the onset of auditory distraction. 
 
After the initial switch to the spatial rule and the switch after 120 trials back to the visual 
rule there were no changes to performance accuracy. Both groups produced smooth 
acquisition curves showing a steady shift in response type as they acquired the new rule 
(Figure 5.5). It was noted that performance in the lesioned group did not stabilised across 
the session at the high level of accuracy seen in the sham group with a reduction in 
accuracy at a number of time points in the last quarter of the session. However, this 
observation was not supported by a repeated measures ANOVA (main effect of Lesion 
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Figure 5.5 Switching rules in 
mPFC lesioned rats 
(A) Rats acquired the side rule gradually 
over the first 120 trials before the rule 
switched back to using visual cues, 
indicated by vertical line. Performance on 
(B) signal trials dropped to less than 20% 
accuracy in the initial trials before 
improving to around 70%. Accuracy then 
dropped to chance levels when the 
switch to the previously learnt visual rule 
was imposed. (C) As the spatial rule 
required all rats to only respond to the 
side previously paired with non-signal 
trials, responding remained high on non-
signal trials. Furthermore, when reward 
was contingent on visual cues, accuracy 
to non-signal trials remained high. There 
was no significant effect of mPFC lesion 
on contingency switching.  
Overall
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5.1.5 Discussion 
The purpose of this study was to determine how performance on the novel SDT was 
altered by removal of mPFC function. The prelimbic cortex was lesioned with damage 
extending into the adjoining anterior cingulate and infralimbic cortices. Overall 
performance remained intact, however lesioned rats made more non-signal errors during 
auditory distraction. 
It was predicted that performance would differ after mPFC lesion on manipulations that 
increased the difficulty of the task. The addition of distractors was used to make signal 
detection more challenging. A visual distractor was also used however performance was 
reduced to chance levels, suggesting the distractor was overwhelming and signal 
detection was not possible. It is likely the signal was not perceivable in the presence of a 
flashing house light. The luminance level of the house light could not be easily adjusted, 
however further investigation of visual distractors with varying luminance may yield better 
results. After the onset of an auditory distractor, lesioned rats made more non-signal errors 
than the sham-treated group. Errors on signal trials, as well as other measures of task 
performance, were not different between treatment groups demonstrating other aspects of 
task performance were unaffected. The non-signal trials may be more difficult to identify 
than the signal trials during distraction, as they require greater vigilance to determine the 
complete absence of stimuli as opposed to detecting its presence. Although not significant, 
it appears as though the sham rats have their greatest % accuracy in the auditory 
distractor block, especially in the first 10 trials, which may be due to rebound effect 
following the visual distractor. The lesioned rats also ‘rebound’ after the visual distractor, 
however not to the extent of the sham rats, and the lesioned rats continue to improve in 
subsequent auditory distractor trials. This may indicate lesioned rats have a delayed ability 
to adapt to the changing conditions. This experiment provides further evidence for the 
theory that the mPFC was required for selectively paying attention to relevant stimuli. The 
use of manipulations that alter performance may be critical for detecting deficits that do not 
present at baseline. 
In comparison to other studies, it has been shown that intra-PFC infusion of the 5-HT2A/C 
antagonist, ketanserin, reduce premature responses on the 5CSRTT, but did not alter 
accuracy (Passetti et al., 2003). Similarly, Maddux and Holland (2011) found that lesions 
to either dorsal (PrL and IL) or ventral (dorsal peduncular cortex and tenia tecta) mPFC did 
not alter accuracy on the 5CSRTT. In contrast, dorsal PFC lesions did reduce accuracy on 
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the combined attention and memory (CAM) task, which incorporates components to test 
attention and memory (Chudasama et al., 2005). The effect of PFC lesions may also 
depend on post-surgery recovery as the initial 5CSRTT deficits in accuracy detected by 
Muir et al. (1996) began disappearing from 10 days post-operation. Although PFC lesions 
may impair other measures, such as premature responding or latency values, accuracy 
has not been consistently impaired on the baseline 5CSRTT. Therefore, further 
manipulations of task difficulty may be required. 
Rats were well trained on the visual signal before the rule switch manipulation was used to 
assess behavioural flexibility. From the start of the session only responses to the non-
signal side were rewarded, however visual signals were still displayed. All rats gradually 
acquired the new rule and after 120 trials the rule switched back to using the visual cues. 
This resulted in two strategy shifts, one at the start of the session and a second halfway 
through the session. Overall accuracy on the spatial rule reached 80% in both sham and 
lesioned rats with comparable acquisition curves. The decrement and recovery of 
performance mid-way through the session when the contingency shifted back to visual 
cues was also similar in both groups. Accuracy towards the end of the session appeared 
lower in lesioned rats, although this was not significant and caution must be used in 
considering this observation. Normal sessions ran for 120 trials, however to capture two 
acquisition curves in this manipulation the number of trials used was increased to 240 
trials. This manipulation was used because reversing the contingency (switching response 
sides for signal and non-signals stimuli) was found in a previous experiment to take an 
average of 12 days to learn (see Chapter 2), whereas this shift was learnt in a single 
session. The extended version of the task may increase attentional fatigue and may be 
worth investigating further in future studies. It was expected that the change in rules would 
require the recruitment of the mPFC, however spatial rules are relatively easy for rodents 
to learn compared to using abstract cues. Switching between a spatial rule and a well 
learnt visual rule might have been too simple to observe deficits after mPFC lesioning. 
For switching behaviour, it has been found that using the attentional set-shifting paradigm, 
rodents require the mPFC, but not the OFC, for making extradimensional shifts (Birrell and 
Brown, 2000). However, the mPFC lesion did not influence performance on 
intradimensional shift. The attentional set-shifting task is based on the human Wisconsin 
card-sorting task (WCST) and requires rodents to select the correct pot based on either 
the texture, digging medium or the odour of the pot (Birrell and Brown, 2000). Within this 
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task an intradimensional shift is a change in target stimuli within a dimension, for example 
from the texture of velvet to sandpaper. An extradimensional shift requires the rodent to 
focus on a target from a different dimension, for example from the texture velvet to the 
odour of cloves (Birrell and Brown, 2000). The authors suggest that this deficit is one of 
selective attention and while we did not observe a deficit on the switching task, this is in 
agreement with the finding that attention during distraction was impaired in the lesioned 
group. In addition, we did not use a range of stimuli within the same dimension to form an 
attentional set which may limit comparison between this manipulation on the SDT and the 
attentional set-shifting task. 
Using an ibotenic acid lesion leads to death of cell bodies, however fibres transiting 
through the mPFC remain intact. This type of lesion would have prevented input being 
received and output being sent from the mPFC. This method was preferable to an 
electrolytic lesion, which would have damaged not only the cell bodies but also all tissue in 
the region. Lesion studies are not very specific but provide information for more targeted 
approaches. However they also need to be considered with caution, as cognitive 
performance is dependent on network function and not on a single brain region. The very 
specific effects of the lesion in this study indicate the network can cope without the mPFC, 
unless the task is more difficult. This study has only compared the effects of mPFC lesions 
in well-trained rats, however performing the lesion prior to acquiring the task may produce 
quite different results. 
The results of the distraction manipulation were also analysed using signal detection 
theory indices, however in this case they did not provide any additional information in 
terms of differences between lesion and sham treated rats. These calculations could not 
be performed on the rule switch experimental data, as rats were required to respond to a 
single magazine. Therefore, although they provide a unique evaluation of SDT 
performance, the use of % correct for signal and non-signal trials has sufficiently captured 
the effects of the manipulations used in the current study and may be more widely 
applicable. 
5.1.5.1 Conclusions 
Using the SDT we have shown that lesions in the mPFC impaired accuracy only when an 
auditory distractor was implemented. However, lesioned rats were able to acquire a spatial 
rule and switch back to using visual cues without performance deficits. These rats were 
Chapter 5. PFC Lesion and SDT 
 108 
highly trained and the switch to a relatively easy spatial task may have been too simple to 
require mPFC functioning. This experiment demonstrates the importance of using 
manipulations that increase task difficulty to observe performance decrements that are 
related to mPFC dysfunction. Future studies should incorporate manipulations that 
challenge performance when higher order cognitive functions are being investigated. 
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6.1 Foreword 
After assessing the effects of genetic, environmental and neurobiological manipulations on 
SDT performance of rats, I wanted to explore the sensitivity of the task to detecting the 
pharmacological effects of amphetamine. In this study I used a range of doses to explore 
the beneficial and detrimental effects of amphetamine on cognitive performance. The 
study was conducted in male and female rats, although there were minimal differences 
between the sexes. The manuscript focuses on the inverted U-shaped response to 
amphetamine, which was given at four doses with the prediction that performance would 
be enhanced at low doses and disrupted by moderate doses. The results of this study 
demonstrate that low dose amphetamine improves attentional performance in rats on the 
SDT and that the magnitude of improvement was dependent on baseline performance. 
These results are important because the findings reflect the pattern of responding 
observed in human studies and provide evidence for the predictive validity of the SDT. 
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6.2 Improvement of attention with amphetamine in low and high 
performing rats 
Karly M. Turner and Thomas H. J. Burne 
6.2.1 Abstract 
Rationale Attentional deficits occur in a range of neuropsychiatric disorders, such as 
schizophrenia and attention deficit hyperactivity disorder. Psychostimulants are one of the 
main treatments for attentional deficits, yet there are limited reports of procognitive effects 
of amphetamine in preclinical studies. Therefore task development may be needed to 
improve predictive validity when measuring attention in rodents. 
Objectives This study aimed to use a modified SDT to determine if and at what doses 
amphetamine could improve attention in rats. 
Methods Sprague-Dawley rats were trained on the SDT prior to amphetamine challenge 
(0.1, 0.25, 0.75 and 1.25mg/kg). This dose range was predicted to enhance and disrupt 
cognition with the effect differing between individuals depending on baseline performance. 
Results Acute low dose amphetamine (0.1 and 0.25mg/kg) improved accuracy, while the 
highest dose (1.25mg/kg) significantly disrupted performance. The effects differed for low 
and high performing groups across these doses. The effect of amphetamine on accuracy 
was found to significantly correlate with baseline performance in rats. 
Conclusions This study demonstrates that improvement in attentional performance with 
systemic amphetamine is dependent on baseline accuracy in rats. Indicative of the 
inverted U-shaped relationship between dopamine and cognition, there was a baseline-
dependent shift in performance with increasing doses of amphetamine. The SDT may be a 
useful tool for investigating individual differences in attention and response to 
psychostimulants in rodents. 
Key words: Attention, amphetamine, cognition, rat, behaviour 
Published: Submitted January 2016 and under review at Psychopharmacology 
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6.2.2 Introduction 
Cognitive deficits are a common feature of a range of neuropsychiatric disorders including 
ADHD and schizophrenia. Antipsychotic medications have been largely ineffective in 
treating cognitive deficits in patients with schizophrenia. Unfortunately, preclinical models 
have been largely disappointing in terms of developing medications with novel drug targets 
and may require further development to enhance predictive validity (Geyer et al., 2012; 
Young and Geyer, 2015). There is general consensus that further development of tasks 
used to measure cognitive performance in rodents is required if we are to understand the 
neurobiological mechanisms of cognitive dysfunction in complex disorders (Pratt et al., 
2012; Lustig et al., 2013). Unfortunately, given the lack of medications that are effective in 
the treatment of cognitive deficits in disorders such as schizophrenia, there are limited 
drugs that can be used as a benchmark to assess the predictive validity of rodent tasks 
(Young and Geyer, 2015). However, low dose amphetamine has been widely used in the 
treatment of attentional deficits in ADHD (Fredriksen et al., 2013; Safer, 2015). In addition, 
a number of studies have demonstrated improved cognitive performance in schizophrenia 
patients when amphetamine was acutely given in combination with antipsychotic 
medication (Barch and Carter, 2005; Pietrzak et al., 2010). Despite the successful use of 
amphetamine in ADHD patients, few preclinical studies have demonstrated attentional 
improvements in rodents (Grilly, 2000; Bizarro et al., 2004; Andrzejewski et al., 2014). A 
task that can reliably detect procognitive effects on attention would allow researchers to 
explore the paradoxical effects of psychostimulant response and also screen novel 
compounds for improving attention. Therefore, this study tested the predicative validity of a 
modified SDT for measuring drug-induced improvements in attention using amphetamine. 
Amphetamine is a non-selective indirect dopamine agonist widely used in the treatment of 
ADHD, but has also been used in military forces and is increasingly being used by college 
students (Smith and Farah, 2011). The growing interest in cognitive enhancing agents has 
led to controversial debates about the ethical use of psychostimulants in healthy 
individuals (Sahakian and Morein-Zamir, 2007; Greely et al., 2008; Ilieva et al., 2013; Allen 
and Strand, 2015). However in healthy control groups, the evidence suggests 
enhancement from stimulants may be dependent on baseline performance (Mattay et al., 
2000; Allman et al., 2010; del Campo et al., 2013). Therefore, investigating the response 
to psychostimulants as a function of individual baseline performance should be 
incorporated into rodent studies, as a similar relationship should be expected (Levin et al., 
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2011). There are limited studies reporting attentional improvement in rats after systemic 
amphetamine (Grilly et al., 1998; Grilly, 2000; Grottick and Higgins, 2002; Andrzejewski et 
al., 2014). There are even fewer studies reporting baseline-dependent effects of 
amphetamine on cognition. This issue was highlighted by a recent paper that re-analysed 
data from prior publications and found that stimulant response was related to baseline 
impulsivity measures in >50% of studies (Bickel et al., 2016). It would be useful to 
determine if similar results hold for the effect of stimulants on attention in rodents. 
Although a positive influence on attention may not be readily available for review, 
determining whether the extent of disruption is baseline dependent would aid our 
understanding of the relationship between stimulants and attention. 
Based on the relationship between dopamine and cognitive performance, it would be 
predicted that the relationship between stimulants and attention would follow an inverse U-
shaped curve. This response pattern has been supported by a number of findings in 
humans demonstrating the complex interaction between dopamine function, cognitive 
performance and psychostimulant action (Mattay et al., 2000; Mattay et al., 2003; Arnsten, 
2006; Cools and D'Esposito, 2011). While low doses have been used to treat attention 
deficits, higher doses of amphetamine are known to induce psychotic symptoms in 
humans and are widely used as a psychomimetic agent in animal models (Grilly and 
Loveland, 2001; Featherstone et al., 2007a; Nestler and Hyman, 2010). Therefore, this 
study selected doses ranging from 0.1mg/kg, where effects on cognition start to be 
reported, and up to 1.25mg/kg where mild locomotor effects are predicted to become 
evident (Grilly and Loveland, 2001). Therefore, the first aim of the current study was to use 
amphetamine at low doses (0.1mg/kg and 0.25mg/kg) expected to enhance cognitive 
performance and to assess whether this improvement was dependent on baseline 
performance. Secondly, we investigated the effects of moderate doses of amphetamine 
(0.75mg/kg and 1.25mg/kg), which were expected to disrupt performance without inducing 
severe motor disturbances. 
6.2.3 Materials and Methods 
6.2.3.1 Animals 
Male and female Sprague Dawley (ARC, WA, Australia; n=20/sex) were housed in a room 
maintained at 21±2°C and 60% humidity with a 12-h light/dark cycle (lights on 0600 h) in 
polypropylene cages with wire lids, aspen chip bedding (Able Scientific, WA, USA), nesting 
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and wood chew (Able Scientific). Rats were kept in same-sex sibling pairs with both male 
and female rats being used in this study following recommendations of the NIH (Clayton 
and Collins, 2014). At 15 weeks of age rats were food restricted to 90% free-feeding body 
weight with free access to water and began operant training. All procedures were 
performed with the approval from The University of Queensland Animal Ethics Committee, 
under the guidelines of the National Health and Medical Research Council of Australia. 
6.2.3.2 Apparatus 
Training was conducted in rat operant chambers housed in ventilated, sound attenuating 
boxes (Med Associates Inc., St. Albans, VT, USA) and behaviour was monitored using an 
overhead mounted camera (CCD Mini CCIR, Samsung, Suwon, South Korea). All operant 
chamber components were mounted on a single wall and comprised of a central house 
light above a custom made stimulus panel (3x3 grid of light emitting diodes, 5mm, green 
diffuse, 80MCD, Jaycar Electronics, NSW, Australia). Below this was a central nose poke 
port fitted with a light and infrared beam to detect responses. Either side of the nose poke 
port was a food magazine also equipped with a light and infrared beam. These were 
attached to pellet dispenser to provide 45mg grain pellets (F0021, dustless precision 
pellet, Bioserv, Frenchtown, NJ, USA) as rewards. MedState Notation was used to design 
the protocol and Med-PC for Windows software (Med Associates Inc., St. Albans, VT, 
USA) was used for chamber operation and data acquisition. 
6.2.3.3 Protocol 
The modified SDT protocol has been described elsewhere (Turner et al., 2016). Briefly, 
rats were initially trained to collect a reward with every magazine head entry rewarded until 
50 pellets were delivered from each magazine or for a maximum of 20min (level 1). Once 
rats had attained >80 pellets on two consecutive days they were trained to nose poke a 
central aperture when it was illuminated to activate either the left or right receptacle, which 
then delivered a reward upon head entry detection (level 2). Finally, after learning to 
initiate trials, the signal was introduced. After initiating trials with a nose poke, a LED panel 
was either illuminated (signal trial) or remained off (non-signal trial) and after 1s both 
magazines illuminated to indicate the rat should make a choice (level 3). A response 
limited hold period was then incorporated in level 4. A schematic of the chamber design 
and flow diagram of the protocol have been presented in Figure 6.1. Depending on the 
visual cue presented, a head entry into one side would lead to a reward, while the other 
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side was incorrect and ended the trial after a brief time out (5s). The pairing of a trial type 
(signal or non-signal) and the correct magazine side (left or right) remained the same for 
each individual but was counter balanced across the cohort. An equal number of signal 
and non-signal trials were presented in a pseudorandom order allowing a maximum of four 
consecutive trials of the same type. Between trials was a variable inter-trial interval (1, 2, 
3s) and the session concluded after either 100 trials or 30min. 
 
Figure 6.1 Signal Detection Task protocol 
(A) Operant chamber wall containing house light, stimulus panel, central nose poke and a food magazine on 
either side. (B) Each trial started with the central nose poke, then the stimuli was displayed and the 
magazines become available for responding. If the correct magazine was chosen a pellet was delivered, 
however if the incorrect side was selected the trial ends with a time out. The next trial was started after the 
central nose poke aperture illuminated. 
6.2.3.4 Task design features 
This modified SDT contains a number of differences to other rodent tasks. These have 
been discussed at length elsewhere (Turner et al., 2016), and therefore will only be briefly 
mentioned here. Omissions were reduced to <1% trials by requiring trial initiation and 
presenting signal or non-signal stimulus immediately upon nose poke detection. 
Throughout the session there are minimal delays between trials as our previous 
experience indicated large time gaps between actions tends to lead to distraction and 
alternative behaviours (including sleeping and grooming). Constraining the rat’s body 
position during testing is difficult without restraint, yet in human testing head position and 
distance to stimulus presentation can be controlled through instruction. To gain better 
control over the rat’s position when the stimulus was presented, we immediately presented 
the stimulus after the central nose poke to initiate trials was detected. Given the stimulus 
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panel was located directly above the central nose poke, stimulus onset always occurred 
when the rat was facing the stimulus panel. The rat could move freely at all times, however 
typically they only moved either left or right to respond into the appropriate receptacle and 
collect a reward. By locating the response receptacles, central nose poke and stimulus on 
the same wall, in conjunction with reduced time gaps, the SDT promotes very rapid task 
performance. From the literature, 5CSRTT was reported to take approximately 30min for 
100 trials (Bari et al., 2008) (~18s/trial) and SAT requires approximately 35min for 100 
trials (Andrzejewski et al., 2014) (~21s/trial), while in this study it took an average of 13min 
to complete 120 trials on the SDT (~6.5s/trial). This result alone promotes higher research 
throughput within a limited suite of chambers. These changes have also resulted in a task 
with short training time, brief session duration and a range of behavioural measures for 
interpretation of performance characteristics (see Table 6.1). 
Table 6.1 Outcome measures derived from the SDT 
Measure Calculation 
Trials initiated Number of trials initiated by centre nose poke 
Session duration Minutes taken to complete maximum (120) trials 
% Omissions Percentage of trials initiated but no response to receptacles 
within 4s 
% Accuracy signal trials Correct signal responses / (Correct signal + Incorrect signal 
responses)*100 
% Accuracy non-signal trials Correct non-signal responses / (Correct non-signal + Incorrect 
non-signal responses)*100 
Latency to initiate trials Time taken to initiate trial after central nose poke illuminates to 
indicate trial can be started 
Response latency Time taken from stimulus cessation and receptacle illumination 
to head entry detection 
Premature HE during ITI Number of head entries into the central nose poke prior to 
illumination during ITI 
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6.2.3.5 Task Manipulations 
Reduction in stimulus duration has often been used to increase task difficulty in rodent 
studies of attention (McGaughy and Sarter, 1995a; Grottick and Higgins, 2002; Riccio et 
al., 2002; Bari et al., 2008). By decreasing accuracy across a range of signal durations, 
ceiling and floor performance effects can be avoided, which is particularly important for 
pharmacological investigations. A selection of reduced stimulus durations (0.01, 0.03, 
0.12, 0.5 or 1s) was used to determine the effects of amphetamine on attention. All drug 
and saline test sessions consisted of 120 trials where the start block (trials 1-30) and end 
block (trials 91-120) presented standard non-signal (0s) and signal (1s) trials only, allowing 
the rats to start and end sessions with a high rate of reward delivery. The central block 
(trials 31-90) consisted of 20 non-signal trials and 40 signal trials with the stimulus duration 
varying across 0.01, 0.03, 0.12 or 0.5s (10 trials per duration). Performance measures 
included accuracy on signal trials and non-signal trials, percentage omissions, number of 
trials initiated, latency to start trials (centre latency), response latency, premature head 
entries into the central aperture during the ITI and premature head entries into either 
receptacle during the stimulus presentation (Table 1). 
6.2.3.6 Pharmacology 
All rats were then treated with vehicle (saline), followed by escalating doses of 
amphetamine (0.1, 0.25 mg/kg, 0.75 and 1.25mg/kg). Saline was also administered on test 
days between each dose and it was confirmed that performance had returned to baseline 
prior to the next drug administration. Escalating drug schedules were used for two 
reasons; firstly to ensure the effect of low dose amphetamine was not disrupted by prior 
drug exposure because this outcome was the priority for the study, and secondly because 
higher doses of amphetamine can result in a sensitised response to subsequent doses 
(Todtenkopf and Carlezon, 2006). The saline treatment day prior to the first dose of 
amphetamine was used for all comparison. d-amphetamine sulfate (Sigma-Aldrich, St. 
Louis, MO, USA) was diluted in 0.9% saline and given i.p. 1ml/kg and 20min prior to the 
session. Dosage and timing was selected based on previous studies (Grilly and Loveland, 
2001; Klinkenberg and Blokland, 2010). 
6.2.3.7 Statistical Analysis 
From the literature on human studies, it was predicted that response to amphetamine 
would be dependent on individual baseline accuracy (Mattay et al., 2000; Allman et al., 
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2010; del Campo et al., 2013). Therefore, analysis of performance sub-groups was 
conducted by median split into either low or high performing groups (n=20/group) based 
on signal trial performance (average accuracy on 0.12, 0.5, 1s) on the saline treatment 
day. The number of high and low performers of each sex was relatively even (n=9-11 in 
each performance group from n=20/sex). Performance on the SDT was initially compared 
using repeated-measures ANOVA incorporating Dose and Duration (0.12, 0.5, 1s) as 
within-subjects factors and Sex (male, female) and Performance group (low, high) as 
between-subjects factors. Signal durations of 0.01 and 0.03s were excluded as mean 
accuracy was near or below chance at baseline. There was no main effect of Sex or Sex x 
Dose interaction, results for signal duration analyses were subsequently pooled for Sex. 
Given opposing effects were expected for different doses of amphetamine, separate 
analyses were performed for low (0, 0.1, 0.25mg/kg) and moderate (0, 0.75, 1.25mg/kg) 
doses. However, due to some animals not completing enough trials after 1.25mg/kg 
amphetamine, the analysis of moderate doses was conducted for 0.75mg/kg and 
1.25mg/kg separately. After the 1.25mg/kg dose a total of 17 out of 40 animals were 
removed from signal duration analysis due to a significant reduction in trials completed 
and insufficient data for each signal duration (see Table 6.1). The minimum number of 
trials initiated by an individual was 23, therefore all other performance measures, aside 
from signal duration accuracy, were analysed for all 40 animals. To further investigate 
individual differences in response to low doses of amphetamine, a difference score was 
calculated by subtracting accuracy after saline treatment from accuracy after amphetamine 
administration. The correlation between baseline performance after vehicle and the 
difference score after amphetamine was analysed. As a negative correlation was 
predicted, regression to the mean adjustment was made to the baseline score using the 
following formula (Finke et al., 2010): 
Equation 6.1 Regression to the mean adjustment: 
Adjusted baseline, x’ = initial baseline score, x + (1-retest reliability, rxx)* 
(mean of total sample, mu – baseline score, x) 
Retest reliability was calculated by correlating performance on saline treatment days prior 
to and at the end of the drug-testing schedule (Pearson correlation=0.593). 
Significant effects were followed by post-hoc pairwise comparison with Bonferroni 
correction and individually assessed by paired t-test. Huynh-Feldt sphericity correction was 
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applied when required. Data have been presented as mean ± S.E.M, *p<0.05. All data 
were analysed using SPSS software package (ver.20, SPSS Inc. IL, USA). 
 
6.2.4 Results 
To ensure performance had returned to baseline levels after each amphetamine dose, 
post-hoc analysis was conducted to compare signal or non-signal trial accuracy across the 
9 days of testing using repeated-measures ANOVA with Bonferroni correction for multiple 
comparisons. It was found that neither accuracy measure was significantly different 
between any two saline treatment days. A main effect of Day was found however this was 
due to differences on amphetamine treatment days, which was explored in detail below. 
6.2.4.1 Low doses of Amphetamine 
A 3x3 repeated measures ANOVA investigating the effects of low doses of amphetamine 
(0, 0.1, 0.25 mg/kg) on signal trial accuracy found a significant effect of Duration 
(F(1.6,51.2)=42.77, p<0.001), Dose (F(2,66)=3.90, p=0.025) and Performance group 
(F(1,33)=25.04, p<0.001). There was also a significant Dose x Performance group 
interaction (F(2,66)=3.76, p=0.028). There was no significant Dose x Duration interaction 
(F(3.3,108)=1.14, ns), indicating a consistent influence of these two factors. To further 
investigate the effects of low dose amphetamine, accuracy was averaged across 0.12, 0.5 
and 1s signal durations. There was a significant improvement in accuracy after 0.1mg/kg 
(t(36)=-2.45, p=0.019) and 0.25mg/kg (t(36)=-2.22, p=0.033) amphetamine across the cohort 
compared to saline. However, when split for Performance group the low performing group 
improved significantly after both 0.1mg/kg (t(16)=-3.145, p=0.006) and 0.25mg/kg (t(16)=-
3.72, p=0.002), while the high performance group did not improve after administration of 
either dose (0.1mg/kg, t(19)=-0.49, ns; 0.25, t(19)=0.03, ns; Figure 6.2). 
Difference scores were then calculated by subtracting the averaged accuracy score after 
saline treatment from the average score after 0.1mg/kg or 0.25mg/kg amphetamine. There 
was a significant negative correlation (after regression to the mean adjustment) between 
performance after saline and the difference score calculated for 0.1mg/kg (r= -0.380, 
p=0.017, N=39) and for 0.25mg/kg (r= -0.496, p=0.002, N=37) amphetamine (Figure 6.3). 
There were no significant changes found for accuracy on non-signal trials (F(1.67,60)=0.17, 
ns), premature responses during the stimulus presentation (F(1.7,59.8)=2.45, ns), number of 
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trials initiated (F(1.1,41.0)=0.31, ns), centre latency time (F(1.52,54.9)=3.05, ns), omissions 
(F(1.41,50.95)=2.88, ns) or response latency (F(2,72)=1.60, ns); demonstrating most measures 
of general task performance were not altered by low doses of amphetamine. Performance 
groups were found to differ significantly on non-signal accuracy (F(1.36)=9.48, p=0.004), 
however they did not differ on any other measure confirming the groups did not differ on 
other aspects of task performance. There was also a main effect of Sex on non-signal 
accuracy (F(1,36)=4.41, p=0.043), omissions (F(1,36)=4.73, p=0.036) and centre latency 
(F(1,36)=8.50, p=0.006), with females having reduced non-signal accuracy, making more 
omissions (although still <0.5%) and initiating trials at a slower rate than males. There was 
a significant reduction in premature head entries during the ITI from 0.1mg/kg to 
0.25mg/kg amphetamine (F(1.9,69.4)=4.04, p=0.023; 0.1mg/kg versus 0.25mg/kg, p=0.008), 
however neither dose differed from saline (see Table 6.2). 
 
Figure 6.2 Signal trial accuracy after low dose amphetamine. 
Signal trial accuracy improved after both 0.1mg/kg and 0.25mg/kg amphetamine in the low performing group, 
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Figure 6.3 Correlations between baseline accuracy and the effect of amphetamine 
There was a significant negative correlation between accuracy at baseline and the change in signal trial 
accuracy after (A) 0.1mg/kg (r= -0.4, p=0.017) and (B) 0.25mg/kg (r= -0.5, p=0.002) amphetamine. 
 
6.2.4.2 Moderate doses of Amphetamine 
Due to reduced trial completion and therefore differences in sample size for the signal 
duration trials, the 0.75mg/kg and 1.25mg/kg doses were compared to saline treatment in 
separate repeated measures ANOVAs. The 2x3 repeated measures ANOVA for 
0.75mg/kg found a significant effect of Duration (F(2,62)=39.91, p<0.001), Performance 
group (F(1,31)=9.64, p=0.004) and a Dose x Performance group interaction (F(1,31)=7.77, 
p=0.009). A paired t-test revealed the low performing group improved significantly after 
0.75mg/kg (t(15)=-2.61, p=0.020), however the high performing group did not (t(22)=1.40, ns, 
Figure 5). The 2x3 repeated measures ANOVA for 1.25mg/kg found a significant effect of 
Duration (F(2,38)=35.28, p<0.001). There was no significant main effect of Performance 
group (F(1,19)=2.73, ns), however there was high variation due to the reduced sample size 
(n=11-12/performance group from N=40). The high performing group had a significant 
reduction in accuracy after 1.25mg/kg (t(10)=2.39, p=0.038), although the low performing 
group did not (t(11)=0.85, ns, Figure 6.4). There was no interaction between Dose and 
Duration for both doses and therefore accuracy was averaged across the three durations. 
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Figure 6.4 Signal trial accuracy after moderate doses of amphetamine 
Accuracy significantly improved in the low performing group after 0.75mg/kg and decreased after 1.25mg/kg 
in the high performing group (n=11-18/group). *p<0.05 for dose accuracy compared to saline. 
 
Difference scores were calculated as the change in performance after drug administration 
and correlated against baseline accuracy after saline. Pearson’s correlation found that 
baseline performance (after regression to the mean adjustment) was negatively correlated 
with the change in performance after 0.75mg/kg (r= -0.543, p=0.001, N=35; Figure 6.5A). 
However, the association with 1.25mg/kg amphetamine (r= -0.409, p=0.053, N=23) failed 
to reach significance (Figure 6.5B). 
 
Figure 6.5 Correlations between baseline accuracy and the effect of amphetamine 
There was a significant negative correlation between accuracy at baseline and the change in signal trial 
accuracy after (A) 0.75mg/kg (r= -0.5, p=0.001) amphetamine. (B) However the association with baseline 
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Performance on non-signal trials was improved by 0.75mg/kg (F(1,36)=7.6, p=0.009) but not 
by 1.25mg/kg (F(1,36)=0.68, ns). There was also a main effect of Performance group after 
0.75mg/kg (F(1,36)=8.24, p=0.007), but not after 1.25mg/kg (F(1,36)=0.24, ns). There was 
also a significant Dose x Performance group interaction (F(1,36)=4.33, p=0.045) indicating 
the performance groups differed after saline but were equivalent after 1.25mg/kg 
amphetamine in non-signal accuracy. Both 0.75mg/kg and 1.25mg/kg amphetamine 
significantly impaired performance across many measures including increased omissions 
(0.75mg/kg, F(1,36)=13.50, p=0.001; 1.25mg/kg, F(1,36)=51.74, p<0.001), increased centre 
latency (0.75mg/kg, F(1,36)=9.66, p=0.004; 1.25mg/kg, F(1,36)=35.28, p<0.001), decreased 
the number of trials initiated (0.75mg/kg, F(1,32)=9.68, p=0.004; 1.25mg/kg, F(1,36)=48.79, 
p<0.001), increased response latency (0.75mg/kg, F(1,36)=4.74, p=0.036; 1.25mg/kg, 
F(1,36)=37.59, p<0.001), decreased premature responses during the ITI (0.75mg/kg, 
F(1,36)=18.64, p<0.001; 1.25mg/kg, F(1,36)=59.01, p<0.001), and during the stimulus after 
1.25mg/kg only (0.75mg/kg, F(1,35)=0.60, ns; 1.25mg/kg, F(1,35)=29.41, p<0.001). Overall 
performance was disrupted after both doses, however this was generally dose-dependent 
with greater impairment at 1.25mg/kg than 0.75mg/kg (Table 6.2). After 1.25mg/kg the 
number of trials completed was reduced and omission rates were particularly high (25%), 
indicating rats were starting but then not completing the trial. 
Overall females made more omissions (F(1,36)=4.47, p=0.042) and a Dose x Sex interaction 
(F(1,36)=4.35, p=0.044) indicated this difference occurred after 0.75mg/kg (t(26.5)=-2.14, 
p=0.041) but not after saline (t(19)=-1.44, ns). There was no effect of Sex on omissions 
after 1.25mg/kg. Male rats initiated more trials than females after 1.25mg/kg (F(1,36)=5.97, 
p=0.020), but there was no effect of Sex after 0.75mg/kg amphetamine. There were no 
other main effects of interactions with Sex after moderate doses of amphetamine. Low and 
high performance groups did not differ on any task measure other than signal and non-
signal accuracy, confirming the groups did not differ on other aspects of task performance. 
Across all doses of amphetamine (0.1-1.25mg/kg), low and high performing groups 
responded in a pattern that reflects the inverted U-shaped relationship between dopamine 
and cognitive performance. Furthermore, the optimal level of performance differed 
between groups, producing a rightward shift in the curve for low compared to high 
performers (Figure 6.6A). These results were not due to ceiling or floor effects, as both 
groups performed worse at short durations and better at long durations compared to the 
brief durations used in these analyses (Figure 6.6B). 
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Figure 6.6 The shift in performance curve with amphetamine differs for low and high 
performing groups 
(A) The low performing group improves from saline at the lower doses, however the high performing group 
does not improve at low doses and had reduced accuracy at the highest dose. (B) Comparison of % correct 
responses for low and high performers after saline, demonstrating the brief durations (average 0.12, 0.5, 1s) 
used for analysis in this study were free from ceiling and floor effects as performance was worse on short 
(0.03s) durations and better on long (1s) durations in both groups. *p<0.05 for dose accuracy compared to 
saline. 
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Table 6.2 Behavioural measures on the SDT after amphetamine 














Baseline Saline 0.1±0.1 116.9±2.2 2.5±0.3 1.3±0.0 138.8±11.1 81.2±6.9 
        
Low 
doses 
0.1 0.1±0.1 116.5±2.5 2.5±0.4 1.3±0.0 149.4±10.7 89.3±7.3 
0.25 0.4±0.2** 115.3±2.3 3.4±0.5 1.3±0.0 131.6±10.8 80.2±7.1 
        
Moderate 
doses 
0.75 9.0±2.4** 106.3±4.0** 8.4±2.1** 1.4±0.0* 98.0±10.1** 86.7±7.9 
1.25 25.8±3.6** 80.6±5.5** 18.5±2.7** 1.7±0.1** 58.7±7.4** 49.2±6.8** 
Compared to saline treatment with paired t-test if a main effect of Dose was detected by repeated measures ANOVA, *p<0.05, **p<0.01, 
N=40 
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6.2.5 Discussion 
These results demonstrate the paradoxical and baseline-dependent effects of 
amphetamine on attention in rats. Low dose amphetamine (0.1mg/kg and 0.25mg/kg) 
enhanced accuracy, whereas the highest dose of amphetamine (1.25mg/kg) disrupted 
performance. Furthermore, it was found that cognitive improvement after amphetamine 
was dependent on baseline accuracy, which has not previously been reported in the 
literature for rats. Importantly, these dose-dependent and baseline-dependent results were 
in agreement with the inverted U-shaped response to psychostimulants observed in 
humans. 
Low dose amphetamine was predicted to enhance performance, particularly on brief signal 
durations where accuracy was challenged and not restricted by ceiling effects. Both 
0.1mg/kg and 0.25mg/kg amphetamine selectively improved accuracy on signal trials 
without altering other behavioural measures such as omissions, premature responses or 
response latency. When split based on individual baseline performance, the low 
performing group significantly improved in accuracy after low dose amphetamine, but the 
high performing group did not. Increasing the dose to 0.75mg/kg again led to an 
improvement only in the low performers. However, at the highest dose of 1.25mg/kg the 
high performing animals had a significant reduction in accuracy while the low performing 
group returned to baseline levels of performance. These results are consistent with the 
inverse U-shaped function of dopamine and cognitive performance (Cools and D'Esposito, 
2011). When comparing the effects of increasing doses of amphetamine, there was a 
rightward-shift in the inverted U-shaped performance curve from low to high performing 
groups (Figure 6.6). Furthermore, there was a significant correlation between the degree 
of improvement in performance and baseline accuracy. These results reflect the baseline-
dependent effects of psychostimulants observed in humans on attentional tasks (Koelega, 
1993; Riccio et al., 2001). Demonstrating improved performance after low dose 
amphetamine supports the predictive validity of this task and demonstrates that systemic 
amphetamine can enhance attention in adult rats (Young et al., 2009a). There are 
relatively few studies demonstrating enhancement of attention with systemic low dose 
amphetamine in rats (Grilly, 2000; Grottick and Higgins, 2002; Chudasama et al., 2005; 
Andrzejewski et al., 2014). Therefore, given the widespread use of psychostimulant agents 
in attentional disorders (Wolraich et al., 2005) and the clinical importance of predictive 
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validity in animal models (Hagan and Jones, 2005; Pratt et al., 2012), these results are 
promising and should be further explored. 
On another signal detection task, it was found that 0.25mg/kg and 0.75mg/kg, but not 
0.125mg/kg amphetamine, improved the number of correct responses in SD rats (Grilly, 
2000). This was also found on a similar sustained attention task where 0.25mg/kg but not 
0.1mg/kg improved detectability of stimulus by improving signal trial accuracy 
(Andrzejewski et al., 2014). These dose-response patterns are generally in agreement with 
the effects observed in the current study. However, neither study compared response to 
amphetamine with individual baseline performance levels. Other reports of improvement 
after amphetamine have shown the reversal of a deficit in treated animals, but no 
improvement in controls. For example, on a combined attention and memory task it was 
found that animals with a dorsal prefrontal cortical lesion experienced improvements in 
accuracy after systemic amphetamine (0.2mg/kg), however no improvement was found in 
sham animals (Chudasama et al., 2005). Using the 5CSRTT in Lister Hooded rats it was 
found that 0.1mg/kg amphetamine improved accuracy and reduced omissions in 2-year 
old, but not 1-year old rats (Grottick and Higgins, 2002). This was replicated in a separate 
study of 1-year old rats, suggesting procognitive effects could only be observed in aged 
rats (Bizarro and Stolerman, 2003). While the remediating effects may be important where 
the deficit is relevant to a specific disorder or system disturbance, amphetamine is known 
to influence human performance in healthy as well as patient populations. Therefore, 
similar actions should be expected in rodent studies using normal, healthy animals. It has 
also been shown that direct infusion of the D1 DA receptor agonist (SKF 38393) into the 
medial prefrontal cortex (Granon et al., 2000) and into the nucleus accumbens (Pezze et 
al., 2007) of Lister Hooded rats improved performance on the 5CSRTT. While these 
studies are important for investigating drug targets, they may not reflect the results of 
systemic administration in patients. Not surprisingly, parallel dosing and administration of 
cognitive enhancing agents has been highlighted as a critical step in improving the 
translation from preclinical to clinical testing (Lustig et al., 2013). Furthermore, 
understanding individual differences in response to psychostimulants will also be highly 
relevant for understanding clinical efficacy. 
Few studies have correlated changes in drug response in individual animals with baseline 
performance despite the use of this measurement in human studies (del Campo et al., 
2013; Cherkasova et al., 2014). This was highlighted by a recent study that reanalysed a 
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series of studies for individual baseline dependency of drug effects (Bickel et al., 2016). 
The authors focussed on clinical and preclinical studies using stimulants on tasks 
measuring impulsivity. Overall, they showed that drug effects were dependent on 
individual baseline impulsivity for the majority of studies, including 72% of the studies 
using amphetamine. Studies using other agents have found evidence for baseline-
dependent improvement after splitting animals in sub-groups (Mohler et al., 2010; 
Tomlinson et al., 2014). Previously, it was shown that administration of a D4 antagonist in 
rats could improve working memory performance in below average, but not above average 
individuals (Zhang et al., 2004). Furthermore, the change in performance after drug 
administration was correlated with individual baseline accuracy. Individual heterogeneity in 
drug response may also be highly informative in terms of understanding pharmacological 
action, particularly given the inverse U-shaped relationship between basal dopamine 
function and cognitive performance. Future work should now investigate individual 
differences in neurobiological measures, such as neurotransmitter levels or receptor 
density, that correlate with baseline attentional performance and psychostimulant 
response. 
Moderate doses (0.75 and 1.25mg/kg) of amphetamine dose-dependently increased 
omissions, reduced the number of trials initiated, increased response latency and 
significantly reduced accuracy in high performing animals after 1.25mg/kg amphetamine. 
These measures provide a good indication of the competing effects of amphetamine on 
cognition and general task performance at the highest dose. In agreement with these 
findings, doses from 0.5-1mg/kg have been shown to mildly increase locomotion whereas 
doses >1mg/kg induce more substantial hyperlocomotion (Grilly and Loveland, 2001). 
Changes in behavioural measures other than accuracy did not differ between the low and 
high performance groups (Appendix II), indicating cognitive performance and changes to 
general task performance may occur independently. It is important to note that ceiling and 
floor effects were minimised in this study by using accuracy at stimulus durations that 
produce sub-optimal performance, but were above chance levels of responding. 
Therefore, both low and high performing groups could perform better on longer stimulus 
durations and worse on shorter stimulus durations at all doses of amphetamine. 
In conclusion, this study reports the first demonstration of baseline-dependent attentional 
improvement in rats after systemic amphetamine, reproducing a phenomena reported in 
the human literature. Few studies have reported an improvement in rodents after low dose 
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amphetamine, despite its widespread use in ADHD treatment. This demonstration of 
baseline-dependent effects of amphetamine is reflective of the pattern observed in both 
ADHD and healthy controls, highlighting a novel tool for investigating individual differences 
in attentional performance and psychostimulant response in rodent models. Future studies 
should further investigate the neurobiological basis of the relationship between baseline 
performance and psychostimulant response, and explore the cognitive enhancing 
properties of other known and novel drugs for the treatment of attentional deficits. 
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7.1 Foreword 
The experiment in this chapter was designed to see if the amphetamine finding observed 
in Chapter 6 could be replicated. My aim was to improve the experimental design with a 
priori hypothesis that baseline performance would correlate with the degree of 
improvement after low dose amphetamine. The study used only male rats, a greater 
sample size and a Latin square within-animal design to increase power and reduce 
variability. Not only were the results replicated but I was also able to investigate 
neurochemical changes related to task performance. I found that across reduced signal 
durations, the impaired accuracy observed low performing rats was reversed by 0.1mg/kg 
amphetamine. Furthermore, across the cohort the level of improvement correlated with 
baseline performance. I was able to show for the first time that baseline performance also 
correlated with levels of dopamine (DA) and the dopaminergic metabolite, homovanillic 
acid (HVA), in the striatum, but not the PFC. Given that amphetamine is an indirect 
dopamine agonist and the relationship between dopamine and cognition is expected to 
follow an inverse U-shaped function, these results indicate a critical role for the striatum in 
understanding attentional deficits and how they may be reversed with psychostimulant 
medication.  
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7.2 Acute amphetamine administration improves attention in rats with 
low baseline performance 
Karly M. Turner, James Peak and Thomas H. J. Burne 
7.2.1 Abstract 
Background: Psychostimulants, such as amphetamine, are widely used to treat attentional 
deficits. However, few studies have demonstrated procognitive effects of amphetamine in 
rodents. In humans, response to dopaminergic medications is complex and task 
dependent with improvement often dependent on baseline performance. Here, our goal 
was to determine if poor attention in rats could be improved following low dose of 
amphetamine. We then examined the relationship between baseline performance, drug 
response and catecholamine levels in corticostriatal tissue.  
Methods: Rats performed a SDT with varying signal durations before systemic 
administration of saline, 0.1 or 0.25mg/kg amphetamine (N=18). Neurochemical analysis 
of catecholamine levels was performed on the PFC and dorsal striatum (CPU). 
Results: Reducing the signal duration impaired accuracy, providing a performance window 
in which accuracy could improve or worsen. Following 0.1mg/kg amphetamine, accuracy 
in poor performing individuals increased to that seen in high performing rats. Furthermore, 
baseline accuracy correlated negatively with the magnitude of improvement after 
amphetamine across all rats. CPU homovanillic acid (HVA) levels were increased in poor 
performers and were also negatively correlated with performance. No changes were found 
in the PFC.  
Conclusions: These results indicated poor performance was associated with greater 
response to amphetamine and altered CPU DA metabolism. In humans, response to 
amphetamine is hypothesised to occur via an inverse U-shaped relationship between 
prefrontal DA and performance. However, these results suggest the balance between 
cortical and striatal DA levels may be fundamental to explaining individual differences in 
response to psychostimulants. 
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Significance Statement 
This study examines the effect of amphetamine on attention in rodents. It was found that 
drug response was dependent on baseline performance, such that poor performing rats 
have the greatest improvement after amphetamine. We demonstrated for the first time that 
levels of a dopamine metabolite were also related to an individual’s baseline performance, 
providing an explanation for the variable action of amphetamine. These results replicate 
patterns observed in humans and indicate rats may be useful for improving our 
understanding of individual differences in attention and response to amphetamine. 
 
Submitted: In January 2016, under review at International Journal of 
Neuropsychopharmacology 
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7.2.2 Introduction 
Altered DA function in cortical and striatal brain regions have been implicated in a number 
of neuropsychiatric disorders, such as schizophrenia, Parkinson’s disease and ADHD. 
Cognitive deficits are a prominent feature of these disorders and drugs acting on 
dopaminergic pathways are often used for treatment. Therefore, it is critical to understand 
the complex relationship between DA activity in the brain, cognitive functioning and the 
effect of dopaminergic drugs. 
Psychostimulants are highly effective in the treatment of attentional deficits in ADHD, but 
are increasingly being used for performance enhancement in healthy individuals 
(Sahakian and Morein-Zamir, 2007; Greely et al., 2008; Ilieva et al., 2013). Irrespective of 
diagnosis, psychostimulants can improve performance in individuals with low baseline 
performance and an individual’s response has been linked to a range of neurological 
changes (Mattay et al., 2000; del Campo et al., 2013). Studies have focussed on the role 
of cortical and striatal brain regions, which are the likely site of neurobiological deficits and 
medication targets (Mattay et al., 2000; Crofts et al., 2001; Cools and D'Esposito, 2011; 
Klanker et al., 2013). However, response to DA agonists is paradoxical with positive and 
negative changes in cognitive performance dependent on dose and task; as well as 
individual characteristics such as baseline performance, genetics and state when tested 
(e.g. stress, tiredness) (Mattay et al., 2003). However, despite being the mainstream 
treatment for attentional deficits in humans, few studies have found that amphetamine 
improves attention in preclinical studies (Grilly et al., 1998; Grilly, 2000; Grottick and 
Higgins, 2002; Andrzejewski et al., 2014). This may be due to species-specific differences 
in drug metabolism or because the relationship between cognitive performance and DA 
function is very complex. 
Human studies demonstrate the importance of considering individual differences in 
response to pharmacological treatment (Klanker et al., 2013). For example, improvement 
after amphetamine has been shown to be dependent on baseline performance, such that 
low performers had the greatest improvement (Mattay et al., 2000; Allman et al., 2010) 
and this has also been shown for methylphenidate (Finke et al., 2010; del Campo et al., 
2013). However, rodent studies commonly compare groups of subjects, rather than taking 
advantage of the variability between individuals (Dellu-Hagedorn, 2005; Dalley et al., 
2007). It remains to be seen if individual differences in baseline attention are related to 
amphetamine-induced enhancement in rats. To enhance individual variability, it should be 
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advantageous to use an outbred strain, such as SD rats. Individual variability in SD rats 
has been used to demonstrate the relationship between working memory performance and 
response to L-745,870, a selective D4 antagonist in rats (Zhang et al., 2004); as well as 
between working memory performance and locomotor response to amphetamine (Dellu-
Hagedorn, 2005). These findings support the hypothesis that individual differences in 
baseline cognitive functioning and response to dopaminergic agents are linked. 
The aim of this study was to determine if attentional performance in rats could be 
improved with low dose amphetamine, and to examine the relationship between task 
performance, drug response and catecholamine levels in corticostriatal tissue. Firstly, it 
was hypothesised that low dose amphetamine would improve accuracy on the SDT in low 
performing rats. Secondly, it was expected that the improvement in performance would 
correlate negatively with baseline accuracy. Finally, this study examined differences in 
catecholamine levels within two task-relevant brain regions; the dorsal striatum and 
prefrontal cortex. Our results suggest that rodents can be used to investigate 
amphetamine-induced improvement in attention and striatal DA metabolism is associated 
with differences in attentional performance. 
7.2.3 Methods and Materials 
7.2.3.1 Animals and housing 
Adult 12 week old male Sprague Dawley (ARC, Australia) rats (N=18) were housed in 
pairs in a room maintained at 21±2°C and 60% humidity and on a 12-h light/dark cycle 
(lights on 0600h) in cages with a high top wire lid, aspen chip bedding, nesting and wood 
chew (Able Scientific, WA, USA). Male rats were selected as sex differences were not 
being examined in this study and males are more commonly used in similar experiments. 
Prior to training, rats were food restricted to 90% of their free-feeding body weight with free 
access to water. All procedures were performed with approval from The University of 
Queensland Animal Ethics Committee, under the guidelines of the National Health and 
Medical Research Council of Australia. 
7.2.3.2 Apparatus 
Operant rat chambers were contained in ventilated, sound attenuated boxes and all 
responding occurred on a single wall. The wall contained a central house light, signal 
display panel and nose poke port, and a food magazine on either side of the nose poke 
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port. Rats were rewarded with 45mg grain pellets (Bioserv, Frenchtown, NJ, USA) 
delivered to the food receptacle, which was equipped with a head entry detector. Prior to 
testing rats were habituated to the dimly lit testing room for 30min. The chamber was 
operated using MED-PC for Windows software and interfacing (Med Associates Inc., St. 
Albans, VT, USA). 
7.2.3.3 Protocol 
The training and testing conditions for the SDT used in this study has previously been 
described in detail, including a comparison with other rodent tasks (Turner et al., 2016). 
Briefly, training commenced with a fixed ratio schedule where every head entry into a food 
receptacle was rewarded until 50 pellets were delivered from each receptacle or after 
20min. After receiving >80 pellets on 2 days, rats were trained to nose poke an illuminated 
central aperture. After learning to nose poke to initiate trials, the SDT was implemented. In 
this protocol the trial was started by a nose poke after which a panel of 9 green LEDs 
(5mm, 80mcd, Jaycar Electronics, NSW, Australia) were either illuminated on signal trials 
or remained off on non-signal trials. Following a 1s delay, both receptacles illuminated and 
the rat needed to make a choice between left or right. Each side was paired with either 
signal or non-signal visual presentation such that the rat would receive a reward for the 
correct choice or a brief time out for the incorrect choice. Each animal experienced the 
same pairing throughout training, with half the group assigned to each combination. A 
variable inter-trial interval occurred between reward collection and nose poke initiation (1, 
2, 3s) and the session ended after 100 trials or 30min. 
7.2.3.4 Signal Duration 
By reducing the signal duration, the task difficulty was varied from near chance 
performance to very high accuracy (55-95% accuracy). Using this manipulation, 
performance could be assessed across a performance range where both ceiling and floor 
effects could be avoided. The stimulus durations used were 0.06, 0.12, 0.25, 0.5 and 1s 
with both magazines illuminating 1s after stimulus onset. The sessions consisted of 120 
trials broken into three blocks. During the first 20 trials and last 20 trials of the session the 
standard signal (1s) and non-signal (0s) trials were presented equally. The reduced signal 
durations occurred in the central block of 80 trials with 20 non-signal (0s) and 15 trials for 
each of the reduced signal durations (0.06, 0.12, 0.25, 0.5; total 60 trials). Rats were 
familiar with responding equally to both receptacle sides and using this adjusted ratio 
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accommodates for the increased erroneous non-signal selection at very low signal 
durations (unpublished pilot study). Rats were trained on the signal duration manipulation 
for a minimum of 15 sessions to ensure performance had plateaued. 
7.2.3.5 Pharmacology 
All rats were treated with d-amphetamine (0.1mg/kg and 0.25 mg/kg) or saline according 
to a Latin-square design balanced for performance prior to drug. d-amphetamine (Sigma-
Aldrich, St. Louis, MO, USA) was diluted in 0.9% saline and given i.p. at 1ml/kg, 20min 
prior to operant testing. Prior to pharmacology experiments, rats were habituated to the 
injection procedure over 13 consecutive days to reduce stress and variability in responding 
during the drug schedule. 
7.2.3.6 Neurochemistry 
After testing was completed rats were housed without testing for a minimum of 12 weeks 
before being euthanised with an overdose of Lethabarb (Virbac Pty. Ltd., Australia). Micro-
dissection of brain regions was rapidly performed and sections were immediately frozen in 
liquid nitrogen (Heffner et al., 1980). Criteria for obtaining brain regions was based on 
Paxinos and Watson (2005) with the PFC consisting of the PrL and IL regions and the 
CPU consisting of the region labelled CPu. Neurotransmitter analysis was conducted by 
high performance liquid chromatography (HPLC) to measure DA, dihydroxyphenyl acetic 
acid (DOPAC), HVA and noradrenaline (NA) against the internal standard 
deoxyepinephrine (DE). Tissue was prepared for HPLC analysis by sonication in ice cold 
0.1M perchloric acid containing 50ng/ml DE before centrifuging samples at 13000rpm for 
5min at 4°C. After filtering (0.22µm, 4mm), 20ul of supernatant was loaded for a 10µl 
injection on the HPLC. An isocratic pump, degasser and autosampler (Model 1100, Agilent 
Technologies, Inc., CA) were connected to a Sunfire C18 4.6mm x 100mm x 5um column 
(Waters Corporation, MA) maintained at 30°C and followed by a Coulochem III 
electrochemical detector (ESA Laboratories, Inc., MA, USA). A guard cell (Model 5020) 
and analytic cell (Model 5014B) were operated at -150 and +300mV (ESA Laboratories, 
Inc., MA, USA). The mobile phase consisted of 75mM monosodium phosphate, 1.4mM 
octane sulfonic acid and 1mM EDTA adjusted to pH 4.13 with phosphoric acid, before 
adjusting to 12% acetonitrile. Flow rate was 1ml/min with a run time of 10 minutes. Analyte 
concentrations were determined by calculating peak area relative to internal standard and 
a standard curve using ChemStation software (Agilent Technologies, Inc., CA). 
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7.2.3.7 Statistical Analysis and Calculations 
Previously, it was found that the procognitive effects of low dose amphetamine were 
dependent on baseline performance and therefore drug response was compared between 
low and high performance groups (Turner et al, unpublished). The number of animals used 
was determined by a power analysis using these previous results. A median split (at 80% 
accuracy) from baseline performance was used to allocate rats into low (n=8) and high 
(n=10) performance groups. Repeated measures ANOVA was used to compare groups 
across signal durations at baseline and after amphetamine. Following this performance 
groups were compared using independent t-tests and paired t-test were used to compare 
measures within groups. Bonferroni adjustment for multiple comparisons was used where 
appropriate. 
A previous study has shown a negative correlation between baseline performance and 
improvement after low dose amphetamine (Mattay et al., 2000). Because this finding 
would be supported by regression to the mean effects, baseline accuracy values were 
subjected to a normalisation adjustment. The following formula was used (Finke et al., 
2010): 
Equation 7.1 Regression to the mean adjustment: 
 
Adjusted baseline, x’ = initial baseline score, x + (1-retest reliability, rxx)* 
(mean of total sample, mu – baseline score, x)  
Reliability was calculated by correlating accuracy after vehicle treatment within the Latin 
square design and after vehicle treatment at the end of the drug schedule (Pearson’s 
correlation, r=0.817). To assess relative improvement in accuracy, a difference score was 
calculated by subtracting accuracy after vehicle from accuracy after amphetamine. All data 
were analysed using SPSS software package (ver.20, SPSS Inc. IL, USA). Significance 
was set at p<0.05 and all data are presented as mean ± S.E.M, *p<0.05. 
7.2.4 Results 
Accuracy in response to 0.5s and 1.0s stimuli was very high (90%) and appeared to 
plateau due to ceiling effects, but was reduced with brief signal durations (Figure 7.1A). 
There was a main effect of duration after vehicle treatment (F(3.6,64)=18.59, p<0.001) and a 
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significant difference in accuracy between low and high performers across all durations as 
expected (F(1,16)=42.51, p<0.001, Figure 7.1B). 
 
Figure 7.1 Manipulating accuracy by reducing signal duration 
(A) Decreasing signal duration led to a reduction in accuracy on the SDT where 50% is chance accuracy 
(N=18). (B) There was a significant difference between low and high performance groups (n=8-10) across all 
signal durations, ***p<0.001. 
 
7.2.4.1 Pharmacology 
A repeated measures ANOVA with 3 drug levels (vehicle, 0.1, 0.25 mg/kg), 5 durations 
(0.06s, 0.12s, 0.25, 0.5, 1s) and a between subjects factor of performance group found a 
main effect of duration (F(4,64)=51.99, p<0.001), performance group (F(1,16)=17.21, p=0.001) 
and a drug x performance group interaction (F(2,32)=7.98, p=0.002). As there was no 
interaction with duration, accuracy across the five signal durations was averaged for each 
individual. Using the average accuracy across durations, independent t-tests revealed that 
the difference between performance groups was present after vehicle (t(16)=-6.52, 
p<0.001), absent after 0.1mg/kg (t(16)=-1.35, p=0.195, Figure 7.2A) but not 0.25mg/kg 
amphetamine (t(16)=-3.08, p=0.007, Figure 7.2A). Paired samples t-tests found that the low 
performing group significantly improved after 0.1mg/kg (t(7)=-3.07, p=0.018) but not 
0.25mg/kg amphetamine (t(9)=-1.56, p=0.163). The average accuracy of the high 
performing was not significantly different after either dose. When compared using a 
difference score (accuracy after amphetamine – accuracy after vehicle) the groups varied 
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in response to 0.1mg/kg amphetamine (t(16)=3.67, p=0.002, Figure 7.2B) and 0.25mg/kg 
amphetamine (t(16)=2.16, p=0.046, Figure 7.2B). 
 
Figure 7.2 Performance accuracy after amphetamine 
(A) The reduced accuracy observed in the low performing group after vehicle was corrected by 0.1mg/kg 
amphetamine (Amph), but not by 0.25mg/kg amphetamine. (B) A difference score was calculated to 
compare accuracy after vehicle and amphetamine, demonstrating a significant difference between low and 
high performing rats in response to 0.1mg/kg amphetamine and 0.25mg/kg amphetamine (n=8-10), *p<0.05. 
 
Next the relationship between baseline performance level and response to amphetamine 
was analysed. A significant negative correlation was observed for 0.1mg/kg (r=-0.764, 
p<0.001) but not 0.25mg/kg amphetamine (r=-0.336, p=0.173). Because the relationship 
was negative, scores were adjusted for regression to the mean effects. The adjusted 
baseline score was also significantly correlated with the recalculated difference score after 
0.1mg/kg (r=-0.763, p<0.001, N=18, Figure 7.3A) but not after 0.25mg/kg amphetamine. 
There were no significant differences between groups or with the administration of 
amphetamine with respect to non-signal accuracy, response latency, latency to initiate 
trials, or the number of additional head entries made during the session. At the conclusion 
of the drug schedule, all rats were treated with vehicle and tested again. There was a 
significant difference in accuracy between performance groups (t(16)=-2.71, p=0.015) and a 
strong correlation between testing days (r=0.817, p<0.001), demonstrating stability of the 
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Figure 7.3 Correlations with baseline performance and response to amphetamine 
After adjustment for regression to the mean effects response to amphetamine was found to negatively 
correlate with baseline performance after (A) 0.1mg/kg amphetamine (r= -0.763, p<0.001) but not (B) 
0.25mg/kg amphetamine (r= -0.336, p=0.173), (N=18). 
 
7.2.4.2 Neurochemistry 
Low performers had significantly higher striatal HVA levels than high performing rats 
(t(16)=3.26, p=0.005, Figure 7.4F) with a subsequent increase in the ratio of HVA to 3MT 
(t(16)=2.14, p=0.048). Furthermore, a significant negative correlation was found between 
baseline accuracy and striatal HVA levels (r=-0.494, p=0.037, N=18, Figure 7.5A) and a 
negative non-significant relationship was found for striatal DA levels (r=-0.455, p=0.058, 
N=18, Figure 7.5B). There were no other differences found between performance group 
measures in the PFC or CPU levels of noradrenaline, dopamine or metabolites (Figure 
7.4).  
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Figure 7.4 Catecholamine levels 
(A, C, E, G) There were no detectable differences in the PFC. (B, D, F, H). However, low performing rats had 
significantly more homovanillic acid (HVA) in the CPU (n=9), *p<0.05. Dopamine (DA), dihydroxyphenyl 
acetic acid (DOPAC), noradrenaline (NA).  
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Figure 7.5 Correlations with baseline performance and neurochemistry 
Baseline performance accuracy was found to negatively correlate with striatal (CPU) levels of (A) 
homovanillic acid (HVA) (r= -0.49, p=0.037) and (B) dopamine were not significantly correlated but showed a 
trend in the same direction (DA) (r= -0.46, p=0.058), (N=18). 
 
7.2.5 Discussion 
The major findings from this study were that (1) attention was improved in low performing 
animals using low dose amphetamine; (2) baseline performance correlated with the 
magnitude of improvement after amphetamine; and (3) HVA levels in the striatum were 
higher in low performing rats with the concentration correlating with baseline performance. 
Only a few studies have demonstrated the effects of amphetamine on attention are 
dependent on baseline performance in rats. Furthermore, we found that individual 
differences in baseline attentional performance were related to DA metabolism in the 
striatum, but not the prefrontal cortex. These findings are significant as they demonstrate 
that individual differences in attention and response to amphetamine, as well as the 
dopaminergic mechanism underpinning this relationship, can be modelled in rats. 
Studies investigating attentional processing in adult rats using the 5CSRTT have mostly 
demonstrated accuracy is unaffected by low doses of amphetamine (<1.0mg/kg) (Cole and 
Robbins, 1987; Bizarro and Stolerman, 2003; Baarendse and Vanderschuren, 2012) but 
see (Grottick and Higgins, 2002; Bizarro et al., 2004). Using signal detection tasks, 
amphetamine has been shown to impair performance (McGaughy and Sarter, 1995a; 
Paolone et al., 2013) or improve accuracy (Grilly, 2000). Previous studies using low dose 
amphetamine in rodents have produced mixed results, however our findings support the 
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procognitive effects observed on signal detection tasks at reduced stimulus durations 
(Andrzejewski et al., 2014). Steps were taken in both the present study and Andrzejewski 
et al. (2014) to improve stability of performance and reduce injection-related stress. Both 
studies also used decreasing signal durations that minimised ceiling and floor effects. By 
manipulating task difficulty, accuracy could be used to assess drug effects on challenging 
trials where performance could be improved or further impaired. However, a unique 
consideration in our study was determining how individual responses differed with respect 
to their baseline performance. 
The investigation of individual differences is imperative given that the effects of 
psychostimulants have been shown to depend on baseline performance in humans. 
Typically, poor performing individuals have the greatest improvement after 
psychostimulants (Mattay et al., 2000; Finke et al., 2010; Ilieva et al., 2013). Therefore, 
finding the same pattern in the current study supports the validity of using animal models 
to understand the mechanisms of psychostimulant action on attention. However, few 
studies have explored whether the effects of amphetamine are related to baseline 
performance accuracy in rodents. Paterson et al. (2011) examined the effect of 
amphetamine (0.1-1.0mg/kg) on 5CSRTT performance in rats selected for sub-optimal 
performance (<75% accuracy) but did not find accuracy was improved. Individual 
differences in response to methylphenidate were noted on a working memory task, 
whereby performance was optimised at different doses, but not explored further (Arnsten 
and Dudley, 2005). One of the few reports investigating individual differences in rodents 
found baseline working memory performance was correlated with response to L-745,870, 
a selective D4 antagonist (Zhang et al., 2004). Together with our data, these previous 
studies indicate there is sufficient variation in SD rats to measure individual differences in 
cognition and pharmacological response. The need for analysis of individual difference in 
stimulant response was recently highlighted by Bickel et al. (2016). They reanalysed data 
from preclinical and clinical studies investigating correlations between individual baseline 
impulsivity and psychostimulant response. They found a significant relationship in the 
majority of studies using amphetamine (72%). Although it remains to be seen if the same 
effects would be observed for attentional measures, the current study provides evidence 
for the baseline dependence of amphetamine action on attention in rodents. Many rodent 
studies thus far have not consider individual differences in response to drug and in 
addition to using a dose with a small effect size, this may in part explain the inconsistent 
results for low dose amphetamine. 
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We next examined catecholamine levels in brain regions relevant to task performance to 
explore the neurobiological differences between individuals. It was predicted that DA 
levels in the striatum and prefrontal cortex would be altered. Although there were no 
changes in the PFC, striatal levels of the final DA metabolite, HVA, were greater in the low 
performing individuals. This finding may be due to overall greater DA production or 
increased turnover. Given, there was a trend towards higher, rather than lower, DA levels 
in the striatum of poor performing animals, we would speculate that greater DA production 
might be increasing HVA levels. Although this hypothesis would require further testing as 
there was not a significant relationship between striatal dopamine and baseline 
performance. This finding is in agreement with studies demonstrating that in children with 
ADHD, greater behavioural response to amphetamine was correlated with higher levels of 
CSF HVA (Castellanos et al., 1996). 
Although it was predicted from the inverted U-shaped relationship between DA and 
cognitive performance that individuals responding positively to amphetamine should have 
low DA levels at baseline, this is likely to depend on many factors including brain region of 
interest, DA D1/D2 receptor activation and task features (Floresco, 2013; Klanker et al., 
2013). For example, it has been suggested that DA may have opposing roles in the 
striatum and prefrontal cortex in terms of modulating behavioural flexibility and stability 
(Cools and D'Esposito, 2011). The balance between these functions would then depend 
on the task. For example, greater cognitive flexibility may improve attentional set shifting 
performance but lead to distraction in a sustained attention task. It has been suggested 
that the balance between striatal and cortical dopaminergic activity regulates these 
cognitive functions, such that relatively high DA levels in the prefrontal cortex promotes 
stability whereas relatively high DA levels in the striatum promote flexibility. In healthy 
people, amphetamine-induced improvement on a switching task was not only dependent 
on baseline performance, but also on DA release in the caudate where greater 
enhancement of performance was associated with greater DA release (Samanez-Larkin et 
al., 2013). Samanez-Larkin et al. (2013) provide evidence in humans that higher DA levels 
in the striatum lead to increased behavioural flexibility. Furthermore, del Campo et al. 
(2013) found that irrespective of ADHD diagnosis, deficits in sustained attention were 
related to reduced D2/D3 binding potential in the caudate. In addition Clatworthy et al. 
(2009) have demonstrated a relationship between DA binding potential in the striatum, 
cognitive performance on different tasks and response to methylphenidate. These findings 
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further implicate striatal DA in baseline cognitive performance and in relation to 
psychostimulant-induced improvement. 
Corticostriatal regions are proposed to operate in a complimentary yet competitive fashion 
(Crofts et al., 2001). In marmosets it has been shown that a reduction in prefrontal 
catecholamine levels (via 6-hydroxydopamine (6-OHDA) lesioning) leads to increased DA 
release in the striatum (Roberts et al., 1994). Furthermore, it was shown that depleting DA 
in the frontal cortex impaired visual discrimination acquisition and increased distraction, 
whereas DA depletion in the striatum resulted in less distraction compared to controls 
(Crofts et al., 2001). These results support the hypothesis that DA in the frontal cortex 
drives cognitive stability and striatal DA increases flexibility/distractibility. These results can 
be extended to explain the outcomes of the current study where low performance was 
associated with higher DA levels in the striatum, which would promote flexibility at the 
expense of greater distractibility. In rats it was shown that low dose psychostimulants 
preferentially act in the PFC and that working memory was improved by the local 
administration of methylphenidate in the PFC but not the dorsal striatum despite both 
regions being essential for task performance (Berridge et al., 2006; Cools and D'Esposito, 
2011; Spencer et al., 2012; Schmeichel and Berridge, 2013). Therefore, it could be 
expected that in this study low doses of amphetamine would act to a greater extent, 
although not exclusively, within the PFC to modulate performance. Therefore, we 
speculate that low performance may be remedied by amphetamine via increases in 
cortical DA level. This may shift the balance between striatal and cortical DA such that 
cognitive stability was restored and the rat performed better on a task requiring attention 
(Cools and D'Esposito, 2011). It should be noted that there were no associations between 
PFC DA levels and task performance. In addition, catecholamine levels were measured 
post mortem and the dynamic changes that occur with amphetamine administration and 
during task performance were not directly measured in this study. This hypothesis could 
be tested in future experiments using an in vivo recording technique, such as 
microdialysis, during drug and task administration. 
The results of this study could be extended by also comparing performance on a task 
requiring behavioural flexibility. Low dose amphetamine has been shown to impair reversal 
learning in rats (Idris et al., 2005), and it would be powerful to show opposing task-related 
effects within the same individuals. In addition, future studies could infuse specific 
dopamine-altering drugs into the PFC or CPU to further test the hypotheses generated 
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from this study. This study only included male SD rats and it would be valuable to 
ascertain whether the same pattern of drug response holds true in female subjects (given 
the potential role of oestrogen in modulating dopamine functions) and other rat strains. 
When differences in drug response are observable in individuals from the same cohort, it 
would be expected that the use of different strains, ages or genders would also lead to 
some variation in drug response patterns. 
Human studies have indicated an effect of amphetamine on reaction time, however in this 
experiment rats were not encouraged to respond as fast as possible. There was a 1s 
delay from stimulus onset until a response could be made to prevent ‘guessing’ behaviour 
in rats. Although reaction time can be an important measure in human tasks in terms of 
speed/accuracy trade off costs this task was optimised to train rats for accurate 
responding rather than speed of responding. There were no motoric effects seen at these 
low doses of amphetamine. These results are testament to the stability of performance 
generated prior to drug administration and the absence of non-cognitive side effects that 
are associated with higher doses of amphetamine. 
7.2.6 Conclusions 
Cognitive deficits related to dysfunction of corticostriatal catecholamine activity have been 
found in a variety of neuropsychiatric disorders including schizophrenia, ADHD, OCD and 
Parkinson’s disease. However, studies exploring the role of DA in cognitive functioning 
have produced paradoxical findings with both increasing and decreasing levels of DA 
improving or impairing performance on different tasks. Here we demonstrate on the SDT 
that poor attentional performance can be improved by low dose amphetamine in rats. 
Furthermore, the degree of amphetamine-induced improvement was associated with 
baseline performance levels across the cohort, which has not previously been reported in 
rodents. Finally, we were able to extend these findings to show that individual differences 
in baseline performance correlate with DA metabolism in the striatum, but not the PFC. 
From these results we propose that high baseline levels of striatal DA production may be 
counteracted by low dose amphetamine treatment, possibly via increased cortical DA 
levels. Low dose psychostimulants have been shown to act preferentially in cortical 
regions and an increase in cortical DA relative to striatal DA would promote stability of task 
representation and reduce distractibility. This study provides new evidence to suggest that 
the balance between cortical and striatal DA levels is central to understanding individual 
differences in attention and response to psychostimulant drugs. Future studies should 
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utilise animal models to further understand how corticostriatal functions differ in individuals 
during task performance, after administration of psychostimulants and characterise the 
dynamic interaction between drug and task-related activation. 
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8.1 Introduction 
Cognitive deficits are a core, but non-diagnostic feature of schizophrenia (Keefe and 
Fenton, 2007). The severity of cognitive symptoms is independent of psychotic symptoms; 
they are common among patients and occur in some first-degree relatives without a 
schizophrenia diagnosis (Green et al., 2004b; Keefe and Fenton, 2007). Treatment for 
cognitive deficits has largely been ineffective despite a surge in research and these 
symptoms being linked to functional outcomes in patients (Green et al., 2000; Hyman and 
Fenton, 2003). Furthermore, newer second-generation antipsychotics are no more 
efficacious than older first-generation treatments in the management of neurocognitive 
deficits in schizophrenia (Keefe et al., 2007). Around 10 years ago the MATRICS consortia 
established recommendations based on prior studies for researchers and the 
pharmaceutical industry to improve treatment research and drug development (Green and 
Nuechterlein, 2004; Marder and Fenton, 2004). Seven separate cognitive domains were 
identified as being disrupted in schizophrenia, however not all can be tested in preclinical 
animal studies. Those determined to be appropriate for animal studies were working 
memory, speed of processing and attention/vigilance (Nuechterlein et al., 2005). For the 
domain of attention/vigilance, CPT-like tasks were suggested as providing a translatable 
platform for preclinical testing (Nuechterlein et al., 2005). From this panel it was concluded 
that: 
“A high priority was recommended for research to identify parallel animal and human 
cognitive paradigms that would allow the prediction of human pharmacological response 
from animal pharmacological response within the same domain.” page 873, (Nuechterlein 
et al., 2005). 
To achieve this goal, preclinical paradigms need to be further developed to improve the 
translatability of findings (Young et al., 2009a; Hyman, 2014). Therefore, the aim of this 
thesis was to design and construct a novel task for measuring attention in rodent models. 
To improve translatability, features of the human CPT were incorporated. The overarching 
goal was to develop a task with face, construct and predictive validity for detecting 
attentional deficits in rodent models, particularly for detecting procognitive effects of drugs. 
There are significant differences between rodent and human testing, however not all of 
these differences can be easily addressed. Rodents require training, whereas humans can 
be provided instructions. The provision of rewards and motivation to perform a task may 
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differ substantially between species. There are also significant differences in the visual 
abilities of humans and rodents. Although these factors (and many others) are important to 
consider, the primary goal was to measure attention. Paying attention in human studies 
typically requires a subject to sit in front of a screen to monitor and respond to stimuli. 
However, in a rodent operant chamber, the rat can freely move around and perform a 
variety of behaviours during stimulus presentation and fixation on the stimulus is lost. 
My primary goal was to develop a task that measured attention in rats with parallels to 
human CPT testing. The task was designed based on elements of tasks already used by 
the field, particularly other signal detection tasks. However some key changes were made 
to improve translatability. The SDT was designed with standard commercially available 
operant chambers with all equipment located on a single wall. Previously rodents had 
been observed to engage in alternative behaviours such as grooming, exploring the 
chamber and even sleeping during operant testing. It was decided that rats should be 
freely moving within the chambers to reduce stress and allow measurement of response 
times without restriction on mobility. Thus to encourage engagement in the task, all 
equipment used in the SDT was mounted on a single wall. This was done to reduce 
ambulation and support the rat staying within the vicinity of the stimulus and response 
receptacles. 
A custom-made stimulus panel was used to present stimuli. However after using many 
stimuli variations it was found that detection, rather than discrimination, could be achieved 
more consistently and acquired more rapidly by SD rats. In addition the reward delivery 
was also located on the same chamber wall to reduce the likelihood of the rodent turning 
away from the stimulus panel. This also promoted rapid trial pace, as minimal movement 
was required. This is in contrast to the traditional arrangement of the 5CSRTT and dSAT 
where the reward is delivered on the opposite wall to the stimulus and leads to lapping 
behaviour within the chamber (McGaughy and Sarter, 1995b; Arnold et al., 2003; Bari et 
al., 2008). Separating the response and reward locations can serve a purpose, for 
example to allow measurement of reward latency, however it appeared to interfere with 
continuous task performance, which was deemed a higher priority in this study. Thirdly, the 
use of the central nose poke was critical to task design and sets the SDT apart from other 
rodent tasks. The self-initiation of trials ensures the rat is motivated to complete the trial 
and aids the reduction of omissions. This is critical because omissions may be due to a 
number of reasons in rodents, such as grooming or exploring the chamber. Omissions 
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typically increase with drug administration and it can be difficult to determine whether the 
impairment is due poor motoric or cognitive functioning. However, the issue I wanted to 
address is the lack of attention/vigilance during omissions. If the rat is performing an 
alternative behaviour, it is not likely to be focussed on the task. Reduced omission rate in 
combination with a fast trial rate, provides an indication of continuous task engagement by 
rats on the SDT. 
The self-initiating nose poke location was directly beneath the stimulus panel to ensure the 
rat is located directly in front of the stimulus during the presentation window. Without head 
fixing or physically restraining the rat, this feature of the SDT can control the body position 
of the rat at stimulus onset, which has not previously been used in rodent studies using 
5CSRTT or dSAT. This was particularly important given the stimulus was visual and body 
position would alter the detectability and accuracy of decision-making. In comparison to 
the human CPT where chin rests, eye tracking and fixation points may be used to reduce 
variation in responding due to shifting position, this element was used to improve the 
translational validity of the SDT. Finally, the timing of events was reduced to promote rapid 
trial pace and reduce alternative behaviours, such as grooming and exploring. This also 
contributed to reducing daily testing duration and may have supported swift task 
acquisition. 
When visually monitoring the rodent performance, it was observed that the rat was 
positioned in front of the stimulus when it was presented and rarely moved away from the 
active chamber wall. By minimising the need for ambulation across the chamber, as 
occurs in the 5CSRTT and dSAT, the rat can pay attention to the stimulus panel and 
rapidly perform trials in a continuous manner comparable to human CPT performance. 
This rapid responding appears to be much more similar to human computer-based testing. 
Rats would continue to respond until all trials were completed, often without breaking. This 
led to a self-directed inter-stimulus interval of around 6.4s (compared to 12.7s on 
5CSRTT), where human CPT’s are fixed and between 0.5s-2s. This demonstrates that 
rats are capable of, and willing to, perform in a fast and continuous manner. The response 
and reward have been spatially combined, which prevents the recording of reward latency. 
However, human CPT subjects would be likely to experience ‘reward’ when they make 
their selection and as they are not normally required to physically collect a reward, there is 
no measure of reward latency. Overall these changes have resulted in a task that can be 
rapidly acquired, with virtually no omissions, a fast trial pace and high level of accuracy. 
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These changes may seem incremental, however the overall effect is rats performing trials 
very rapidly (hence the short session duration), with negligible numbers of omissions 
(<0.5%) and rats appear to be paying attention in a more continuous manner. Ultimately, 
the purpose of these changes is to improve the validity of the task for measuring attention 
in rodents. It was predicted that by making the task more similar to the way testing is 
conducted in humans, that the results from rodent studies should be more translatable. To 
test this idea, I performed a series of experiments using different manipulations that were 
known to alter attentional performance. Here they will be discussed in terms of how these 
results address the issues of task validity. 
8.2 Validation of the SDT 
Validation is frequently considered across three separate areas; face, construct and 
predictive validity (Young et al., 2009a; Young and Geyer, 2015). Face validity is 
determined by the degree to which the condition appears similar between rodents and 
humans. In terms of cognitive task development, this has been used to describe common 
features of task performance between species and is useful to consider during initial task 
development. Construct validity is arguably the most important as it determines the 
specificity of the task to measure the cognitive process it was proposed to measure. 
Predictive validity refers to the ability of the task to provide an outcome that would be 
predicted by prior knowledge or results. In this context, we would expect the same result in 
rodents and humans. Perhaps most critically, predictive validity determines the ability of a 
pharmacological agent to affect task performance thus potentially identifying medications 
that will be useful for treating cognitive deficits. Experiments addressing these forms of 
validation are discussed below. 
Face Validity: Does the SDT appear to measure attention in a similar way to the human 
CPT? 
Face validity was carefully considered throughout task design and development. There are 
already a number of rodent tasks that were designed to replicate features of the human 
CPT, including the 5CSRTT, 5C-CPT and SAT (McGaughy and Sarter, 1995b; Bari et al., 
2008; Young et al., 2009b). There are also many variants of the human CPT; therefore 
features common to many variants were used for rodent task development. I decided to 
use a signal detection task as it has many parallel features in comparison with the human 
CPT. In the human CPT, a single stream of stimuli are presented and the subject must 
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remember a rule about the type of stimuli to respond appropriately. On a rodent signal 
detection task, trials of present or absent stimuli are presented and the rat must also 
remember a rule about how to respond correctly. However, in previous versions of the 
rodent task, the rat must move from the stimulus to the opposing wall to collect a reward 
after each correct trial. This diverts the rat’s attention away from the stimulus wall and can 
result in distraction as observed by initiation of alternative behaviours. As a consequence, 
the scoring of omissions in rodents is not the same as the interpretation of an omission in 
human testing. Omissions in humans are likely to occur due to a lapse in concentration, 
however in rodents it may occur because they were performing another action, such as 
grooming or exploring the chamber. At face level changes such as controlling body 
position and increasing trial rate, have resulted in a task where the rodent attends to 
stimuli and responds rapidly with few breaks. There is limited ambulation required and 
rodents rarely make omissions. Although these protocol changes may appear minor, they 
have a significant overall effect on the rat’s behaviour, as evidenced by the results in 
Chapter 3. Therefore, it was concluded that the SDT has improved face validity for 
measuring attention in a similar manner to the human CPT. 
At this point it is important to note that there was no inhibitory component incorporated in 
the rodent SDT, despite inclusion in many versions of the human CPT. Inhibitory control is 
an important component of cognitive deficits in many disorders and has been extensively 
studied. Within this study, faster responding was prioritised over a measure of inhibition. 
There are other rodent tasks that excel in measuring impulsive behaviours (including the 
5CSRTT, stop signal reaction time task and delay discounting). Although impulsivity is 
linked to attention, it is not strictly used as a measure of attention and therefore was not 
incorporated into the SDT. It could be included, for example by delaying responding and 
punishing premature head entries into the magazines; however this would significantly 
slow trial rate and may increase task disengagement and omissions. In addition, response 
times are not as informative in the rodent SDT as they are in the human CPT. When rats 
were allowed to respond immediately with stimulus presentation, they were found to 
impulsively guess. With a 50% chance of reward and the fast trial rate, many did not learn 
to associate the stimuli and response side. By imposing a 1 second delay on responding, 
they slow their responses and learn the contingency. Although they are not responding as 
fast as possible, assessing the rat’s ability to make the correct decision was deemed more 
important. In human testing, this response may be more comparable performance where 
the instruction is to maintain accuracy rather than speed. 
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Construct Validity: Does the SDT measure attention? 
Determining a method for measuring attention and confirming the task is measuring 
attention is not as simple as it may seem. Generally, both the human CPT and rodent 
equivalent tasks are said to measure ‘sustained attention’, which may be observed by a 
reduction in accuracy over time. However, satiation levels also influence motivation when 
using food rewards in rodents and lead to a reduction in accuracy over time. The task also 
relies on both perceptual and attentional capacity of the rat. The concepts are tightly 
interconnected and it is experimentally difficult to measure either ability without influence 
of the other. Therefore, experiments will aim to test stimuli within the perceptual limits of 
the rat, but use manipulations that challenge attentional demands. Rather than aiming to 
measure a specific type of attention, the goal was to measure the same form of attention 
as the human CPT. Hence, the assessment of construct validity relied on manipulations 
with a known effect on attentional performance in humans and rodents. For example, 
performance was impaired by reducing the signal duration or by including distracting 
stimuli. Both these manipulations have been used in rodent and human studies (Riccio et 
al., 2002; Bari et al., 2008; Demeter et al., 2013). In addition, performance on the SDT was 
directly compared to performance on the 5CSRTT (Chapter 3), one of the most well 
validated tasks for measuring attention in rodents (Robbins, 2002). Furthermore, the 
importance of the PFC in maintaining attention during distraction was demonstrated 
(Chapter 5). Together these findings indicate that the construct of attention can be 
measured and manipulated using the SDT. 
Predictive Validity: Does performance on the SDT reflect the outcomes demonstrated in 
humans on measures of attention? 
This question was addressed by investigating the influence of genetics and environmental 
factors and through pharmacology experiments. Firstly, it is known that genetic and 
environmental factors influence a range of cognitive outcomes, as well as being involved 
in the development of numerous neuropsychiatric disorders. While the complex interplay 
of genetic and environmental factors experienced by humans is not easily replicated in 
rodents, it is well known that different strains and housing conditions alter behavioural 
phenotypes. Therefore, it was predicted that the SDT would detect differences between 
strain and housing conditions (Chapter 4). This study found that genetic and 
environmental factors have an influence on cognitive performance that can be measured 
with the SDT. 
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A key feature of predictive validity for tasks used in preclinical animal models is the ability 
to predict drug response in humans. However, there is a lack of benchmark drugs to 
determine task sensitivity because there are no effective medications for the treatment of 
cognitive deficits in schizophrenia. To determine if the SDT could detect procognitive drug 
effects, I used low dose amphetamine as it is widely used in the treatment of attentional 
deficits in ADHD (Chapter 6). This study found that low-dose amphetamine significantly 
improved performance in rats, indicating the potential of the SDT for detecting procognitive 
effects. Furthermore, efficacy was baseline-dependent as has been found in human 
studies. These outcomes were replicated in a second study where the findings were 
extended to reveal a relationship between striatal DA metabolism and baseline 
performance (Chapter 7). These results are highly relevant to the inverted U-shaped 
relationship between cognition and DA that has been hypothesised from human and non-
human primate studies. Overall, these results support the predictive validity of the SDT, 
indicating this task may be sensitive to detecting the procognitive effects of medications. 
Task development 
From a practical perspective there were also a number of goals set in terms of improving 
feasibility for researchers using operant testing paradigms in rodent models. The time 
required for training animals repeatedly for weeks or months makes these studies 
expensive and unfeasible for many researchers. Therefore, I wanted to develop a task that 
could be acquired relatively quickly and required minimal time per session to encourage 
higher throughput. This goal was achieved and is demonstrated by the rapid training and 
testing times presented in Chapter 3 when the SDT was compared to a traditional task for 
measuring attention, the 5CSRTT. In comparison to another rodent signal detection task, 
the SAT, the SDT also required considerably less training time. The SAT is reported to 
require 4-8 months when training 5-6 days per week, equating to around 80-200 sessions 
(Arnold et al., 2003). This is substantially longer than the 12-27 sessions required for 
training rats on the SDT in Chapter 3, although stability requirements were not matched. In 
addition, session duration on the SDT is under 15min, while on 5CSRTT it was >20min 
and is reported as >30min for SAT. With a limited number of chambers, more sessions 
and therefore more rats can be tested in a day using the SDT. This may be an important 
constraint to studies incorporating multiple groups where sufficient numbers are needed to 
attain statistical power. In addition, the use of such tasks in preclinical drug studies has 
been limited due to the extensive investment required. In practice, the changes 
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implemented in the SDT make it more accessible to researchers constrained by limited 
time, funding or access to operant chamber facilities. Ultimately the quality of the 
experimental design and selection of the most appropriate task are paramount, however to 
improve uptake and make this type of research more feasible, consideration must be given 
to the investment of time and money required. 
8.3 Implications of findings 
Firstly, the results of this thesis demonstrate that even subtle changes to protocol design 
can have a significant impact on cognitive performance outcomes and an animal’s ability 
to acquire a task. Secondly, genetic and environmental factors are important in 
determining a rodent’s behavioural phenotype and cognitive performance. This study 
highlights the importance of describing home cage details in rodent studies as minor 
differences, such as the inclusion of shelter, may influence behavioural traits. Thirdly, 
repeated operant testing commonly leads to habitual responding, which may be related 
more strongly to striatal functioning and is often desirable when stable performance is 
needed (such as within-animal drug studies). However, manipulations may be needed to 
reinvigorate the activity of passive cognitive circuitry and increase task demands. Finally, 
the importance of considering individual differences was addressed. It is likely that 
individual characteristics are an important determinant of cognitive performance and drug 
response. When examining drug effects, using a cohort mean value may wash out effects 
due to non-responders or potentially opposing effects in different individuals. By 
considering baseline performance when analysing performance after drug administration, 
a more accurate picture of drug efficacy may be evident. In addition, these studies may 
reveal important neurobiological alterations between individuals relating to their cognitive 
performance and drug response. Studies of this nature parsing responders from non-
responders may prove useful given the non-responsive nature of many patients to certain 
medications. Alternative medications may be better suited to certain sub-groups of 
individuals based on performance characteristics, however preclinical studies are typically 
designed to measure group effects rather than stratifying cohorts. This may be a fruitful 
avenue for future research, not just for psychostimulant treatment of attention deficits, but 
across many cognitive domains and drug classes. 
 
In addition, this thesis contributes to the field in a number of ways. Having established the 
validity of the SDT, this task could be used by researchers to investigate attentional 
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deficits in a range of animal models relevant to neuropsychiatric disorders. The results 
presented in Chapter 6 and Chapter 7 demonstrates the SDT is well suited to measuring 
procognitive effects of the psychostimulant, amphetamine. Therefore, the SDT is a prime 
candidate for screening other drugs with similar action, such as methylphenidate or 
atomoxetine, and potentially for discovering novel agents. Much of the literature aiming to 
understand the neurobiological mechanisms of psychostimulant effects on attention have 
relied on imaging studies in humans. Using the SDT, a more comprehensive assessment 
of molecular factors related to attention can now be made in rodents. This may lead to 
new insights into the physical manifestation of attentional deficits and how different risk 
factors are responsible for the development of attentional disorders. When compared to 
other available tasks, there are similarities and contrasts in protocol design, however few 
studies have demonstrated improved in attention in rats after amphetamine. Predictive 
validity is potentially the most valuable asset for a preclinical task and this finding suggests 
the SDT may provide a novel read-out for screening procognitive compounds. 
 
These results also provide evidence for the use of rodent models to investigate cognitive 
deficits relevant to neuropsychiatric disorders. Rodent models are beneficial as they allow 
the experimenter to control for many extraneous factors. Also the potential to use more 
invasive techniques will allow questions to be addressed that cannot easily be undertaken 
in human studies. Humans and rodents can be compared across many behavioural and 
cognitive domains; however it is their shared neuroanatomical function and response to 
pharmaceuticals that further validates the use of rodents for investigating brain disorders 
(Young et al., 2009a). Rodent models allow invasive manipulations of different brain 
regions, genetic manipulations and probing circuitry functions. Although some questions 
will be limited when comparing rodent and human cognition, this model provides a 
‘simpler’ brain for asking questions about fundamental shared functions, such as attention.  
Other benefits of using rodent models include the cost of housing, ease of breeding and 
continuous technical advances that provide new tools for probing brain functions (such as 
optogenetic approaches, genetic sequencing and advances in imaging). To improve 
treatment outcomes for patients we need successful clinical trials, which in many cases 
are preceded by preclinical animal studies. Therefore, we need preclinical tasks to indicate 
which treatment targets are potentially useful and to reject those that will be ineffective. 
The SDT was designed to provide a new tool for this purpose. Having shown that the SDT 
can detect the procognitive effects of a drug that improves attention in humans, it is hoped 
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this task can be used to screen new compounds. As attentional deficits occur in a number 
of neuropsychiatric disorders, the discovery of novel drug targets may lead to new 
treatments for disorders such as schizophrenia, ADHD and dementia. 
The momentum for this project originated in the need for better treatments for cognitive 
deficits in schizophrenia. The main purpose was to develop a tool that could be used to 
screen novel compounds and investigate animal models relevant to schizophrenia. This 
thesis covers the first steps in this process by selecting a task that is sensitive to cognitive 
deficits in schizophrenia and developing a similar paradigm in rats. This was followed by a 
series of experiments to characterise the effect of core manipulations, such as genetic, 
environmental and pharmacological interventions. Although the primary purpose of this 
task was for the assessment of cognitive deficits relevant to schizophrenia, the SDT may 
be used to measure attentional processing in a number of disorders, just like the human 
CPT. 
8.4 Limitations 
In considering the richness of cognitive functioning in both rodents and humans it is clear 
that no single task can be used to measure ‘cognitive deficits’. In fact, a single task cannot 
fully evaluate the scope of a single domain such as ‘attention’. Each task is better 
considered as a single tool among a large suite of tasks, where researchers can select the 
most appropriate tool for the question at hand. The use of several tasks will be especially 
necessary to unpick and elucidate the nature of mild cognitive deficits. For this reason, the 
use of a battery of tasks is often suggested. The changes made to increase throughput on 
the SDT will aid the use of this task in such batteries. However, the investment required for 
a thorough examination of cognitive function should be far more beneficial in the long-term 
than the use of simple, stand-alone tasks that may not accurately measure cognitive 
performance. 
Compared to other tasks that measure attention, the SDT presents stimuli in a predictable 
location and with a certain degree of temporal certainty. This has allowed a fast 
presentation rate, but limits the requirement for attention to be maintained over spatial 
locations or durations when the stimulus may appear unpredictably. This has been a 
trade-off in moving the task from humans to rodents. If the stimulus is spatially/temporally 
unpredictable, the trial rate is slower and the animal may not be engaged in the task 
consistently across trials. This is not a major problem in humans as they can follow 
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instructions to stay on task. Alternatively, if the stimuli are presented with 
spatially/temporally predictability, the rat can perform with an increased trial rate and will 
stay engaged in the task for longer. Uncertainty is used to drive the ‘sustained’ component 
of sustained attention. However, in my experience, rodents take breaks in these 
conditions. Allowing the rat to set the task pace results in faster trial pace and more 
consistency in task engagement. Therefore, their behaviour appears more similar to the 
sort of responding observed in humans on the CPT. In addition, a detection paradigm was 
used rather than requiring discrimination between visual stimuli or requiring working 
memory. However, these adaptations could be made to the SDT if required. For example, 
a delay could be imposed between stimulus presentation and the ability to make a 
response to measure short-term memory. 
There are still significant inherent differences in the assessment of attention in rodents in 
comparison to human tasks. In contrast to human CPT testing, rodents cannot be 
instructed on how to perform a task. In addition, they have relatively poor visual acuity 
compared to the more advanced visual system in humans. And although human subjects 
may be motivated to perform a task for a variety of reasons (course credit, money, 
psychological assessment), rodents must be rewarded throughout the session and are 
typically further motivated by food restriction. In addition, the visual system is poorly 
developed in rodents compared to humans. However, processing of visual information by 
the primary visual cortex may be relatively similar between species. Whether the simple 
stimuli used in the SDT requires processing in the primary visual cortex was not directly 
tested. These differences cannot easily be modified (if at all), but must be considered 
when comparing rodent and human testing. Rats and mice also differ somewhat in their 
preferred testing conditions. Nose poking was selected as the response action for the SDT 
as both mice and rats are more willing and learn to nose poke faster than lever press. In a 
study separate from this thesis, we have used the SDT in two strains of mice with very few 
changes. In addition, we have begun piloting a reverse translational SDT in humans. This 
will allow the translational testing of the SDT across mice, rats and humans. 
It should be noted that performance on the SDT could be measured using signal detection 
theory indices. There are four response options: hit (correct signal trial), correct rejection 
(correct non-signal trial), false alarm (incorrect signal trial) and miss (incorrect non-signal 
trial). Therefore, the probability of a hit or false alarm can be derived, along with additional 
measures of detection sensitivity (d’) and response bias (β). Some of the results from this 
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thesis were analysed using this method, however the interpretations and conclusions were 
the same as when using % correct for signal and non-signal trials. Results have generally 
been presented using % correct as these results are suitable for the main objective of 
each chapter and provide consistency throughout the thesis. However in future studies 
signal detection theory outcomes may be more informative where either a response bias 
or sensitivity differences are expected. 
When comparisons were made between 5CSRTT and the SDT, there were a number of 
factors that could have altered task acquisition and performance. These include the 
number of training steps required, trial rate, luminance of the light stimuli, the predictability 
of the stimulus location/timing and the number of response options. The purpose of the 
comparison in this thesis was to assess differences in the standard versions of each task. 
However, it would be interesting to test each of these components separately to determine 
which has the greatest impact on the measures that differed between tasks.   
The majority of studies were performed in male SD rats, although females and LE rats 
were included in some studies. The majority of measures were the same for female and 
male rats, as observed in Chapter 6. Subtle sex differences were only observed after 
amphetamine administration and this may be due to differences in drug metabolism 
kinetics. In some models, females may be of greater interest than males and my results 
indicate the SDT would be a suitable task for measuring attention in both male and female 
rats. Unfortunately, the source of LE rats was closed during my PhD candidature, 
preventing selection of this strain for subsequent studies. This strain is commonly used in 
behavioural studies and it would be interesting to see what the effects of amphetamine are 
on attention in LE or other rat strains. This thesis demonstrates some key findings using 
the SDT covering a range of research topics. From these studies, there are a number of 
future directions that could be explored. 
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8.5 Future directions 
 Cross-species translation: The translation of this task in mice and humans would 
be useful to directly address the translational validity of the SDT. In collaboration 
with other researchers, such studies have commenced and initial results in both 
humans and mice has been promising. Future comparative research could 
investigate similarities and differences in performance between species. 
 Animal models of neuropsychiatric disorders: In addition, the SDT can now be 
applied to other animal models of schizophrenia or attentional deficits. For example 
models in which genes (such as COMT or DISC1) are known to produce cognitive 
deficits. Additionally adverse environmental exposures (chronic social stress model) 
could be examined. It would be particularly interesting to assess animal models that 
have previously been tested using the 5CSRTT or SAT to compare attentional 
deficits across these tasks. It is expected that like the human CPT, deficits on the 
SDT would not be disease specific but the task should be sensitive to detect deficits 
in a range of animal models with cognitive dysfunction. Therefore, animal models 
from a wide range of neuropsychiatric disorders, such as dementia, depression, 
traumatic brain injury or ADHD, could be examined using the SDT. 
 Pharmacology studies: When considering the importance of developing better 
therapeutics, the SDT may be most useful for improving our understanding of the 
procognitive actions of psychostimulants on attention. In schizophrenia patients, 
procognitive treatments would be provided chronically and in combination with 
antipsychotic medications. Therefore, it would be beneficial to also investigate the 
chronic administration of low dose amphetamine, and the effects of co-treatment 
with antipsychotic drugs. Other drugs used to improve cognitive performance could 
also be tested, such as modafinil, methylphenidate and atomoxetine. 
 Mechanism of action: The amphetamine results in Chapters 6 and 7 have not 
been previously reported and suggest much could be learnt about the neurobiology 
of individual differences in attentional performance and how this is associated with 
psychostimulant response in rodents. Future research should focus on functional 
assessment of neurotransmitter release or neural activity during task performance 
and after systemic drug administration in low and high performing individuals. 
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8.6 Conclusion 
In conclusion, the work presented in this thesis provides a unique way to assess 
attentional performance in rodents, and to preclinically screen drugs to improve cognitive 
impairments in disorders such as schizophrenia. Through a diverse series of experiments 
the face, construct and predictive validity of the SDT has been measured. Important 
factors in cognitive performance, such as genetic, environmental, neurobiological and 
pharmacological perturbations have been used to demonstrate the utility of the SDT. 
Critically, the SDT has demonstrated reliable predictive validity for the procognitive effects 
of a low dose psychostimulant on attention. This task may now be used for future studies 
exploring attentional deficits in animal models relevant to a wide range of neuropsychiatric 
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Supplementary Table 6.1. Same as previous but split for performance group although there was no main effect or interaction with 
Performance group for any of these measures to justify independent group t-tests. 
 Low Performers High Performers 
 Baseline Low Doses Moderate Doses Baseline Low Doses Moderate Doses 
Measure 0 0.1 0.25 0.75 1.25 0 0.1 0.25 0.75 1.25 
% Omissions 0.2±0.-2 0.1±0.1 0.5±0.3 9.2±4.2 22.0±5.0 0±0 0.1±0.1 0.3±0.2 8.7±2.6 29.6±5.2 
# Trials Initiated 113.8±4.2 112.9±4.8 114.3±3.8 106.2±5.8 84.4±8.3 120±0 120±0 116.3±2.6 106.5±5.7 76.8±7.3 
Centre Lat (s) 2.6±0.5 3.0±0.8 3.7±0.9 8.8±3.7 16.8±3.7 2.4±0.4 2.1±0.3 3.1±0.6 8.0±2.2 20.3±4.0 
Response Lat (s) 1.3±0.0 1.3±0.0 1.3±0.0 1.4±0.0 1.7±0.1 1.3±0.0 1.3±0.0 1.3±0.0 1.4±0.0 1.7±0.1 
Premature 
responses ITI 





82.6±11.0 87.8±11.7 84.6±10.5 96.0±12.2 63.0±11.0 79.7±8.5 90.9±9.1 75.9±9.7 77.4±10.0 35.4±6.8 
 
 
